[
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_a050271.html",
    "subject": "Lysis of Epidural Adhesions",
    "document_number": "SURG.00072",
    "publish_date": "04/10/2024",
    "status": "Reviewed",
    "last_review_date": "02/15/2024",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>Lysis of epidural adhesions by any means, including but not limited to, use of hypertonic saline injections, mechanical catheter manipulation, hyaluronidase, whether done with or without steroids or analgesics, is considered <strong>investigational and not medically necessary</strong><strong>.</strong></p>",
    "content": "Investigational and Not Medically Necessary:\nLysis of epidural adhesions by any means, including but not limited to, use of hypertonic saline injections, mechanical catheter manipulation, hyaluronidase, whether done with or without steroids or analgesics, is considered investigational and not medically necessary.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Lysis of epidural adhesions by any means",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Lysis of epidural adhesions by any means, including but not limited to, use of hypertonic saline injections, mechanical catheter manipulation, hyaluronidase, whether done with or without steroids or analgesics, is considered investigational and not medically necessary.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 987,
          "prompt_tokens": 875,
          "completion_tokens": 112,
          "total_cost": 0.0060550000000000005,
          "processing_time": 2.2484312057495117
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_c108473.html",
    "subject": "Artificial Retinal Devices",
    "document_number": "SURG.00113",
    "publish_date": "04/10/2024",
    "status": "Reviewed",
    "last_review_date": "02/15/2024",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>The use of artificial retinal devices is considered <strong>investigational and not medically necessary</strong> for all indications.</p>",
    "content": "Investigational and Not Medically Necessary:\nThe use of artificial retinal devices is considered investigational and not medically necessary for all indications.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Artificial Retinal Devices",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "The use of artificial retinal devices is considered investigational and not medically necessary for all indications.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 909,
          "prompt_tokens": 839,
          "completion_tokens": 70,
          "total_cost": 0.005245,
          "processing_time": 2.931264877319336
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_c171884.html",
    "subject": "Intraoperative Assessment of Surgical Margins During Breast-Conserving Surgery with Radiofrequency Spectroscopy or Optical Coherence Tomography",
    "document_number": "SURG.00139",
    "publish_date": "04/10/2024",
    "status": "Reviewed",
    "last_review_date": "02/15/2024",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>The use of radiofrequency spectroscopy or optical coherence tomography for intraoperative assessment of surgical margins during breast-conserving surgery is considered <strong>investigational and not medically necessary.</strong></p>",
    "content": "Investigational and Not Medically Necessary:\nThe use of radiofrequency spectroscopy or optical coherence tomography for intraoperative assessment of surgical margins during breast-conserving surgery is considered investigational and not medically necessary.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Use of radiofrequency spectroscopy or optical coherence tomography for intraoperative assessment of surgical margins during breast-conserving surgery",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "The use of radiofrequency spectroscopy or optical coherence tomography for intraoperative assessment of surgical margins during breast-conserving surgery is considered investigational and not medically necessary.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 955,
          "prompt_tokens": 853,
          "completion_tokens": 102,
          "total_cost": 0.005795,
          "processing_time": 2.2838070392608643
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_c155965.html",
    "subject": "Renal Sympathetic Nerve Ablation",
    "document_number": "SURG.00135",
    "publish_date": "04/10/2024",
    "status": "Revised",
    "last_review_date": "02/15/2024",
    "html_content": "<p><strong>Investigational and Not edically Necessary:</strong></p>\n<p>Ablation of the renal sympathetic nerves is considered <strong>investigational and not medically necessary </strong>for all indications.</p>",
    "content": "Investigational and Not edically Necessary:\nAblation of the renal sympathetic nerves is considered investigational and not medically necessary for all indications.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Ablation of the renal sympathetic nerves",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Ablation of the renal sympathetic nerves is considered investigational and not medically necessary for all indications.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 917,
          "prompt_tokens": 841,
          "completion_tokens": 76,
          "total_cost": 0.005344999999999999,
          "processing_time": 1.7413108348846436
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_d090901.html",
    "subject": "Wireless Left Ventricular Pacing for Cardiac Resynchronization Therapy",
    "document_number": "SURG.00152",
    "publish_date": "04/10/2024",
    "status": "Revised",
    "last_review_date": "02/15/2024",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>Wireless left ventricular pacing for CRT is considered <strong>investigational and not medically necessary</strong> for all indications, including heart failure.</p>",
    "content": "Investigational and Not Medically Necessary:\nWireless left ventricular pacing for CRT is considered investigational and not medically necessary for all indications, including heart failure.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Wireless left ventricular pacing for CRT",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Wireless left ventricular pacing for CRT is considered investigational and not medically necessary for all indications, including heart failure.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 919,
          "prompt_tokens": 843,
          "completion_tokens": 76,
          "total_cost": 0.005355,
          "processing_time": 2.356287956237793
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_a053512.html",
    "subject": "Surgical and Ablative Treatments for Chronic Headaches",
    "document_number": "SURG.00096",
    "publish_date": "04/10/2024",
    "status": "Reviewed",
    "last_review_date": "02/15/2024",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>Surgical treatment for chronic headaches (including but not limited to chronic migraine headache and chronic tension type headache) is considered <strong>investigational and not medically necessary.</strong> This includes, but is not limited to, the following procedures:</p>\n<ul>\t<li>Resection of musculature, including but not limited to the corrugator supercilii muscle, or any soft tissue from the forehead, periorbital, occipital or other facial or scalp areas; <strong>or</strong></li>\t<li>Manipulation or repositioning of any muscle or other soft tissue within these areas; <strong>or </strong></li>\t<li>Resection of any portion of the trigeminal nerve or its branches; <strong>or</strong></li>\t<li>Closure of patent foramen ovale.</li></ul>\n<li>Resection of musculature, including but not limited to the corrugator supercilii muscle, or any soft tissue from the forehead, periorbital, occipital or other facial or scalp areas; <strong>or</strong></li>\n<li>Manipulation or repositioning of any muscle or other soft tissue within these areas; <strong>or </strong></li>\n<li>Resection of any portion of the trigeminal nerve or its branches; <strong>or</strong></li>\n<li>Closure of patent foramen ovale.</li>\n<p>Surgical and ablative treatments of occipital neuralgia are considered <strong>investigational and not medically necessary.</strong> This includes, but is not limited to, the following procedures for treatment of occipital neuralgia:</p>\n<ul>\t<li>Thermal neurolysis (thermal and cryodenervation);</li>\t<li>Neuroplasty;</li>\t<li>Decompression of the occipital nerves;</li>\t<li>Resection or partial resection of muscle or tissue.</li></ul>\n<li>Thermal neurolysis (thermal and cryodenervation);</li>\n<li>Neuroplasty;</li>\n<li>Decompression of the occipital nerves;</li>\n<li>Resection or partial resection of muscle or tissue.</li>",
    "content": "Investigational and Not Medically Necessary:\nSurgical treatment for chronic headaches (including but not limited to chronic migraine headache and chronic tension type headache) is considered investigational and not medically necessary. This includes, but is not limited to, the following procedures:\n<ul> <li>Resection of musculature, including but not limited to the corrugator supercilii muscle, or any soft tissue from the forehead, periorbital, occipital or other facial or scalp areas; or</li> <li>Manipulation or repositioning of any muscle or other soft tissue within these areas; or </li> <li>Resection of any portion of the trigeminal nerve or its branches; or</li> <li>Closure of patent foramen ovale.</li></ul>\n<li>Resection of musculature, including but not limited to the corrugator supercilii muscle, or any soft tissue from the forehead, periorbital, occipital or other facial or scalp areas; or</li>\n<li>Manipulation or repositioning of any muscle or other soft tissue within these areas; or </li>\n<li>Resection of any portion of the trigeminal nerve or its branches; or</li>\n<li>Closure of patent foramen ovale.</li>\nSurgical and ablative treatments of occipital neuralgia are considered investigational and not medically necessary. This includes, but is not limited to, the following procedures for treatment of occipital neuralgia:\n<ul> <li>Thermal neurolysis (thermal and cryodenervation);</li> <li>Neuroplasty;</li> <li>Decompression of the occipital nerves;</li> <li>Resection or partial resection of muscle or tissue.</li></ul>\n<li>Thermal neurolysis (thermal and cryodenervation);</li>\n<li>Neuroplasty;</li>\n<li>Decompression of the occipital nerves;</li>\n<li>Resection or partial resection of muscle or tissue.</li>",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Surgical treatment for chronic headaches",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Surgical treatment for chronic headaches (including but not limited to chronic migraine headache and chronic tension type headache) is considered investigational and not medically necessary. This includes, but is not limited to, the following procedures:",
            "conditions": {
              "ANY": [
                {
                  "desc": "Resection of musculature, including but not limited to the corrugator supercilii muscle, or any soft tissue from the forehead, periorbital, occipital or other facial or scalp areas",
                  "conditions": null
                },
                {
                  "desc": "Manipulation or repositioning of any muscle or other soft tissue within these areas",
                  "conditions": null
                },
                {
                  "desc": "Resection of any portion of the trigeminal nerve or its branches",
                  "conditions": null
                },
                {
                  "desc": "Closure of patent foramen ovale",
                  "conditions": null
                }
              ]
            }
          },
          {
            "medical_act": "Surgical and ablative treatments of occipital neuralgia",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Surgical and ablative treatments of occipital neuralgia are considered investigational and not medically necessary. This includes, but is not limited to, the following procedures for treatment of occipital neuralgia:",
            "conditions": {
              "ANY": [
                {
                  "desc": "Thermal neurolysis (thermal and cryodenervation)",
                  "conditions": null
                },
                {
                  "desc": "Neuroplasty",
                  "conditions": null
                },
                {
                  "desc": "Decompression of the occipital nerves",
                  "conditions": null
                },
                {
                  "desc": "Resection or partial resection of muscle or tissue",
                  "conditions": null
                }
              ]
            }
          }
        ],
        "usage": {
          "total_tokens": 1662,
          "prompt_tokens": 1238,
          "completion_tokens": 424,
          "total_cost": 0.012549999999999999,
          "processing_time": 11.589536905288696
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_a053826.html",
    "subject": "Mechanical Circulatory Assist Devices (Ventricular Assist Devices, Percutaneous Ventricular Assist Devices and Artificial Hearts)",
    "document_number": "SURG.00145",
    "publish_date": "04/10/2024",
    "status": "Revised",
    "last_review_date": "02/15/2024",
    "html_content": "<p><strong>I. <em>Ventricular Assist Devices (VADs) including Left, Right and Biventricular Assist Devices (Adult)</em></strong></p>\n<p><strong>&nbsp; </strong><strong>Medically Necessary:</strong></p>\n<li>U.S. Food and Drug Administration (FDA) approved ventricular assist devices (VADs)*, used in accordance with FDA approval, are considered <strong>medically necessary </strong>as a <em>bridge to heart transplant</em> for individuals when <strong>all</strong> of the following criteria have been met:\t<ol>\t\t<li>Have severe end stage heart failure; <strong>and</strong></li>\t\t<li>Are not expected to survive until a donor heart can be obtained; <strong>and</strong></li>\t\t<li>When <strong>one</strong> of the following criteria has been met:\t\t<ol start=\"1\" style=\"list-style-type:lower-alpha\">\t\t\t<li>Currently listed as a heart transplant candidate; <strong>or</strong></li>\t\t\t<li>Undergoing evaluation to determine candidacy for heart transplant.</li>\t\t</ol>\t\t</li>\t</ol>\t</li>\n<li>Have severe end stage heart failure; <strong>and</strong></li>\n<li>Are not expected to survive until a donor heart can be obtained; <strong>and</strong></li>\n<li>When <strong>one</strong> of the following criteria has been met:\t\t<ol start=\"1\" style=\"list-style-type:lower-alpha\">\t\t\t<li>Currently listed as a heart transplant candidate; <strong>or</strong></li>\t\t\t<li>Undergoing evaluation to determine candidacy for heart transplant.</li>\t\t</ol>\t\t</li>\n<li>Currently listed as a heart transplant candidate; <strong>or</strong></li>\n<li>Undergoing evaluation to determine candidacy for heart transplant.</li>\n<li>FDA approved VADs*, used in accordance with FDA approval, are considered <strong>medically necessary </strong>in the <em>post-cardiotomy setting</em> as a means of myocardial recovery support for individuals who are unable to be weaned off cardiopulmonary bypass.</li>\n<li>FDA approved VADs*, used in accordance with FDA approval, are considered <strong>medically necessary</strong> when used as a <em>permanent alternative (destination therapy)</em> to heart transplantation for an individual when <strong>all</strong> of the following criteria have been met:\t<ol>\t\t<li>Was evaluated and determined not to be eligible for a heart transplant; <strong>and</strong></li>\t\t<li>Has documented Class III or IV New York Heart Association (NYHA) end stage left ventricular heart failure; <strong>and</strong></li>\t\t<li>Has received optimal medical management, for at least 45 of the last 60 days or the individual\u2019s survival is in jeopardy; <strong>and</strong></li>\t\t<li>Has a life expectancy of less than 2 years due to heart disease.</li>\t</ol>\t</li>\n<li>Was evaluated and determined not to be eligible for a heart transplant; <strong>and</strong></li>\n<li>Has documented Class III or IV New York Heart Association (NYHA) end stage left ventricular heart failure; <strong>and</strong></li>\n<li>Has received optimal medical management, for at least 45 of the last 60 days or the individual\u2019s survival is in jeopardy; <strong>and</strong></li>\n<li>Has a life expectancy of less than 2 years due to heart disease.</li>\n<p><strong>*Note: </strong>Please refer to the background section of the document for a list of FDA approved VADs.</p>\n<p><strong>Not Medically Necessary:</strong></p>\n<p>VADs are considered <strong>not medically necessary </strong>when the medically necessary criteria above are not met and for all other indications.</p>\n<p><strong>II. <em>Ventricular Assist Devices (Pediatric)</em></strong></p>\n<p><strong>Medically Necessary:</strong></p>\n<p>FDA approved VADs appropriate for pediatrics, including humanitarian device approvals, used in accordance with FDA approval, are considered <strong>medically necessary</strong> for use in children when <strong>all</strong> of the following criteria have been met:</p>\n<li>Child has documented end-stage left ventricular or biventricular failure; <strong>and</strong></li>\n<li>Pediatric appropriate VAD* (based on FDA approved use) will be used; and meets <em>either</em> criteria (1) or (2) below:\t<ol>\t\t<li>Until a donor heart can be obtained; <strong>or</strong></li>\t\t<li>When used as a <em>permanent alternative (destination therapy)</em> in children who have been evaluated and determined not to be eligible for a heart transplant.</li>\t</ol>\t</li>\n<li>Until a donor heart can be obtained; <strong>or</strong></li>\n<li>When used as a <em>permanent alternative (destination therapy)</em> in children who have been evaluated and determined not to be eligible for a heart transplant.</li>\n<p>*Current FDA approved ventricular assist devices appropriate for pediatrics:</p>\n<li>Child under age 5: the Berlin Heart EXCOR<sup>\u00ae</sup> Pediatric Ventricular Assist Device (severe isolated left ventricular or biventricular dysfunction); <strong>or</strong></li>\n<li>Child between ages 5 and 16: either the HeartAssist<sup>\u00ae</sup>5 Pediatric Ventricular Assist Device or the Berlin Heart EXCOR Pediatric Ventricular Assist Device (severe isolated left ventricular or biventricular dysfunction); <strong>or</strong></li>\n<li>Child with body surface area (BSA) greater than or equal to 1.0 meter squared (m<sup>2</sup>): The HeartMate\u2122 3 Left Ventricular Assist System (FDA approved as bridge to transplant <strong>or</strong> <em>destination therapy</em> without a specific age requirement and this may be used in pediatric populations).</li>\n<p><strong>Not Medically Necessary:</strong></p>\n<p>Pediatric VADs are considered <strong>not medically necessary</strong> in children when the medically necessary criteria above are not met and for all other indications.</p>\n<p><strong>III.<em> Percutaneous Ventricular Assist Devices (pVADs)</em></strong></p>\n<p><strong>Medically Necessary:</strong></p>\n<p>FDA approved pVADs*, used in accordance with FDA approval are considered <strong>medically necessary</strong> for the treatment of individuals with cardiogenic shock when the following criteria are met (A and B):</p>\n<li>Either of the following criteria are met (1 or 2):\t<ol>\t\t<li>Treatment is intended as an alternative to, or concomitant therapy with, extracorporeal membrane oxygenation (ECMO); <strong>or </strong></li>\t\t<li>Optimal medical management and conventional treatment measures (that is, volume loading and use of pressors and inotropes) have failed to provide sufficient improvement; <strong>and</strong></li>\t</ol>\t</li>\n<li>Treatment is intended as an alternative to, or concomitant therapy with, extracorporeal membrane oxygenation (ECMO); <strong>or </strong></li>\n<li>Optimal medical management and conventional treatment measures (that is, volume loading and use of pressors and inotropes) have failed to provide sufficient improvement; <strong>and</strong></li>\n<li>Individual is suspected to have a reversible cardiac injury and does not have irreversible end-organ injury including renal, hepatic or neurologic systems (care is not felt to be futile).</li>\n<p><strong>*Note: </strong>Please refer to the background section of the document for a list of FDA approved pVADs.</p>\n<p><strong>Not Medically Necessary:</strong></p>\n<p>The use of pVADs is considered <strong>not medically necessary</strong> when the medically necessary criteria above are not met, and for all other indications.</p>\n<p><strong>IV.<em> Artificial Heart Systems</em></strong></p>\n<p><strong>Medically Necessary:</strong></p>\n<p>The SynCardia temporary Total Artificial Heart (TAH-t), used in accordance with FDA approval, is considered <strong>medically necessary</strong> as a bridge to heart transplantation for individuals who have no other reasonable medical or surgical treatment options, who are ineligible for other univentricular or biventricular support devices, and who meet <strong>all</strong> of the following criteria:</p>\n<li>Eligible for heart transplantation; <strong>and</strong></li>\n<li>Listed for heart transplantation and in imminent danger of dying within 48 hours or becoming ineligible for transplant; <strong>and</strong></li>\n<li>NYHA Functional Class IV; <strong>and</strong></li>\n<li>Presence of biventricular failure and rapid decompensation; <strong>and</strong></li>\n<li>Unavailability of heart donor and likelihood that condition will deteriorate before donor can be identified; <strong>and</strong></li>\n<li>Body surface area 1.7-2.5 m\u00b2*, <strong>or</strong> have a distance between the sternum and the 10th anterior vertebral body measured by computed tomography imaging (CT scan) greater than or equal to 10 cm (See asterisk below for factors that may allow an exception to this criteria.); <strong>and</strong></li>\n<li>Absence of active systemic infection; <strong>and</strong></li>\n<li>Absence of irreversible organ dysfunction; <strong>and</strong></li>\n<li>Serum Creatinine less than 5 mg/dl; <strong>and</strong></li>\n<li>Total Bilirubin less than 5 mg/dl; <strong>and</strong></li>\n<li>Pulmonary Vascular Resistance less than 8 Wood units; <strong>and</strong></li>\n<li>Unresponsive to optimal medical therapy; <strong>and</strong></li>\n<li>Presence of hemodynamic insufficiency demonstrated by Society for Cardiovascular Angiography and Interventions (SCAI) Shock stage class D or E.</li>\n<p><strong>Not</strong><strong> Medically Necessary:</strong></p>\n<p>The SynCardia temporary Total Artificial Heart (TAH-t) is considered <strong>not medically necessary </strong>when the medically necessary criteria above are not met, and<strong> </strong>for all other indications.</p>\n<p>All other artificial heart systems are considered <strong>not medically necessary </strong>for all indications.</p>\n<p><strong>*Note:</strong> The proper functioning of the implanted SynCardia TAH-t can be impaired in smaller individuals, that is, those with a body surface area of less than 1.7 m\u00b2 and a heart size less than or equal to 1500 cc, or whose anteroposterior diameter from the sternum inner table to the anterior vertebral body is less than 10 cm. In these cases, the implanted device may compress the inferior vena cava or the pulmonary veins. If an individual has a body size area less than 1.7 m\u00b2, implantation of a TAH may still be possible if the presence of cardiomegaly allows for sufficient space for device placement.<br><strong>Note:</strong> In general age greater than or equal to 18 years and less than or equal to 59 years is a relative indication.</p>",
    "content": "I. Ventricular Assist Devices (VADs) including Left, Right and Biventricular Assist Devices (Adult)\n\u00a0 Medically Necessary:\n<li>U.S. Food and Drug Administration (FDA) approved ventricular assist devices (VADs)*, used in accordance with FDA approval, are considered medically necessary as a bridge to heart transplant for individuals when all of the following criteria have been met:\t<ol> <li>Have severe end stage heart failure; and</li> <li>Are not expected to survive until a donor heart can be obtained; and</li> <li>When one of the following criteria has been met:\t\t<ol start=\"1\" style=\"list-style-type:lower-alpha\"> <li>Currently listed as a heart transplant candidate; or</li> <li>Undergoing evaluation to determine candidacy for heart transplant.</li> </ol> </li> </ol> </li>\n<li>Have severe end stage heart failure; and</li>\n<li>Are not expected to survive until a donor heart can be obtained; and</li>\n<li>When one of the following criteria has been met:\t\t<ol start=\"1\" style=\"list-style-type:lower-alpha\"> <li>Currently listed as a heart transplant candidate; or</li> <li>Undergoing evaluation to determine candidacy for heart transplant.</li> </ol> </li>\n<li>Currently listed as a heart transplant candidate; or</li>\n<li>Undergoing evaluation to determine candidacy for heart transplant.</li>\n<li>FDA approved VADs*, used in accordance with FDA approval, are considered medically necessary in the post-cardiotomy setting as a means of myocardial recovery support for individuals who are unable to be weaned off cardiopulmonary bypass.</li>\n<li>FDA approved VADs*, used in accordance with FDA approval, are considered medically necessary when used as a permanent alternative (destination therapy) to heart transplantation for an individual when all of the following criteria have been met:\t<ol> <li>Was evaluated and determined not to be eligible for a heart transplant; and</li> <li>Has documented Class III or IV New York Heart Association (NYHA) end stage left ventricular heart failure; and</li> <li>Has received optimal medical management, for at least 45 of the last 60 days or the individual\u2019s survival is in jeopardy; and</li> <li>Has a life expectancy of less than 2 years due to heart disease.</li> </ol> </li>\n<li>Was evaluated and determined not to be eligible for a heart transplant; and</li>\n<li>Has documented Class III or IV New York Heart Association (NYHA) end stage left ventricular heart failure; and</li>\n<li>Has received optimal medical management, for at least 45 of the last 60 days or the individual\u2019s survival is in jeopardy; and</li>\n<li>Has a life expectancy of less than 2 years due to heart disease.</li>\n*Note: Please refer to the background section of the document for a list of FDA approved VADs.\nNot Medically Necessary:\nVADs are considered not medically necessary when the medically necessary criteria above are not met and for all other indications.\nII. Ventricular Assist Devices (Pediatric)\nMedically Necessary:\nFDA approved VADs appropriate for pediatrics, including humanitarian device approvals, used in accordance with FDA approval, are considered medically necessary for use in children when all of the following criteria have been met:\n<li>Child has documented end-stage left ventricular or biventricular failure; and</li>\n<li>Pediatric appropriate VAD* (based on FDA approved use) will be used; and meets either criteria (1) or (2) below:\t<ol> <li>Until a donor heart can be obtained; or</li> <li>When used as a permanent alternative (destination therapy) in children who have been evaluated and determined not to be eligible for a heart transplant.</li> </ol> </li>\n<li>Until a donor heart can be obtained; or</li>\n<li>When used as a permanent alternative (destination therapy) in children who have been evaluated and determined not to be eligible for a heart transplant.</li>\n*Current FDA approved ventricular assist devices appropriate for pediatrics:\n<li>Child under age 5: the Berlin Heart EXCOR<sup>\u00ae</sup> Pediatric Ventricular Assist Device (severe isolated left ventricular or biventricular dysfunction); or</li>\n<li>Child between ages 5 and 16: either the HeartAssist<sup>\u00ae</sup>5 Pediatric Ventricular Assist Device or the Berlin Heart EXCOR Pediatric Ventricular Assist Device (severe isolated left ventricular or biventricular dysfunction); or</li>\n<li>Child with body surface area (BSA) greater than or equal to 1.0 meter squared (m<sup>2</sup>): The HeartMate\u2122 3 Left Ventricular Assist System (FDA approved as bridge to transplant or destination therapy without a specific age requirement and this may be used in pediatric populations).</li>\nNot Medically Necessary:\nPediatric VADs are considered not medically necessary in children when the medically necessary criteria above are not met and for all other indications.\nIII. Percutaneous Ventricular Assist Devices (pVADs)\nMedically Necessary:\nFDA approved pVADs*, used in accordance with FDA approval are considered medically necessary for the treatment of individuals with cardiogenic shock when the following criteria are met (A and B):\n<li>Either of the following criteria are met (1 or 2):\t<ol> <li>Treatment is intended as an alternative to, or concomitant therapy with, extracorporeal membrane oxygenation (ECMO); or </li> <li>Optimal medical management and conventional treatment measures (that is, volume loading and use of pressors and inotropes) have failed to provide sufficient improvement; and</li> </ol> </li>\n<li>Treatment is intended as an alternative to, or concomitant therapy with, extracorporeal membrane oxygenation (ECMO); or </li>\n<li>Optimal medical management and conventional treatment measures (that is, volume loading and use of pressors and inotropes) have failed to provide sufficient improvement; and</li>\n<li>Individual is suspected to have a reversible cardiac injury and does not have irreversible end-organ injury including renal, hepatic or neurologic systems (care is not felt to be futile).</li>\n*Note: Please refer to the background section of the document for a list of FDA approved pVADs.\nNot Medically Necessary:\nThe use of pVADs is considered not medically necessary when the medically necessary criteria above are not met, and for all other indications.\nIV. Artificial Heart Systems\nMedically Necessary:\nThe SynCardia temporary Total Artificial Heart (TAH-t), used in accordance with FDA approval, is considered medically necessary as a bridge to heart transplantation for individuals who have no other reasonable medical or surgical treatment options, who are ineligible for other univentricular or biventricular support devices, and who meet all of the following criteria:\n<li>Eligible for heart transplantation; and</li>\n<li>Listed for heart transplantation and in imminent danger of dying within 48 hours or becoming ineligible for transplant; and</li>\n<li>NYHA Functional Class IV; and</li>\n<li>Presence of biventricular failure and rapid decompensation; and</li>\n<li>Unavailability of heart donor and likelihood that condition will deteriorate before donor can be identified; and</li>\n<li>Body surface area 1.7-2.5 m\u00b2*, or have a distance between the sternum and the 10th anterior vertebral body measured by computed tomography imaging (CT scan) greater than or equal to 10 cm (See asterisk below for factors that may allow an exception to this criteria.); and</li>\n<li>Absence of active systemic infection; and</li>\n<li>Absence of irreversible organ dysfunction; and</li>\n<li>Serum Creatinine less than 5 mg/dl; and</li>\n<li>Total Bilirubin less than 5 mg/dl; and</li>\n<li>Pulmonary Vascular Resistance less than 8 Wood units; and</li>\n<li>Unresponsive to optimal medical therapy; and</li>\n<li>Presence of hemodynamic insufficiency demonstrated by Society for Cardiovascular Angiography and Interventions (SCAI) Shock stage class D or E.</li>\nNot Medically Necessary:\nThe SynCardia temporary Total Artificial Heart (TAH-t) is considered not medically necessary when the medically necessary criteria above are not met, and for all other indications.\nAll other artificial heart systems are considered not medically necessary for all indications.\n*Note: The proper functioning of the implanted SynCardia TAH-t can be impaired in smaller individuals, that is, those with a body surface area of less than 1.7 m\u00b2 and a heart size less than or equal to 1500 cc, or whose anteroposterior diameter from the sternum inner table to the anterior vertebral body is less than 10 cm. In these cases, the implanted device may compress the inferior vena cava or the pulmonary veins. If an individual has a body size area less than 1.7 m\u00b2, implantation of a TAH may still be possible if the presence of cardiomegaly allows for sufficient space for device placement.<br/>Note: In general age greater than or equal to 18 years and less than or equal to 59 years is a relative indication.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Ventricular Assist Devices (VADs) including Left, Right and Biventricular Assist Devices (Adult)",
            "sub_medical_act": null,
            "necessity_type": "Medically Necessary",
            "description": "FDA approved ventricular assist devices (VADs)*, used in accordance with FDA approval, are considered medically necessary as a bridge to heart transplant for individuals when all of the following criteria have been met:",
            "conditions": {
              "ALL": [
                {
                  "desc": "Have severe end stage heart failure",
                  "conditions": null
                },
                {
                  "desc": "Are not expected to survive until a donor heart can be obtained",
                  "conditions": null
                },
                {
                  "ANY": [
                    {
                      "desc": "Currently listed as a heart transplant candidate",
                      "conditions": null
                    },
                    {
                      "desc": "Undergoing evaluation to determine candidacy for heart transplant",
                      "conditions": null
                    }
                  ]
                }
              ]
            }
          },
          {
            "medical_act": "Ventricular Assist Devices (VADs) including Left, Right and Biventricular Assist Devices (Adult)",
            "sub_medical_act": null,
            "necessity_type": "Medically Necessary",
            "description": "FDA approved VADs*, used in accordance with FDA approval, are considered medically necessary in the post-cardiotomy setting as a means of myocardial recovery support for individuals who are unable to be weaned off cardiopulmonary bypass.",
            "conditions": null
          },
          {
            "medical_act": "Ventricular Assist Devices (VADs) including Left, Right and Biventricular Assist Devices (Adult)",
            "sub_medical_act": null,
            "necessity_type": "Medically Necessary",
            "description": "FDA approved VADs*, used in accordance with FDA approval, are considered medically necessary when used as a permanent alternative (destination therapy) to heart transplantation for an individual when all of the following criteria have been met:",
            "conditions": {
              "ALL": [
                {
                  "desc": "Was evaluated and determined not to be eligible for a heart transplant",
                  "conditions": null
                },
                {
                  "desc": "Has documented Class III or IV New York Heart Association (NYHA) end stage left ventricular heart failure",
                  "conditions": null
                },
                {
                  "desc": "Has received optimal medical management, for at least 45 of the last 60 days or the individual\u2019s survival is in jeopardy",
                  "conditions": null
                },
                {
                  "desc": "Has a life expectancy of less than 2 years due to heart disease",
                  "conditions": null
                }
              ]
            }
          },
          {
            "medical_act": "Ventricular Assist Devices (VADs) including Left, Right and Biventricular Assist Devices (Adult)",
            "sub_medical_act": null,
            "necessity_type": "Not Medically Necessary",
            "description": "VADs are considered not medically necessary when the medically necessary criteria above are not met and for all other indications.",
            "conditions": null
          },
          {
            "medical_act": "Ventricular Assist Devices (Pediatric)",
            "sub_medical_act": null,
            "necessity_type": "Medically Necessary",
            "description": "FDA approved VADs appropriate for pediatrics, including humanitarian device approvals, used in accordance with FDA approval, are considered medically necessary for use in children when all of the following criteria have been met:",
            "conditions": {
              "ALL": [
                {
                  "desc": "Child has documented end-stage left ventricular or biventricular failure",
                  "conditions": null
                },
                {
                  "desc": "Pediatric appropriate VAD* (based on FDA approved use) will be used",
                  "conditions": null
                },
                {
                  "ANY": [
                    {
                      "desc": "Until a donor heart can be obtained",
                      "conditions": null
                    },
                    {
                      "desc": "When used as a permanent alternative (destination therapy) in children who have been evaluated and determined not to be eligible for a heart transplant",
                      "conditions": null
                    }
                  ]
                }
              ]
            }
          },
          {
            "medical_act": "Ventricular Assist Devices (Pediatric)",
            "sub_medical_act": null,
            "necessity_type": "Not Medically Necessary",
            "description": "Pediatric VADs are considered not medically necessary in children when the medically necessary criteria above are not met and for all other indications.",
            "conditions": null
          },
          {
            "medical_act": "Percutaneous Ventricular Assist Devices (pVADs)",
            "sub_medical_act": null,
            "necessity_type": "Medically Necessary",
            "description": "FDA approved pVADs*, used in accordance with FDA approval are considered medically necessary for the treatment of individuals with cardiogenic shock when the following criteria are met (A and B):",
            "conditions": {
              "ALL": [
                {
                  "ANY": [
                    {
                      "desc": "Treatment is intended as an alternative to, or concomitant therapy with, extracorporeal membrane oxygenation (ECMO)",
                      "conditions": null
                    },
                    {
                      "desc": "Optimal medical management and conventional treatment measures (that is, volume loading and use of pressors and inotropes) have failed to provide sufficient improvement",
                      "conditions": null
                    }
                  ]
                },
                {
                  "desc": "Individual is suspected to have a reversible cardiac injury and does not have irreversible end-organ injury including renal, hepatic or neurologic systems (care is not felt to be futile)",
                  "conditions": null
                }
              ]
            }
          },
          {
            "medical_act": "Percutaneous Ventricular Assist Devices (pVADs)",
            "sub_medical_act": null,
            "necessity_type": "Not Medically Necessary",
            "description": "The use of pVADs is considered not medically necessary when the medically necessary criteria above are not met, and for all other indications.",
            "conditions": null
          },
          {
            "medical_act": "Artificial Heart Systems",
            "sub_medical_act": null,
            "necessity_type": "Medically Necessary",
            "description": "The SynCardia temporary Total Artificial Heart (TAH-t), used in accordance with FDA approval, is considered medically necessary as a bridge to heart transplantation for individuals who have no other reasonable medical or surgical treatment options, who are ineligible for other univentricular or biventricular support devices, and who meet all of the following criteria:",
            "conditions": {
              "ALL": [
                {
                  "desc": "Eligible for heart transplantation",
                  "conditions": null
                },
                {
                  "desc": "Listed for heart transplantation and in imminent danger of dying within 48 hours or becoming ineligible for transplant",
                  "conditions": null
                },
                {
                  "desc": "NYHA Functional Class IV",
                  "conditions": null
                },
                {
                  "desc": "Presence of biventricular failure and rapid decompensation",
                  "conditions": null
                },
                {
                  "desc": "Unavailability of heart donor and likelihood that condition will deteriorate before donor can be identified",
                  "conditions": null
                },
                {
                  "desc": "Body surface area 1.7-2.5 m\u00b2, or have a distance between the sternum and the 10th anterior vertebral body measured by computed tomography imaging (CT scan) greater than or equal to 10 cm",
                  "conditions": null
                },
                {
                  "desc": "Absence of active systemic infection",
                  "conditions": null
                },
                {
                  "desc": "Absence of irreversible organ dysfunction",
                  "conditions": null
                },
                {
                  "desc": "Serum Creatinine less than 5 mg/dl",
                  "conditions": null
                },
                {
                  "desc": "Total Bilirubin less than 5 mg/dl",
                  "conditions": null
                },
                {
                  "desc": "Pulmonary Vascular Resistance less than 8 Wood units",
                  "conditions": null
                },
                {
                  "desc": "Unresponsive to optimal medical therapy",
                  "conditions": null
                },
                {
                  "desc": "Presence of hemodynamic insufficiency demonstrated by Society for Cardiovascular Angiography and Interventions (SCAI) Shock stage class D or E",
                  "conditions": null
                }
              ]
            }
          },
          {
            "medical_act": "Artificial Heart Systems",
            "sub_medical_act": null,
            "necessity_type": "Not Medically Necessary",
            "description": "The SynCardia temporary Total Artificial Heart (TAH-t) is considered not medically necessary when the medically necessary criteria above are not met, and for all other indications. All other artificial heart systems are considered not medically necessary for all indications.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 4642,
          "prompt_tokens": 2817,
          "completion_tokens": 1825,
          "total_cost": 0.04146,
          "processing_time": 42.990843296051025
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_c139287.html",
    "subject": "Carotid Sinus Baroreceptor Stimulation Devices",
    "document_number": "SURG.00124",
    "publish_date": "04/10/2024",
    "status": "Reviewed",
    "last_review_date": "02/15/2024",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>The use of a carotid sinus baroreflex activation device is considered <strong>investigational and not medically necessary</strong> for all indications.</p>",
    "content": "Investigational and Not Medically Necessary:\nThe use of a carotid sinus baroreflex activation device is considered investigational and not medically necessary for all indications.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Use of a carotid sinus baroreflex activation device",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "The use of a carotid sinus baroreflex activation device is considered investigational and not medically necessary for all indications.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 928,
          "prompt_tokens": 845,
          "completion_tokens": 83,
          "total_cost": 0.005469999999999999,
          "processing_time": 1.5632610321044922
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_c181196.html",
    "subject": "Peripheral Nerve Blocks for Treatment of Neuropathic Pain",
    "document_number": "SURG.00140",
    "publish_date": "04/10/2024",
    "status": "Reviewed",
    "last_review_date": "02/15/2024",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>Peripheral nerve blocks are considered <strong>investigational and not medically necessary</strong> for management of neuropathic pain,<strong> </strong>including but not limited to treatment of <strong>any</strong> of the following:</p>\n<ul>\t<li>Chemotherapy-induced peripheral neuropathy (CIPN);</li>\t<li>Chronic nonmalignant pain;</li>\t<li>Peripheral neuropathy (for example, diabetic neuropathy, HIV-related neuropathies, etc.);</li>\t<li>Trauma induced neuropathy.</li></ul>\n<li>Chemotherapy-induced peripheral neuropathy (CIPN);</li>\n<li>Chronic nonmalignant pain;</li>\n<li>Peripheral neuropathy (for example, diabetic neuropathy, HIV-related neuropathies, etc.);</li>\n<li>Trauma induced neuropathy.</li>",
    "content": "Investigational and Not Medically Necessary:\nPeripheral nerve blocks are considered investigational and not medically necessary for management of neuropathic pain, including but not limited to treatment of any of the following:\n<ul> <li>Chemotherapy-induced peripheral neuropathy (CIPN);</li> <li>Chronic nonmalignant pain;</li> <li>Peripheral neuropathy (for example, diabetic neuropathy, HIV-related neuropathies, etc.);</li> <li>Trauma induced neuropathy.</li></ul>\n<li>Chemotherapy-induced peripheral neuropathy (CIPN);</li>\n<li>Chronic nonmalignant pain;</li>\n<li>Peripheral neuropathy (for example, diabetic neuropathy, HIV-related neuropathies, etc.);</li>\n<li>Trauma induced neuropathy.</li>",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Peripheral nerve blocks",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Peripheral nerve blocks are considered investigational and not medically necessary for management of neuropathic pain, including but not limited to treatment of any of the following:",
            "conditions": {
              "ANY": [
                {
                  "desc": "Chemotherapy-induced peripheral neuropathy (CIPN)",
                  "conditions": null
                },
                {
                  "desc": "Chronic nonmalignant pain",
                  "conditions": null
                },
                {
                  "desc": "Peripheral neuropathy (for example, diabetic neuropathy, HIV-related neuropathies, etc.)",
                  "conditions": null
                },
                {
                  "desc": "Trauma induced neuropathy",
                  "conditions": null
                }
              ]
            }
          }
        ],
        "usage": {
          "total_tokens": 1162,
          "prompt_tokens": 984,
          "completion_tokens": 178,
          "total_cost": 0.0075899999999999995,
          "processing_time": 3.4647738933563232
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_c152781.html",
    "subject": "Drug-Eluting Devices for Maintaining Sinus Ostial Patency",
    "document_number": "SURG.00132",
    "publish_date": "04/10/2024",
    "status": "Reviewed",
    "last_review_date": "02/15/2024",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>The use of drug-eluting devices for maintaining sinus ostial patency or the treatment of nasal polyps is considered <strong>investigational and not medically necessary</strong> for all indications.</p>",
    "content": "Investigational and Not Medically Necessary:\nThe use of drug-eluting devices for maintaining sinus ostial patency or the treatment of nasal polyps is considered investigational and not medically necessary for all indications.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "The use of drug-eluting devices for maintaining sinus ostial patency or the treatment of nasal polyps",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "The use of drug-eluting devices for maintaining sinus ostial patency or the treatment of nasal polyps is considered investigational and not medically necessary for all indications.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 956,
          "prompt_tokens": 854,
          "completion_tokens": 102,
          "total_cost": 0.0058000000000000005,
          "processing_time": 2.448530912399292
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_c196772.html",
    "subject": "Percutaneous Ultrasonic Ablation of Soft Tissue",
    "document_number": "SURG.00149",
    "publish_date": "04/10/2024",
    "status": "Reviewed",
    "last_review_date": "02/15/2024",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>Percutaneous ultrasonic ablation of soft tissue is considered <strong>investigational and not medically necessary</strong> for the treatment of <strong>any</strong> condition, including, but not limited to <strong>any</strong> of the following musculoskeletal conditions:</p>\n<li>Achilles tendinosis; <strong>or</strong></li>\n<li>Lateral or medial elbow tendinosis; <strong>or</strong></li>\n<li>Patellar tendinosis; <strong>or</strong></li>\n<li>Recalcitrant plantar fasciitis; <strong>or</strong></li>\n<li>Rotator cuff or shoulder tendinosis.</li>",
    "content": "Investigational and Not Medically Necessary:\nPercutaneous ultrasonic ablation of soft tissue is considered investigational and not medically necessary for the treatment of any condition, including, but not limited to any of the following musculoskeletal conditions:\n<li>Achilles tendinosis; or</li>\n<li>Lateral or medial elbow tendinosis; or</li>\n<li>Patellar tendinosis; or</li>\n<li>Recalcitrant plantar fasciitis; or</li>\n<li>Rotator cuff or shoulder tendinosis.</li>",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Percutaneous ultrasonic ablation of soft tissue",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Percutaneous ultrasonic ablation of soft tissue is considered investigational and not medically necessary for the treatment of any condition, including, but not limited to any of the following musculoskeletal conditions:",
            "conditions": {
              "ANY": [
                {
                  "desc": "Achilles tendinosis",
                  "conditions": null
                },
                {
                  "desc": "Lateral or medial elbow tendinosis",
                  "conditions": null
                },
                {
                  "desc": "Patellar tendinosis",
                  "conditions": null
                },
                {
                  "desc": "Recalcitrant plantar fasciitis",
                  "conditions": null
                },
                {
                  "desc": "Rotator cuff or shoulder tendinosis",
                  "conditions": null
                }
              ]
            }
          }
        ],
        "usage": {
          "total_tokens": 1122,
          "prompt_tokens": 925,
          "completion_tokens": 197,
          "total_cost": 0.007580000000000001,
          "processing_time": 4.250230073928833
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_a053351.html",
    "subject": "Percutaneous Vertebral Disc and Vertebral Endplate Procedures",
    "document_number": "SURG.00052",
    "publish_date": "04/10/2024",
    "status": "Revised",
    "last_review_date": "02/15/2024",
    "html_content": "<p><strong>Medically Necessary:</strong></p>\n<p>Intraosseous basivertebral nerve ablation (BVNA) is considered <strong>medically necessary</strong> when all of the following criteria are met:</p>\n<li>Individual is skeletally mature; <strong>and</strong></li>\n<li>Chronic unremitting low back pain of at least 6 months duration is present; <strong>and</strong></li>\n<li>Has failed to respond to at least 6 months of supervised conservative medical management (for example, exercise, nonsteroidal and/or steroidal medication [unless contraindicated], physical therapy, including passive and active treatment modalities, and activity/lifestyle modification); <strong>and</strong></li>\n<li>Diagnosis of vertebrogenic pain meeting the following criteria:\t<ol style=\"list-style-type:lower-alpha\">\t\t<li>Documented by history and physical examination; <strong>and</strong></li>\t\t<li>Magnetic resonance imaging (MRI)-demonstrated Modic Type 1 or 2 changes in at least one vertebral endplate, at one or more levels from L3 to S1, including the following:\t\t<ol style=\"list-style-type:lower-roman\">\t\t\t<li>Fibrovascular bone marrow changes are present (hypointense MRI signal for Modic Type 1);<strong> or</strong></li>\t\t\t<li>Fatty bone marrow changes are present (hyperintense MRI signal for Modic Type 2);<br>\t\t\t<strong>and</strong></li>\t\t</ol>\t\t</li>\t</ol>\t</li>\n<li>Documented by history and physical examination; <strong>and</strong></li>\n<li>Magnetic resonance imaging (MRI)-demonstrated Modic Type 1 or 2 changes in at least one vertebral endplate, at one or more levels from L3 to S1, including the following:\t\t<ol style=\"list-style-type:lower-roman\">\t\t\t<li>Fibrovascular bone marrow changes are present (hypointense MRI signal for Modic Type 1);<strong> or</strong></li>\t\t\t<li>Fatty bone marrow changes are present (hyperintense MRI signal for Modic Type 2);<br>\t\t\t<strong>and</strong></li>\t\t</ol>\t\t</li>\n<li>Fibrovascular bone marrow changes are present (hypointense MRI signal for Modic Type 1);<strong> or</strong></li>\n<li>Fatty bone marrow changes are present (hyperintense MRI signal for Modic Type 2);<br>\t\t\t<strong>and</strong></li>\n<li>Qualifying Modic changes have been confirmed by two independent physicians*; <strong>and</strong></li>\n<li>Qualifying Modic changes are exhibited at each level to be treated; <strong>and</strong></li>\n<li>There is no previous history of lumbar spine surgery; <strong>and</strong></li>\n<li>There is no previous history of BVNA at the planned level of treatment; <strong>and</strong></li>\n<li>No evidence on imaging (MRI, flexion/extension radiographs, CT) of other causes of low back pain (including, but not limited to: lumbar stenosis, degenerative scoliosis, spondylolisthesis, segmental instability, facet arthropathy and disc disease); <strong>and</strong></li>\n<li>No evidence of lumbar radiculopathy or radicular pain; <strong>and</strong></li>\n<li>No evidence of metabolic bone disease (for example, osteoporosis with T score \u2264 -2.5).</li>\n<p>*Note: All imaging must be performed and read by an independent radiologist. If discrepancies should arise in the interpretation of the imaging, the radiologist report will supersede. The results of all imaging studies should correlate with the clinical findings in support of the requested procedure.</p>\n<p><strong>Not Medically Necessary:</strong></p>\n<p>BVNA is considered <strong>not</strong> <strong>medically necessary</strong> when the criteria above are not met, and for all other indications.</p>\n<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>The following procedures are considered <strong>investigational and not medically necessary:</strong></p>\n<li>Percutaneous intradiscal electrothermal therapy; <strong>or</strong></li>\n<li>Percutaneous intradiscal radiofrequency thermocoagulation; <strong>or</strong></li>\n<li>Intradiscal biacuplasty.</li>",
    "content": "Medically Necessary:\nIntraosseous basivertebral nerve ablation (BVNA) is considered medically necessary when all of the following criteria are met:\n<li>Individual is skeletally mature; and</li>\n<li>Chronic unremitting low back pain of at least 6 months duration is present; and</li>\n<li>Has failed to respond to at least 6 months of supervised conservative medical management (for example, exercise, nonsteroidal and/or steroidal medication [unless contraindicated], physical therapy, including passive and active treatment modalities, and activity/lifestyle modification); and</li>\n<li>Diagnosis of vertebrogenic pain meeting the following criteria:\t<ol style=\"list-style-type:lower-alpha\"> <li>Documented by history and physical examination; and</li> <li>Magnetic resonance imaging (MRI)-demonstrated Modic Type 1 or 2 changes in at least one vertebral endplate, at one or more levels from L3 to S1, including the following:\t\t<ol style=\"list-style-type:lower-roman\"> <li>Fibrovascular bone marrow changes are present (hypointense MRI signal for Modic Type 1); or</li> <li>Fatty bone marrow changes are present (hyperintense MRI signal for Modic Type 2);<br/> and</li> </ol> </li> </ol> </li>\n<li>Documented by history and physical examination; and</li>\n<li>Magnetic resonance imaging (MRI)-demonstrated Modic Type 1 or 2 changes in at least one vertebral endplate, at one or more levels from L3 to S1, including the following:\t\t<ol style=\"list-style-type:lower-roman\"> <li>Fibrovascular bone marrow changes are present (hypointense MRI signal for Modic Type 1); or</li> <li>Fatty bone marrow changes are present (hyperintense MRI signal for Modic Type 2);<br/> and</li> </ol> </li>\n<li>Fibrovascular bone marrow changes are present (hypointense MRI signal for Modic Type 1); or</li>\n<li>Fatty bone marrow changes are present (hyperintense MRI signal for Modic Type 2);<br/> and</li>\n<li>Qualifying Modic changes have been confirmed by two independent physicians*; and</li>\n<li>Qualifying Modic changes are exhibited at each level to be treated; and</li>\n<li>There is no previous history of lumbar spine surgery; and</li>\n<li>There is no previous history of BVNA at the planned level of treatment; and</li>\n<li>No evidence on imaging (MRI, flexion/extension radiographs, CT) of other causes of low back pain (including, but not limited to: lumbar stenosis, degenerative scoliosis, spondylolisthesis, segmental instability, facet arthropathy and disc disease); and</li>\n<li>No evidence of lumbar radiculopathy or radicular pain; and</li>\n<li>No evidence of metabolic bone disease (for example, osteoporosis with T score \u2264 -2.5).</li>\n*Note: All imaging must be performed and read by an independent radiologist. If discrepancies should arise in the interpretation of the imaging, the radiologist report will supersede. The results of all imaging studies should correlate with the clinical findings in support of the requested procedure.\nNot Medically Necessary:\nBVNA is considered not medically necessary when the criteria above are not met, and for all other indications.\nInvestigational and Not Medically Necessary:\nThe following procedures are considered investigational and not medically necessary:\n<li>Percutaneous intradiscal electrothermal therapy; or</li>\n<li>Percutaneous intradiscal radiofrequency thermocoagulation; or</li>\n<li>Intradiscal biacuplasty.</li>",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Intraosseous basivertebral nerve ablation (BVNA)",
            "sub_medical_act": null,
            "necessity_type": "Medically Necessary",
            "description": "BVNA is considered medically necessary when all of the following criteria are met:",
            "conditions": {
              "ALL": [
                {
                  "desc": "Individual is skeletally mature",
                  "conditions": null
                },
                {
                  "desc": "Chronic unremitting low back pain of at least 6 months duration is present",
                  "conditions": null
                },
                {
                  "desc": "Has failed to respond to at least 6 months of supervised conservative medical management (for example, exercise, nonsteroidal and/or steroidal medication [unless contraindicated], physical therapy, including passive and active treatment modalities, and activity/lifestyle modification)",
                  "conditions": null
                },
                {
                  "desc": "Diagnosis of vertebrogenic pain meeting the following criteria",
                  "conditions": {
                    "ALL": [
                      {
                        "desc": "Documented by history and physical examination",
                        "conditions": null
                      },
                      {
                        "desc": "Magnetic resonance imaging (MRI)-demonstrated Modic Type 1 or 2 changes in at least one vertebral endplate, at one or more levels from L3 to S1, including the following",
                        "conditions": {
                          "ANY": [
                            {
                              "desc": "Fibrovascular bone marrow changes are present (hypointense MRI signal for Modic Type 1)",
                              "conditions": null
                            },
                            {
                              "desc": "Fatty bone marrow changes are present (hyperintense MRI signal for Modic Type 2)",
                              "conditions": null
                            }
                          ]
                        }
                      }
                    ]
                  }
                },
                {
                  "desc": "Qualifying Modic changes have been confirmed by two independent physicians",
                  "conditions": null
                },
                {
                  "desc": "Qualifying Modic changes are exhibited at each level to be treated",
                  "conditions": null
                },
                {
                  "desc": "There is no previous history of lumbar spine surgery",
                  "conditions": null
                },
                {
                  "desc": "There is no previous history of BVNA at the planned level of treatment",
                  "conditions": null
                },
                {
                  "desc": "No evidence on imaging (MRI, flexion/extension radiographs, CT) of other causes of low back pain (including, but not limited to: lumbar stenosis, degenerative scoliosis, spondylolisthesis, segmental instability, facet arthropathy and disc disease)",
                  "conditions": null
                },
                {
                  "desc": "No evidence of lumbar radiculopathy or radicular pain",
                  "conditions": null
                },
                {
                  "desc": "No evidence of metabolic bone disease (for example, osteoporosis with T score \u2264 -2.5)",
                  "conditions": null
                }
              ]
            }
          },
          {
            "medical_act": "Intraosseous basivertebral nerve ablation (BVNA)",
            "sub_medical_act": null,
            "necessity_type": "Not Medically Necessary",
            "description": "BVNA is considered not medically necessary when the criteria above are not met, and for all other indications.",
            "conditions": null
          },
          {
            "medical_act": "Percutaneous intradiscal electrothermal therapy",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "The following procedures are considered investigational and not medically necessary:",
            "conditions": null
          },
          {
            "medical_act": "Percutaneous intradiscal radiofrequency thermocoagulation",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "The following procedures are considered investigational and not medically necessary:",
            "conditions": null
          },
          {
            "medical_act": "Intradiscal biacuplasty",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "The following procedures are considered investigational and not medically necessary:",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 2509,
          "prompt_tokens": 1632,
          "completion_tokens": 877,
          "total_cost": 0.021315,
          "processing_time": 20.53302025794983
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_a050254.html",
    "subject": "Electrothermal Shrinkage of Joint Capsules, Ligaments, and Tendons",
    "document_number": "SURG.00043",
    "publish_date": "04/10/2024",
    "status": "Reviewed",
    "last_review_date": "02/15/2024",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>Electrothermal shrinkage used as a stand-alone treatment or as an adjunct to arthroscopic or open surgery is considered <strong>investigational and not medically necessary </strong>for all indications, including but not limited to the tightening of joint capsules, ligaments, and tendons.</p>",
    "content": "Investigational and Not Medically Necessary:\nElectrothermal shrinkage used as a stand-alone treatment or as an adjunct to arthroscopic or open surgery is considered investigational and not medically necessary for all indications, including but not limited to the tightening of joint capsules, ligaments, and tendons.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Electrothermal shrinkage",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Electrothermal shrinkage used as a stand-alone treatment or as an adjunct to arthroscopic or open surgery is considered investigational and not medically necessary for all indications, including but not limited to the tightening of joint capsules, ligaments, and tendons.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 976,
          "prompt_tokens": 872,
          "completion_tokens": 104,
          "total_cost": 0.00592,
          "processing_time": 2.6604411602020264
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_e001584.html",
    "subject": "Implanted Port Delivery Systems to Treat Ocular Disease",
    "document_number": "SURG.00160",
    "publish_date": "04/10/2024",
    "status": "Reviewed",
    "last_review_date": "02/15/2024",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>The use of a port delivery system to treat ocular disease is considered <strong>investigational and not medically necessary</strong> for all indications.</p>",
    "content": "Investigational and Not Medically Necessary:\nThe use of a port delivery system to treat ocular disease is considered investigational and not medically necessary for all indications.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Use of a port delivery system to treat ocular disease",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "The use of a port delivery system to treat ocular disease is considered investigational and not medically necessary for all indications.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 925,
          "prompt_tokens": 844,
          "completion_tokens": 81,
          "total_cost": 0.005435,
          "processing_time": 2.0909669399261475
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_a053488.html",
    "subject": "Self-Expanding Absorptive Sinus Ostial Dilation",
    "document_number": "SURG.00089",
    "publish_date": "04/10/2024",
    "status": "Reviewed",
    "last_review_date": "02/15/2024",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>The use of self-expanding absorptive sinus ostial dilation for the treatment of <em>any</em> sinus condition, including, but not limited to sinusitis, is considered <strong>investigational and not medically necessary.</strong></p>",
    "content": "Investigational and Not Medically Necessary:\nThe use of self-expanding absorptive sinus ostial dilation for the treatment of any sinus condition, including, but not limited to sinusitis, is considered investigational and not medically necessary.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Self-expanding absorptive sinus ostial dilation",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "The use of self-expanding absorptive sinus ostial dilation for the treatment of any sinus condition, including, but not limited to sinusitis, is considered investigational and not medically necessary.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 954,
          "prompt_tokens": 859,
          "completion_tokens": 95,
          "total_cost": 0.00572,
          "processing_time": 1.765002965927124
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_c196770.html",
    "subject": "Spectral Analysis of Prostate Tissue by Fluorescence Spectroscopy",
    "document_number": "SURG.00148",
    "publish_date": "04/10/2024",
    "status": "Reviewed",
    "last_review_date": "02/15/2024",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>Spectral analysis of prostate tissue by fluorescence spectroscopy is considered <strong>investigational and not medically necessary</strong> for all indications.</p>",
    "content": "Investigational and Not Medically Necessary:\nSpectral analysis of prostate tissue by fluorescence spectroscopy is considered investigational and not medically necessary for all indications.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Spectral analysis of prostate tissue by fluorescence spectroscopy",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Spectral analysis of prostate tissue by fluorescence spectroscopy is considered investigational and not medically necessary for all indications.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 920,
          "prompt_tokens": 842,
          "completion_tokens": 78,
          "total_cost": 0.00538,
          "processing_time": 2.3893988132476807
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_a050260.html",
    "subject": "Transanal Radiofrequency Treatment of Fecal Incontinence",
    "document_number": "SURG.00056",
    "publish_date": "04/10/2024",
    "status": "Reviewed",
    "last_review_date": "02/15/2024",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>Transanal radiofrequency therapy for the treatment of fecal incontinence is considered <strong>investigational and not medically necessary.</strong></p>",
    "content": "Investigational and Not Medically Necessary:\nTransanal radiofrequency therapy for the treatment of fecal incontinence is considered investigational and not medically necessary.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Transanal radiofrequency therapy for the treatment of fecal incontinence",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Transanal radiofrequency therapy for the treatment of fecal incontinence is considered investigational and not medically necessary.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 926,
          "prompt_tokens": 843,
          "completion_tokens": 83,
          "total_cost": 0.00546,
          "processing_time": 1.9713969230651855
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_a050264.html",
    "subject": "Presbyopia and Astigmatism-Correcting Intraocular Lenses",
    "document_number": "SURG.00061",
    "publish_date": "04/10/2024",
    "status": "Reviewed",
    "last_review_date": "02/15/2024",
    "html_content": "<p><strong>Not Medically Necessary:</strong></p>\n<p>The use of presbyopia-correcting intraocular lenses is considered <strong>not medically necessary </strong>for all indications.</p>\n<p>The use of astigmatism-correcting intraocular lenses is considered <strong>not medically necessary</strong> for all indications.</p>",
    "content": "Not Medically Necessary:\nThe use of presbyopia-correcting intraocular lenses is considered not medically necessary for all indications.\nThe use of astigmatism-correcting intraocular lenses is considered not medically necessary for all indications.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Presbyopia-Correcting Intraocular Lenses",
            "sub_medical_act": null,
            "necessity_type": "Not Medically Necessary",
            "description": "The use of presbyopia-correcting intraocular lenses is considered not medically necessary for all indications.",
            "conditions": null
          },
          {
            "medical_act": "Astigmatism-Correcting Intraocular Lenses",
            "sub_medical_act": null,
            "necessity_type": "Not Medically Necessary",
            "description": "The use of astigmatism-correcting intraocular lenses is considered not medically necessary for all indications.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 1015,
          "prompt_tokens": 861,
          "completion_tokens": 154,
          "total_cost": 0.006614999999999999,
          "processing_time": 4.258333921432495
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_a050273.html",
    "subject": "Intervertebral Stabilization Devices",
    "document_number": "SURG.00075",
    "publish_date": "04/10/2024",
    "status": "Reviewed",
    "last_review_date": "02/15/2024",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>Use of intervertebral stabilization devices is considered <strong>investigational and not medically necessary</strong> for all indications.</p>",
    "content": "Investigational and Not Medically Necessary:\nUse of intervertebral stabilization devices is considered investigational and not medically necessary for all indications.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Use of intervertebral stabilization devices",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Use of intervertebral stabilization devices is considered investigational and not medically necessary for all indications.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 914,
          "prompt_tokens": 840,
          "completion_tokens": 74,
          "total_cost": 0.00531,
          "processing_time": 1.9998879432678223
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_e000977.html",
    "subject": "Focal Laser Ablation for the Treatment of Prostate Cancer",
    "document_number": "SURG.00159",
    "publish_date": "04/10/2024",
    "status": "Reviewed",
    "last_review_date": "02/15/2024",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>Focal laser ablation is considered <strong>investigational and not medically necessary</strong> for the treatment of prostate cancer.</p>",
    "content": "Investigational and Not Medically Necessary:\nFocal laser ablation is considered investigational and not medically necessary for the treatment of prostate cancer.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Focal laser ablation",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Focal laser ablation is considered investigational and not medically necessary for the treatment of prostate cancer.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 914,
          "prompt_tokens": 841,
          "completion_tokens": 73,
          "total_cost": 0.005299999999999999,
          "processing_time": 1.597060203552246
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_e002903.html",
    "subject": "Implantable Shock Absorber for Treatment of Knee Osteoarthritis",
    "document_number": "SURG.00162",
    "publish_date": "04/10/2024",
    "status": "New",
    "last_review_date": "02/15/2024",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>Use of an implantable shock absorber device for treatment of osteoarthritis of the knee is considered <strong>investigational and not medically necessary</strong>.</p>",
    "content": "Investigational and Not Medically Necessary:\nUse of an implantable shock absorber device for treatment of osteoarthritis of the knee is considered investigational and not medically necessary.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Use of an implantable shock absorber device for treatment of osteoarthritis of the knee",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Use of an implantable shock absorber device for treatment of osteoarthritis of the knee is considered investigational and not medically necessary.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 935,
          "prompt_tokens": 846,
          "completion_tokens": 89,
          "total_cost": 0.0055650000000000005,
          "processing_time": 1.695261001586914
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_a053309.html",
    "subject": "Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting",
    "document_number": "SURG.00011",
    "publish_date": "04/01/2024",
    "status": "Revised",
    "last_review_date": "02/15/2024",
    "html_content": "<p><strong>Medically Necessary:</strong></p>\n<p>I.<em>&nbsp; Breast reconstruction surgery</em></p>\n<p>The following products are considered <strong>medically necessary</strong> when used for breast reconstruction surgery:</p>\n<li>AlloDerm Regenerative Tissue Matrix (aseptic or sterile); <strong>or</strong></li>\n<li>Cortiva<sup>\u00ae</sup>; <strong>or</strong></li>\n<li>DermACELL<sup>\u2122</sup>; <strong>or</strong></li>\n<li>DermaMatrix<sup>\u00ae</sup>; <strong>or</strong></li>\n<li>FlexHD<sup>\u00ae</sup>; <strong>or</strong></li>\n<li>SimpliDerm<sup>\u2122</sup>; <strong>or</strong></li>\n<li>Strattice<sup>\u2122</sup>; <strong>or</strong></li>\n<li>SurgiMend<sup>\u00ae.</sup></li>\n<p>II.<em>&nbsp; Burns</em></p>\n<p>The following products are considered <strong>medically necessary </strong>when used for the treatment of full-thickness or deep partial-thickness burns:</p>\n<li>Biobrane; <strong>or</strong></li>\n<li>Epicel<sup>\u00ae; </sup><strong>or</strong></li>\n<li>EZ Derm<sup>\u2122</sup>; <strong>or</strong></li>\n<li>Fresh frozen unprocessed allograft skin products (for example, AlloSkin<sup>\u2122</sup>*, TheraSkin<sup>\u00ae</sup>); <strong>or</strong></li>\n<li>Integra<sup>\u2122</sup> Bilayer Matrix Wound Dressing; <strong>or</strong></li>\n<li>Integra<sup>\u00ae</sup> Omnigraft Dermal Regeneration Template; <strong>or</strong></li>\n<li>ReCell<sup>\u2122</sup> Autologous Harvesting Device;<strong> or</strong></li>\n<li>StrataGraft<sup>\u00ae</sup>.</li>\n<p style=\"margin-left:24px\"><strong>*Note:</strong> \u201cAlloSkin\u201d, \u201cAlloSkin RT<sup>\u2122</sup>\u201d, and \u201cAlloskin<sup>\u2122</sup> AC\u201d are different products. AlloSkin is a fresh-frozen product, AlloSkin RT is a fresh irradiated product (not frozen) and Alloskin AC is an acellular dermal matrix product. Please see the investigational and not medically necessary section below for the position on AlloSkin RT<sup>\u2122</sup> and Alloskin<sup>\u2122</sup> AC.</p>\n<p>III.<em>&nbsp; Complex abdominal wall wounds </em></p>\n<p>The following products are considered <strong>medically necessary</strong> for the surgical repair of complex abdominal wall wounds:</p>\n<li>AlloDerm Regenerative Tissue Matrix (aseptic or sterile); <strong>or</strong></li>\n<li>Strattice; <strong>or</strong></li>\n<li>OviTex<sup>\u2122</sup>.</li>\n<p>IV.<em>&nbsp; Diabetic foot ulcers</em></p>\n<p>The following products are considered <strong>medically necessary</strong> for the treatment of diabetic foot ulcers when the clinical criteria below have been met:</p>\n<li>Products:\t<ol>\t\t<li>AmnioBand<sup>\u00ae</sup>, sheet or membrane form; <strong>or</strong></li>\t\t<li>Apligraf<sup>\u00ae</sup>; <strong>or</strong></li>\t\t<li>Biovance<sup>\u00ae</sup>; <strong>or</strong></li>\t\t<li>DermACELL<sup>\u2122</sup>; <strong>or</strong></li>\t\t<li>Dermagraft<sup>\u00ae</sup>; <strong>or</strong></li>\t\t<li>EpiCord; <strong>or</strong></li>\t\t<li>EpiFix<sup>\u2122</sup>; <strong>or</strong></li>\t\t<li>Grafix<sup>\u00ae</sup> PRIME; <strong>or</strong></li>\t\t<li>Kerecis<sup>\u00ae</sup>; <strong>or</strong></li>\t\t<li>mVASC; <strong>or</strong></li>\t\t<li>Oasis<sup>\u2122</sup>; <strong>or</strong></li>\t\t<li>TheraSkin<sup>\u00ae</sup>;<br>\t\t<strong>and</strong></li>\t</ol>\t</li>\n<li>AmnioBand<sup>\u00ae</sup>, sheet or membrane form; <strong>or</strong></li>\n<li>Apligraf<sup>\u00ae</sup>; <strong>or</strong></li>\n<li>Biovance<sup>\u00ae</sup>; <strong>or</strong></li>\n<li>DermACELL<sup>\u2122</sup>; <strong>or</strong></li>\n<li>Dermagraft<sup>\u00ae</sup>; <strong>or</strong></li>\n<li>EpiCord; <strong>or</strong></li>\n<li>EpiFix<sup>\u2122</sup>; <strong>or</strong></li>\n<li>Grafix<sup>\u00ae</sup> PRIME; <strong>or</strong></li>\n<li>Kerecis<sup>\u00ae</sup>; <strong>or</strong></li>\n<li>mVASC; <strong>or</strong></li>\n<li>Oasis<sup>\u2122</sup>; <strong>or</strong></li>\n<li>TheraSkin<sup>\u00ae</sup>;<br>\t\t<strong>and</strong></li>\n<li>Clinical Criteria:\t<ol>\t\t<li>Ulcers that have not healed with standard conservative therapy (such as surgical debridement, complete off-loading, and standard dressing changes) attempted for at least 1 month but not greater than 52 weeks.</li>\t</ol>\t</li>\n<li>Ulcers that have not healed with standard conservative therapy (such as surgical debridement, complete off-loading, and standard dressing changes) attempted for at least 1 month but not greater than 52 weeks.</li>\n<p><em>V.&nbsp; Dystrophic epidermolysis bullosa</em></p>\n<p>The following products are considered <strong>medically necessary</strong> for the treatment dystrophic epidermolysis bullosa:</p>\n<li>Dermagraft<sup>\u00ae</sup>;<strong> or</strong></li>\n<li>OrCel<sup>\u2122</sup>.</li>\n<p>VI.&nbsp;<em> Lower extremity dermal wounds</em></p>\n<p>The following products are considered <strong>medically necessary </strong>for the treatment of lower extremity dermal wounds when the clinical criteria below have been met:</p>\n<li>Products:\t<ol>\t\t<li>GraftJacket\u2122, sheet or membrane form; <strong>or</strong></li>\t\t<li>Oasis<sup>\u2122</sup>; <strong>or</strong></li>\t\t<li>PriMatrix<sup>\u2122</sup>; <strong>or</strong></li>\t\t<li>TheraSkin;<br>\t\t<strong>and</strong></li>\t</ol>\t</li>\n<li>GraftJacket\u2122, sheet or membrane form; <strong>or</strong></li>\n<li>Oasis<sup>\u2122</sup>; <strong>or</strong></li>\n<li>PriMatrix<sup>\u2122</sup>; <strong>or</strong></li>\n<li>TheraSkin;<br>\t\t<strong>and</strong></li>\n<li>Clinical Criteria:\t<ol>\t\t<li>Wounds that have not healed with standard conservative therapy (such as surgical debridement, complete off-loading, standard dressing changes, and compression therapy) attempted for at least 1 month but not greater than 52 weeks.</li>\t</ol>\t</li>\n<li>Wounds that have not healed with standard conservative therapy (such as surgical debridement, complete off-loading, standard dressing changes, and compression therapy) attempted for at least 1 month but not greater than 52 weeks.</li>\n<p>VII.&nbsp; Ocular indications</p>\n<p>Allogeneic amniotic membrane-derived grafts or wound coverings, including, but not limited to the following, are considered <strong>medically necessary</strong> when the clinical criteria below have been met:</p>\n<li>Products:\t<ol>\t\t<li>AmbioDisk<sup>\u2122</sup>; <strong>or</strong></li>\t\t<li>AmnioGraft<sup>\u00ae</sup>; <strong>or</strong></li>\t\t<li>Artacent<sup>\u00ae</sup> Ocular; <strong>or</strong></li>\t\t<li>Prokera<sup>\u00ae</sup>; <strong>or</strong></li>\t\t<li>Vendaje Optic<sup>\u2122</sup>*;<strong>and</strong></li>\t</ol>\t</li>\n<li>AmbioDisk<sup>\u2122</sup>; <strong>or</strong></li>\n<li>AmnioGraft<sup>\u00ae</sup>; <strong>or</strong></li>\n<li>Artacent<sup>\u00ae</sup> Ocular; <strong>or</strong></li>\n<li>Prokera<sup>\u00ae</sup>; <strong>or</strong></li>\n<li>Vendaje Optic<sup>\u2122</sup>*;<strong>and</strong></li>\n<li>Clinical Criteria:\t<ol>\t\t<li>Reconstruction of large conjunctival resections; <strong>or</strong></li>\t\t<li>Treatment of corneal injuries; <strong>or</strong></li>\t\t<li>As an adjunct to surgical procedures involving the cornea.</li>\t</ol>\t</li>\n<li>Reconstruction of large conjunctival resections; <strong>or</strong></li>\n<li>Treatment of corneal injuries; <strong>or</strong></li>\n<li>As an adjunct to surgical procedures involving the cornea.</li>\n<p style=\"margin-left:40px\">*See Investigational and Not Medically necessary section for the use of other Vendaje products.</p>\n<p>VIII.&nbsp; Venous stasis ulcers</p>\n<p>The following products are considered <strong>medically necessary</strong> for the treatment of chronic venous stasis ulcers when the clinical criteria are met:</p>\n<li>Products:\t<ol>\t\t<li>AmnioBand, sheet or membrane form; <strong>or</strong></li>\t\t<li>Apligraf<sup>\u00ae</sup>; <strong>or</strong></li>\t\t<li>EpiFix<sup>\u2122</sup>;<br>\t\t<strong>and</strong></li>\t</ol>\t</li>\n<li>AmnioBand, sheet or membrane form; <strong>or</strong></li>\n<li>Apligraf<sup>\u00ae</sup>; <strong>or</strong></li>\n<li>EpiFix<sup>\u2122</sup>;<br>\t\t<strong>and</strong></li>\n<li>Clinical Criteria:\t<ol>\t\t<li>Wound has been present for at least 1 month; <strong>and</strong></li>\t\t<li>Has been unsuccessfully treated with compression therapy for at least 14 days.</li>\t</ol>\t</li>\n<li>Wound has been present for at least 1 month; <strong>and</strong></li>\n<li>Has been unsuccessfully treated with compression therapy for at least 14 days.</li>\n<p><strong>Not Medically Necessary:</strong></p>\n<p>The following products are considered <strong>not medically necessary</strong> when criteria above are not met and for any use not listed above:</p>\n<li>AlloDerm Regenerative Tissue Matrix (aseptic or sterile)</li>\n<li>Allogeneic amniotic membrane-derived grafts or wound coverings when used for ocular indications</li>\n<li>AlloSkin</li>\n<li>AmbioDisk</li>\n<li>AmnioBand, sheet or membrane form</li>\n<li>AmnioGraft</li>\n<li>Apligraf</li>\n<li>Artacent Ocular</li>\n<li>Biobrane</li>\n<li>Biovance</li>\n<li>Cortiva</li>\n<li>DermACELL</li>\n<li>Dermagraft</li>\n<li>DermaMatrix</li>\n<li>Epicel</li>\n<li>EpiCord</li>\n<li>EpiFix, sheet or membrane form</li>\n<li>EZ Derm</li>\n<li>FlexHD</li>\n<li>Fresh frozen unprocessed allograft skin products (for example, AlloSkin*, TheraSkin)</li>\n<li>Grafix PRIME</li>\n<li>GraftJacket, sheet or membrane form</li>\n<li>Integra Bilayer Matrix Wound Dressing</li>\n<li>Integra<sup>\u00ae</sup> Omnigraft Dermal Regeneration Template</li>\n<li>Kerecis<sup>\u2122</sup></li>\n<li>mVASC</li>\n<li>Oasis<sup>\u2122</sup></li>\n<li>Omnigraft (also see Integra Omnigraft Dermal Regeneration Template)</li>\n<li>OrCel</li>\n<li>OviTex</li>\n<li>PriMatrix</li>\n<li>Prokera</li>\n<li>ReCell\u2122 Autologous Harvesting Device</li>\n<li>SimpliDerm</li>\n<li>StrataGraft</li>\n<li>Strattice</li>\n<li>SurgiMend<sup>\u00ae</sup></li>\n<li>TheraSkin</li>\n<li>Vendaje Optic</li>\n<p><strong>Investigational and Not Medically Necessary</strong></p>\n<p>The use of <strong>all</strong> other allogeneic, xenographic, synthetic, and composite products for wound healing or soft tissue grafting, including but not limited to the following products, is considered <strong>investigational and not medically necessary</strong> for all uses:</p>\n<li>Ac5 advanced wound system</li>\n<li>Acesso DL</li>\n<li>Acesso TL</li>\n<li>ACM Extra Surgical Collagen</li>\n<li>ACM Extra Surgical Collagen Powder</li>\n<li>ACM Surgical Collagen</li>\n<li>Actishield<sup>\u2122</sup></li>\n<li>ActiveBarrier<sup>\u00ae</sup></li>\n<li>ActiveMatrix<sup>\u00ae</sup></li>\n<li>Affinity<sup>\u2122</sup></li>\n<li>AlloGen-LI<sup>\u2122</sup>&nbsp;</li>\n<li>AlloGen<sup>\u2122</sup>&nbsp;</li>\n<li>AlloMax<sup>\u2122</sup></li>\n<li>AlloMend<sup>\u2122</sup></li>\n<li>Allopatch HD<sup>\u2122</sup></li>\n<li>AlloPatch<sup>\u00ae</sup> Pliable</li>\n<li>Alloskin AC</li>\n<li>AlloSkin RT<sup> </sup></li>\n<li>AlloWrap<sup>\u00ae</sup></li>\n<li>AlloWrap<sup>\u2122</sup> Dry</li>\n<li>AlloWrap<sup>\u2122</sup> DS</li>\n<li>Alphaplex<sup>\u2122</sup> with MariGen Omega3<sup>\u2122</sup></li>\n<li>AltiPly<sup>\u2122</sup></li>\n<li>AmbientFactor<sup>\u2122</sup></li>\n<li>Ambio5<sup>\u00ae</sup></li>\n<li>AmniCore Pro+</li>\n<li>Amnio FRT\u2122</li>\n<li>Amnio F\u2122</li>\n<li>Amnio Quad-Core</li>\n<li>Amnio Restore<sup>\u2122</sup></li>\n<li>Amnio Tri-Core amniotic</li>\n<li>Amnio wound</li>\n<li>AmnioAMP-MP</li>\n<li>AmnioAMP-PF</li>\n<li>AmnioAMP-X</li>\n<li>AmnioArmor<sup>\u00ae</sup></li>\n<li>AmnioBand, particulate or injectable form</li>\n<li>AmnioBind</li>\n<li>AmnioCare<sup>\u00ae</sup></li>\n<li>AmnioClear<sup>\u00ae</sup></li>\n<li>AmnioCord<sup>\u00ae</sup></li>\n<li>AmnioCore</li>\n<li>AmnioCore Pro</li>\n<li>AmnioCyte</li>\n<li>AMNIOEXCEL<sup>\u2122</sup></li>\n<li>Amniofill<sup>\u00ae</sup></li>\n<li>AmnioFix<sup>\u2122</sup></li>\n<li>Amnioflex<sup>\u2122</sup></li>\n<li>AmnioGuard<sup>\u00ae</sup></li>\n<li>AmnioHeal<sup>\u00ae</sup></li>\n<li>AmnioMatrix<sup>\u2122</sup></li>\n<li>AmnioMTM<sup>\u2122</sup></li>\n<li>Amniopro<sup>\u2122</sup></li>\n<li>AMNIOREPAIR<sup>\u2122</sup></li>\n<li>Amnios<sup>\u00ae</sup></li>\n<li>Amnios<sup>\u00ae</sup> RT</li>\n<li>AmnioShield<sup>\u00ae</sup></li>\n<li>Amniostrip<sup>\u2122</sup></li>\n<li>Amniotext</li>\n<li>Amniovo\u2122 (Solo, Dual, and Matrix)</li>\n<li>Amniovo\u2122 Max</li>\n<li>Amniowrap2<sup>\u2122</sup></li>\n<li>Amniply</li>\n<li>AmnyoFactor<sup>\u2122</sup></li>\n<li>AmnyoFluid<sup>\u2122</sup></li>\n<li>Anu RHEO<sup>\u2122</sup></li>\n<li>Aongen<sup>\u2122</sup> Collagen Matrix</li>\n<li>Apis<sup>\u00ae</sup></li>\n<li>Architect Extracellular Matrix<sup>\u2122</sup></li>\n<li>AROA ECM<sup>\u2122</sup></li>\n<li>Artacent<sup>\u00ae</sup> AC Powder</li>\n<li>Artacent<sup>\u00ae</sup> cord</li>\n<li>Artacent<sup>\u00ae</sup> Flex</li>\n<li>Artacent<sup>\u00ae</sup> Wound</li>\n<li>Artelon<sup>\u00ae</sup></li>\n<li>Arthrex<sup>\u00ae</sup> Amnion matrix</li>\n<li>ArthroFlex<sup>\u2122</sup></li>\n<li>ARTIA\u2122 Reconstructive Tissue Matrix</li>\n<li>Ascent<sup>\u00ae</sup></li>\n<li>Atlas Wound Matrix</li>\n<li>Avance<sup>\u00ae</sup> Nerve Graft</li>\n<li>Avaulta Plus<sup>\u2122</sup></li>\n<li>Avive<sup>\u00ae</sup></li>\n<li>AxoBioMembrane</li>\n<li>Axograft<sup>\u2122</sup></li>\n<li>AxoGuard<sup>\u00ae</sup> nerve connector</li>\n<li>AxoGuard<sup>\u00ae</sup> nerve protector</li>\n<li>Axolotl Ambient<sup>\u2122</sup></li>\n<li>Axolotl Cryo<sup>\u2122</sup></li>\n<li>Axolotl DualGraft<sup>\u2122</sup></li>\n<li>Axolotl Graft<sup>\u2122</sup></li>\n<li>Axolotl Shot<sup>\u2122</sup></li>\n<li>BEAR<sup>\u00ae</sup> (Bridge-Enhanced ACL Repair) Implant</li>\n<li>BellaCell HD</li>\n<li>Belladerm<sup>\u00ae</sup></li>\n<li>BellaGen<sup>\u2122</sup></li>\n<li>Bio-ConneKt<sup>\u00ae</sup></li>\n<li>BioDDryFlex<sup>\u00ae </sup>Resorbable Adhesion Barrier</li>\n<li>Biodesign Nipple Reconstruction Cylinder</li>\n<li>BioDExCel<sup>\u2122</sup></li>\n<li>BioDFactor<sup>\u2122</sup></li>\n<li>BioDFence<sup>\u2122</sup></li>\n<li>BioDOptix<sup>\u2122</sup></li>\n<li>Bioengineered autologous skin-derived products (for example, SkinTE<sup>\u2122</sup>, MyOwn Skin<sup>\u2122</sup>)</li>\n<li>BioFiber<sup>\u2122</sup></li>\n<li>BioFix</li>\n<li>BioSkin<sup>\u00ae</sup> Flow Amniotic Wound Matrix</li>\n<li>Biotape XM Tissue Matrix</li>\n<li>BioWound</li>\n<li>BioWound plus</li>\n<li>BioWound Xplus</li>\n<li>Cardiamend<sup>\u2122</sup></li>\n<li>CardioCel<sup>\u00ae</sup></li>\n<li>CardioGRAFT<sup>\u00ae</sup></li>\n<li>Celera Dual Layer<sup>\u2122</sup></li>\n<li>Celera Dual Membrane<sup>\u2122</sup></li>\n<li>CellerateRX<sup>\u00ae</sup></li>\n<li>Cellesta amnion granulate</li>\n<li>Cellesta amniotic membrane</li>\n<li>Cellesta cord</li>\n<li>Cellesta flowable amnion</li>\n<li>Cellesta<sup>\u2122</sup> Amniotic Membrane</li>\n<li>CG CryoDerm<sup>\u2122</sup></li>\n<li>CLARIX<sup>\u2122</sup> 100 Quick-Peel Wound Matrix</li>\n<li>CLARIX<sup>\u2122</sup> 1k</li>\n<li>CLARIX<sup>\u2122</sup> FLO</li>\n<li>Cocoon Membrane</li>\n<li>Cogenex Amniotic Membrane</li>\n<li>Cogenex Flowable Amnion</li>\n<li>CollaFilm<sup>\u00ae</sup></li>\n<li>CollaFix<sup>\u2122</sup></li>\n<li>CollaGUARD<sup>\u00ae</sup></li>\n<li>CollaMend<sup>\u2122</sup></li>\n<li>COLLARX<sup>\u00ae</sup></li>\n<li>CollaSorb<sup>\u2122</sup></li>\n<li>CollaWound<sup>\u2122</sup></li>\n<li>Coll-e-Derm<sup>\u2122</sup></li>\n<li>Collexa<sup>\u00ae</sup></li>\n<li>Collieva<sup>\u00ae</sup></li>\n<li>Complete AA</li>\n<li>Complete ACA</li>\n<li>Complete FT</li>\n<li>Complete SL</li>\n<li>Conexa<sup>\u2122</sup></li>\n<li>Connext<sup>\u2122</sup> Surgical Matrix</li>\n<li>CoreCyte<sup>\u2122</sup></li>\n<li>Coreleader Colla-Pad</li>\n<li>Coretext<sup>\u2122</sup></li>\n<li>CorMatrix<sup>\u00ae</sup></li>\n<li>Corova</li>\n<li>Corplex<sup>\u2122</sup></li>\n<li>C-QUR<sup>\u2122</sup></li>\n<li>CRXa<sup>\u2122</sup></li>\n<li>Cryo-Cord<sup>\u2122</sup></li>\n<li>CryoMatrix<sup>\u00ae</sup></li>\n<li>CryoSkin<sup>\u00ae</sup></li>\n<li>Cuffpatch<sup>\u2122</sup></li>\n<li>CYGNUS Matrix<sup>\u2122</sup></li>\n<li>CYGNUS Max<sup>\u2122</sup></li>\n<li>CYGNUS Solo<sup>\u2122</sup></li>\n<li>Cymetra<sup>\u00ae</sup></li>\n<li>Cytal<sup>\u00ae</sup> Burn Matrix (formerly MatriStem)</li>\n<li>Cytal<sup>\u00ae </sup>Multilayer Matrix (formerly MatriStem)</li>\n<li>Cytal<sup>\u00ae</sup> Wound Matrix (formerly MatriStem)</li>\n<li>Cytoflex<sup>\u00ae</sup></li>\n<li>Cytoplast<sup>\u2122</sup></li>\n<li>DeNovo<sup>\u00ae</sup> NT Graft</li>\n<li>DermaBind CH</li>\n<li>DermaBind SL</li>\n<li>Dermacyte</li>\n<li>DermADAPT<sup>\u2122</sup> Wound Dressing</li>\n<li>Derma-Gide<sup>\u00ae</sup></li>\n<li>DermaPure<sup>\u2122</sup></li>\n<li>DermaSpan<sup>\u2122</sup></li>\n<li>Dermavest 2<sup>\u2122</sup></li>\n<li>Dermavest<sup>\u2122</sup></li>\n<li>DermMatrix</li>\n<li>Derm-Maxx</li>\n<li>DressSkin<sup>\u2122</sup></li>\n<li>DuraForm<sup>\u2122</sup></li>\n<li>Duragen<sup>\u00ae</sup> XS</li>\n<li>Duragen<sup>\u2122</sup> Plus</li>\n<li>DuraMatrix<sup>\u2122</sup></li>\n<li>Durepair<sup>\u00ae</sup> Regeneration Matrix</li>\n<li>Emerge Matrix</li>\n<li>Endobon<sup>\u00ae</sup> Xenograft Granules</li>\n<li>Endoform<sup>\u00ae </sup>Antimicrobial</li>\n<li>Endoform<sup>\u00ae </sup>Natural Dermal Template</li>\n<li>ENDURAgen<sup>\u2122</sup></li>\n<li>Enverse<sup>\u00ae</sup></li>\n<li>EpiBurn</li>\n<li>EpiDex<sup>\u00ae</sup></li>\n<li>EpiFix<sup>\u2122</sup>, particulate or injectable form</li>\n<li>EpiFlex<sup>\u00ae</sup></li>\n<li>Excellagen<sup>\u00ae</sup>&nbsp;</li>\n<li>Fibro-Gide<sup>\u00ae</sup></li>\n<li>FloGraft<sup>\u2122</sup></li>\n<li>FlowerDerm<sup>\u2122</sup></li>\n<li>FlowerFlo<sup>\u2122</sup> (FlowerAmnioFlo)</li>\n<li>FlowerPatch<sup>\u2122</sup> (FlowerAMINOPatch)</li>\n<li>Fluid flow<sup>\u2122</sup></li>\n<li>Fluid GF<sup>\u2122</sup></li>\n<li>FortaDerm<sup>\u2122</sup> Wound Dressing (see PuraPly<sup>\u2122</sup>)</li>\n<li>Fortiva<sup>\u2122</sup> Porcine Dermis</li>\n<li>GalaFLEX<sup>\u00ae</sup></li>\n<li>GalaFORM<sup>\u00ae</sup></li>\n<li>GalaSHAPE<sup>\u00ae</sup> 3D</li>\n<li>Gammagraft<sup>\u2122</sup></li>\n<li>Genesis amniotic membrane</li>\n<li>Gentrix<sup>\u00ae</sup> Surgical Matrix</li>\n<li>GENTRIX<sup>\u2122</sup></li>\n<li>GORE BIO-A<sup>\u00ae</sup> Fistula Plug</li>\n<li>Gore<sup>\u00ae</sup> Acuseal Cardiovascular Patch</li>\n<li>Grafix plus</li>\n<li>Grafix<sup>\u00ae</sup> CORE</li>\n<li>GrafixPL PRIME<sup>\u00ae</sup></li>\n<li>Graftjacket<sup>\u2122</sup> Xpress injectable</li>\n<li>GraftJacket<sup>\u2122</sup>, injectable form</li>\n<li>GraftRope<sup>\u2122</sup></li>\n<li>HA Absorbent Wound Dressing</li>\n<li>Helicoll</li>\n<li>HeliMEND</li>\n<li>Helisorb<sup>\u00ae</sup></li>\n<li>hMatrix<sup>\u00ae</sup></li>\n<li>Human health factor 10<sup>\u2122</sup> amniotic patch (hhf10-p)</li>\n<li>Hyalomatrix<sup>\u00ae</sup></li>\n<li>Impax Dual Layer</li>\n<li>Inforce<sup>\u00ae</sup></li>\n<li>InnovaBurn\u00ae</li>\n<li>InnovaMatrix<sup>\u00ae</sup> PD</li>\n<li>InnovaMatrix<sup>\u00ae </sup>AC</li>\n<li>InnovaMatrix<sup>\u00ae</sup> FS</li>\n<li>Integra<sup>\u00ae</sup> Flow</li>\n<li>InteguPly<sup>\u2122</sup></li>\n<li>Interfy</li>\n<li>Jaloskin<sup>\u00ae</sup></li>\n<li>Keramatrix<sup>\u00ae</sup></li>\n<li>Kerasorb<sup>\u00ae</sup></li>\n<li>KeraSys<sup>\u2122</sup></li>\n<li>Keroxx Flowable Wound Matrix</li>\n<li>Lamellas</li>\n<li>Lamellas XT</li>\n<li>LiquidGen<sup>\u2122</sup></li>\n<li>Lyoplant<sup>\u00ae</sup> (See Tutopatch)</li>\n<li>MariGen Shield</li>\n<li>MatrACELL<sup>\u00ae</sup></li>\n<li>MatriDerm<sup>\u00ae</sup></li>\n<li>Matrion</li>\n<li>MatriStem<sup>\u00ae</sup></li>\n<li>Matrix HD<sup>\u2122</sup></li>\n<li>MatrixDerm<sup>\u2122</sup> (see Cytal)</li>\n<li>Medeor<sup>\u2122</sup></li>\n<li>MediHoney<sup>\u00ae</sup></li>\n<li>Mediskin<sup>\u00ae</sup></li>\n<li>Membrane Graft<sup>\u2122</sup></li>\n<li>Membrane Patch<sup>\u2122</sup></li>\n<li>Membrane Wrap <sup>\u2122</sup></li>\n<li>Membrane Wrap-Hydro</li>\n<li>Memoderm<sup>\u2122</sup></li>\n<li>Menaflex<sup>\u2122</sup> Collagen Meniscus Implant</li>\n<li>Meso BioMatrix<sup>\u2122</sup></li>\n<li>MIAMNION<sup>\u00ae</sup></li>\n<li>Microlyte matrix<sup>\u00ae</sup></li>\n<li>Miro3D</li>\n<li>MIRODERM<sup>\u2122</sup></li>\n<li>Miromatrix Biological Mesh</li>\n<li>Miromesh<sup>\u00ae</sup></li>\n<li>MLG-Complete</li>\n<li>MyOwn Skin</li>\n<li>Myriad Matrix<sup>\u2122</sup></li>\n<li>Myriad Morcells<sup>\u2122</sup></li>\n<li>Nanofactor<sup>\u2122</sup> Flow</li>\n<li>Nanofactor<sup>\u2122 </sup>Membrane</li>\n<li>Neoform Dermis<sup>\u2122</sup></li>\n<li>NeoMatriX</li>\n<li>Neopatch</li>\n<li>Neostim DL</li>\n<li>Neostim membrane</li>\n<li>Neostim TL</li>\n<li>Neox RT<sup>\u00ae</sup></li>\n<li>NEOX<sup>\u00ae </sup>100 Quick-Peel Wound Matrix</li>\n<li>NEOX<sup>\u00ae</sup> 1k Wound Matrix</li>\n<li>NEOX<sup>\u00ae </sup>FLO&nbsp;</li>\n<li>Neuragen<sup>\u00ae</sup> Nerve Guide</li>\n<li>Neuragen<sup>\u00ae</sup> Nerve Wrap</li>\n<li>NeuraWrap<sup>\u2122</sup></li>\n<li>Neuroflex<sup>\u2122</sup></li>\n<li>NeuroMatrix<sup>\u2122</sup></li>\n<li>NeuroMend<sup>\u2122</sup></li>\n<li>NEVELIA<sup>\u00ae</sup> bi-layer matrix</li>\n<li>Novachor</li>\n<li>Novafix<sup>\u2122</sup></li>\n<li>Novomaix Rebound Matrix</li>\n<li>Novosorb<sup>\u2122</sup> Biodegradable Temporizing Matrix (BMT)</li>\n<li>NuCel<sup>\u00ae</sup></li>\n<li>NuDyn<sup>\u2122</sup></li>\n<li>NuShield<sup>\u00ae</sup></li>\n<li>Ologen<sup>\u2122</sup> Collagen Matrix</li>\n<li>Omeza Collagen Matrix</li>\n<li>OrthADAPT<sup>\u2122</sup></li>\n<li>Orthoflow</li>\n<li>OsseoGuard<sup>\u00ae</sup></li>\n<li>Ovation<sup>\u00ae</sup></li>\n<li>PalinGen Flow<sup>\u2122</sup></li>\n<li>PalinGen SportFlow<sup>\u2122</sup></li>\n<li>PalinGen<sup>\u00ae</sup> Xplus Hydromembrane</li>\n<li>PalinGen<sup>\u00ae</sup> Xplus Membrane</li>\n<li>Pelvicol<sup>\u00ae</sup></li>\n<li>PelviSoft<sup>\u00ae</sup></li>\n<li>Pericol<sup>\u00ae</sup></li>\n<li>Peri-Guard<sup>\u00ae</sup> Repair Patch</li>\n<li>Peri-Strips Dry<sup>\u00ae</sup></li>\n<li>Permacol<sup>\u2122</sup></li>\n<li>PermeaDerm B</li>\n<li>PermeaDerm C</li>\n<li>PermeaDerm Glove</li>\n<li>Phasix Mesh<sup>\u2122</sup></li>\n<li>Phoenix<sup>\u2122</sup> Wound Matrix</li>\n<li>PhotoFix<sup>\u00ae</sup> Decellularized Bovine Pericardium</li>\n<li>Plurivest<sup>\u00ae</sup></li>\n<li>PolyCyte\u2122</li>\n<li>Preclude<sup>\u00ae</sup> Pericardial Membrane</li>\n<li>Preclude<sup>\u00ae</sup> Vessel Guard</li>\n<li>Procenta<sup>\u00ae</sup></li>\n<li>ProgenaMatrix<sup>\u2122</sup></li>\n<li>ProLayer</li>\n<li>ProMatrX ACF</li>\n<li>Promogran<sup>\u2122</sup></li>\n<li>Protext<sup>\u2122</sup></li>\n<li>PTFE felt</li>\n<li>Puracol<sup>\u00ae</sup></li>\n<li>PuraPly<sup>\u2122</sup> (see Fortaderm)</li>\n<li>Puros<sup>\u00ae</sup> Dermis</li>\n<li>PX50<sup>\u00ae</sup> and X50<sup>\u00ae</sup> Plus</li>\n<li>RegenePro<sup>\u2122</sup></li>\n<li>REGENETEN<sup>\u2122</sup></li>\n<li>REGUaRD</li>\n<li>ReNu<sup>\u00ae</sup></li>\n<li>Renuva<sup>\u00ae</sup></li>\n<li>Repliform<sup>\u00ae</sup></li>\n<li>Repriza<sup>\u2122</sup></li>\n<li>Resolve Matrix\u2122</li>\n<li>Restore<sup>\u00ae</sup> Orthobiologic Soft Tissue Implant</li>\n<li>Restorigin</li>\n<li>Restrata<sup>\u00ae</sup></li>\n<li>REVITA<sup>\u00ae </sup></li>\n<li>Revita<sup>\u00ae</sup></li>\n<li>Revitalon<sup>\u2122</sup></li>\n<li>RevoShield + Amniotic Barrier</li>\n<li>Rx Flow</li>\n<li>Rx Membrane</li>\n<li>Seamguard<sup>\u00ae</sup></li>\n<li>SERAGYN<sup>\u00ae</sup> BR</li>\n<li>SERASYNTH<sup>\u00ae</sup> MESH</li>\n<li>SERI<sup>\u00ae</sup> Surgical Scaffold</li>\n<li>Signature A Patch</li>\n<li>SIS Wound Dressing II</li>\n<li>SJM<sup>\u2122</sup> Pericardial Patch</li>\n<li>SkinTE</li>\n<li>SportMatrix</li>\n<li>SportMesh<sup>\u2122</sup></li>\n<li>SS Matrix<sup>\u2122</sup></li>\n<li>SteriGraft<sup>\u2122</sup></li>\n<li>SteriMatrix<sup>\u2122</sup></li>\n<li>SteriShield<sup>\u2122</sup></li>\n<li>Stimulen<sup>\u2122</sup> Collagen</li>\n<li>Stravix<sup>\u2122</sup></li>\n<li>SUPRA SDRM<sup>\u00ae</sup></li>\n<li>Suprathel<sup>\u00ae</sup></li>\n<li>SureDerm<sup>\u00ae</sup></li>\n<li>SurFactor<sup>\u00ae</sup></li>\n<li>SurGraft<sup>\u00ae</sup></li>\n<li>SurGraft FT</li>\n<li>SurGraftXL</li>\n<li>SurgiCord<sup>\u2122</sup></li>\n<li>surgiGRAFT<sup>\u2122</sup></li>\n<li>surgiGRAFT<sup>\u2122</sup> nano</li>\n<li>surgiGRAFT<sup>\u2122</sup>-Dual</li>\n<li>Surgisis<sup>\u00ae</sup> (including Surgisis<sup>\u00ae</sup> AFP<sup>\u2122</sup> Anal Fistula Plug, Surgisis<sup>\u00ae</sup> Gold<sup>\u2122</sup> Hernia Repair Grafts, and Surgisis<sup>\u00ae</sup> Biodesign<sup>\u2122</sup>)</li>\n<li>Symphony<sup>\u2122</sup></li>\n<li>Talymed<sup>\u2122</sup></li>\n<li>tarSys<sup>\u2122</sup></li>\n<li>TenoGlide<sup>\u2122</sup></li>\n<li>TenSIX<sup>\u2122</sup></li>\n<li>TheraForm<sup>\u2122</sup> Standard/Sheet</li>\n<li>TheraGenesis<sup>\u00ae</sup></li>\n<li>TIGR Matrix Surgical Mesh</li>\n<li>TiLOOP<sup>\u00ae</sup> Bra</li>\n<li>TissueMend<sup>\u00ae</sup></li>\n<li>Tornier<sup>\u00ae</sup> BioFiber Absorbable Biological Scaffold</li>\n<li>TranzGraft<sup>\u00ae</sup></li>\n<li>TruSkin<sup>\u2122</sup></li>\n<li>Tutomesh<sup>\u2122</sup> Fenestrated Bovine Pericardium</li>\n<li>Tutopatch<sup>\u2122</sup> Bovine Pericardium</li>\n<li>Unite<sup>\u2122</sup></li>\n<li>Vascu-Guard<sup>\u00ae</sup></li>\n<li>Vendaje (Other than for ocular indications. See medically necessary section for use for ocular indications)</li>\n<li>Veritas<sup>\u00ae</sup> Collagen Matrix</li>\n<li>VersaShield<sup>\u2122</sup></li>\n<li>VersaWrap<sup>\u00ae</sup></li>\n<li>VIA DERMIS<sup>\u2122</sup></li>\n<li>Via Disc<sup>\u00ae </sup>NP</li>\n<li>Viable Allograft Supplemental Disc Regeneration (VAST)</li>\n<li>Viaflow</li>\n<li>VIAGENEX<sup>\u00ae</sup></li>\n<li>VIM<sup>\u00ae</sup> human amniotic membrane</li>\n<li>WoundEx<sup>\u00ae</sup></li>\n<li>Woundfix Plus</li>\n<li>Woundfix Xplus</li>\n<li>Woundfix,</li>\n<li>WoundFix<sup>\u2122</sup></li>\n<li>Xceed<sup>\u2122</sup></li>\n<li>Xcellistem<sup>\u00ae</sup></li>\n<li>XCM Biologic<sup>\u2122</sup></li>\n<li>Xelma<sup>\u00ae</sup></li>\n<li>XenMatrix<sup>\u2122</sup> Surgical Graft</li>\n<li>XenoSure<sup>\u00ae</sup> Biologic Patch</li>\n<li>X-Repair</li>\n<li>Xwrap<sup>\u2122</sup> (Hydro, DRY, and ECM)</li>\n<li>Zenith<sup>\u2122</sup> human amniotic membrane.</li>",
    "content": "Medically Necessary:\nI.\u00a0 Breast reconstruction surgery\nThe following products are considered medically necessary when used for breast reconstruction surgery:\n<li>AlloDerm Regenerative Tissue Matrix (aseptic or sterile); or</li>\n<li>Cortiva<sup>\u00ae</sup>; or</li>\n<li>DermACELL<sup>\u2122</sup>; or</li>\n<li>DermaMatrix<sup>\u00ae</sup>; or</li>\n<li>FlexHD<sup>\u00ae</sup>; or</li>\n<li>SimpliDerm<sup>\u2122</sup>; or</li>\n<li>Strattice<sup>\u2122</sup>; or</li>\n<li>SurgiMend<sup>\u00ae.</sup></li>\nII.\u00a0 Burns\nThe following products are considered medically necessary when used for the treatment of full-thickness or deep partial-thickness burns:\n<li>Biobrane; or</li>\n<li>Epicel<sup>\u00ae; </sup>or</li>\n<li>EZ Derm<sup>\u2122</sup>; or</li>\n<li>Fresh frozen unprocessed allograft skin products (for example, AlloSkin<sup>\u2122</sup>*, TheraSkin<sup>\u00ae</sup>); or</li>\n<li>Integra<sup>\u2122</sup> Bilayer Matrix Wound Dressing; or</li>\n<li>Integra<sup>\u00ae</sup> Omnigraft Dermal Regeneration Template; or</li>\n<li>ReCell<sup>\u2122</sup> Autologous Harvesting Device; or</li>\n<li>StrataGraft<sup>\u00ae</sup>.</li>\n*Note: \u201cAlloSkin\u201d, \u201cAlloSkin RT<sup>\u2122</sup>\u201d, and \u201cAlloskin<sup>\u2122</sup> AC\u201d are different products. AlloSkin is a fresh-frozen product, AlloSkin RT is a fresh irradiated product (not frozen) and Alloskin AC is an acellular dermal matrix product. Please see the investigational and not medically necessary section below for the position on AlloSkin RT<sup>\u2122</sup> and Alloskin<sup>\u2122</sup> AC.\nIII.\u00a0 Complex abdominal wall wounds \nThe following products are considered medically necessary for the surgical repair of complex abdominal wall wounds:\n<li>AlloDerm Regenerative Tissue Matrix (aseptic or sterile); or</li>\n<li>Strattice; or</li>\n<li>OviTex<sup>\u2122</sup>.</li>\nIV.\u00a0 Diabetic foot ulcers\nThe following products are considered medically necessary for the treatment of diabetic foot ulcers when the clinical criteria below have been met:\n<li>Products:\t<ol> <li>AmnioBand<sup>\u00ae</sup>, sheet or membrane form; or</li> <li>Apligraf<sup>\u00ae</sup>; or</li> <li>Biovance<sup>\u00ae</sup>; or</li> <li>DermACELL<sup>\u2122</sup>; or</li> <li>Dermagraft<sup>\u00ae</sup>; or</li> <li>EpiCord; or</li> <li>EpiFix<sup>\u2122</sup>; or</li> <li>Grafix<sup>\u00ae</sup> PRIME; or</li> <li>Kerecis<sup>\u00ae</sup>; or</li> <li>mVASC; or</li> <li>Oasis<sup>\u2122</sup>; or</li> <li>TheraSkin<sup>\u00ae</sup>;<br/> and</li> </ol> </li>\n<li>AmnioBand<sup>\u00ae</sup>, sheet or membrane form; or</li>\n<li>Apligraf<sup>\u00ae</sup>; or</li>\n<li>Biovance<sup>\u00ae</sup>; or</li>\n<li>DermACELL<sup>\u2122</sup>; or</li>\n<li>Dermagraft<sup>\u00ae</sup>; or</li>\n<li>EpiCord; or</li>\n<li>EpiFix<sup>\u2122</sup>; or</li>\n<li>Grafix<sup>\u00ae</sup> PRIME; or</li>\n<li>Kerecis<sup>\u00ae</sup>; or</li>\n<li>mVASC; or</li>\n<li>Oasis<sup>\u2122</sup>; or</li>\n<li>TheraSkin<sup>\u00ae</sup>;<br/> and</li>\n<li>Clinical Criteria:\t<ol> <li>Ulcers that have not healed with standard conservative therapy (such as surgical debridement, complete off-loading, and standard dressing changes) attempted for at least 1 month but not greater than 52 weeks.</li> </ol> </li>\n<li>Ulcers that have not healed with standard conservative therapy (such as surgical debridement, complete off-loading, and standard dressing changes) attempted for at least 1 month but not greater than 52 weeks.</li>\nV.\u00a0 Dystrophic epidermolysis bullosa\nThe following products are considered medically necessary for the treatment dystrophic epidermolysis bullosa:\n<li>Dermagraft<sup>\u00ae</sup>; or</li>\n<li>OrCel<sup>\u2122</sup>.</li>\nVI.\u00a0 Lower extremity dermal wounds\nThe following products are considered medically necessary for the treatment of lower extremity dermal wounds when the clinical criteria below have been met:\n<li>Products:\t<ol> <li>GraftJacket\u2122, sheet or membrane form; or</li> <li>Oasis<sup>\u2122</sup>; or</li> <li>PriMatrix<sup>\u2122</sup>; or</li> <li>TheraSkin;<br/> and</li> </ol> </li>\n<li>GraftJacket\u2122, sheet or membrane form; or</li>\n<li>Oasis<sup>\u2122</sup>; or</li>\n<li>PriMatrix<sup>\u2122</sup>; or</li>\n<li>TheraSkin;<br/> and</li>\n<li>Clinical Criteria:\t<ol> <li>Wounds that have not healed with standard conservative therapy (such as surgical debridement, complete off-loading, standard dressing changes, and compression therapy) attempted for at least 1 month but not greater than 52 weeks.</li> </ol> </li>\n<li>Wounds that have not healed with standard conservative therapy (such as surgical debridement, complete off-loading, standard dressing changes, and compression therapy) attempted for at least 1 month but not greater than 52 weeks.</li>\nVII.\u00a0 Ocular indications\nAllogeneic amniotic membrane-derived grafts or wound coverings, including, but not limited to the following, are considered medically necessary when the clinical criteria below have been met:\n<li>Products:\t<ol> <li>AmbioDisk<sup>\u2122</sup>; or</li> <li>AmnioGraft<sup>\u00ae</sup>; or</li> <li>Artacent<sup>\u00ae</sup> Ocular; or</li> <li>Prokera<sup>\u00ae</sup>; or</li> <li>Vendaje Optic<sup>\u2122</sup>*;and</li> </ol> </li>\n<li>AmbioDisk<sup>\u2122</sup>; or</li>\n<li>AmnioGraft<sup>\u00ae</sup>; or</li>\n<li>Artacent<sup>\u00ae</sup> Ocular; or</li>\n<li>Prokera<sup>\u00ae</sup>; or</li>\n<li>Vendaje Optic<sup>\u2122</sup>*;and</li>\n<li>Clinical Criteria:\t<ol> <li>Reconstruction of large conjunctival resections; or</li> <li>Treatment of corneal injuries; or</li> <li>As an adjunct to surgical procedures involving the cornea.</li> </ol> </li>\n<li>Reconstruction of large conjunctival resections; or</li>\n<li>Treatment of corneal injuries; or</li>\n<li>As an adjunct to surgical procedures involving the cornea.</li>\n*See Investigational and Not Medically necessary section for the use of other Vendaje products.\nVIII.\u00a0 Venous stasis ulcers\nThe following products are considered medically necessary for the treatment of chronic venous stasis ulcers when the clinical criteria are met:\n<li>Products:\t<ol> <li>AmnioBand, sheet or membrane form; or</li> <li>Apligraf<sup>\u00ae</sup>; or</li> <li>EpiFix<sup>\u2122</sup>;<br/> and</li> </ol> </li>\n<li>AmnioBand, sheet or membrane form; or</li>\n<li>Apligraf<sup>\u00ae</sup>; or</li>\n<li>EpiFix<sup>\u2122</sup>;<br/> and</li>\n<li>Clinical Criteria:\t<ol> <li>Wound has been present for at least 1 month; and</li> <li>Has been unsuccessfully treated with compression therapy for at least 14 days.</li> </ol> </li>\n<li>Wound has been present for at least 1 month; and</li>\n<li>Has been unsuccessfully treated with compression therapy for at least 14 days.</li>\nNot Medically Necessary:\nThe following products are considered not medically necessary when criteria above are not met and for any use not listed above:\n<li>AlloDerm Regenerative Tissue Matrix (aseptic or sterile)</li>\n<li>Allogeneic amniotic membrane-derived grafts or wound coverings when used for ocular indications</li>\n<li>AlloSkin</li>\n<li>AmbioDisk</li>\n<li>AmnioBand, sheet or membrane form</li>\n<li>AmnioGraft</li>\n<li>Apligraf</li>\n<li>Artacent Ocular</li>\n<li>Biobrane</li>\n<li>Biovance</li>\n<li>Cortiva</li>\n<li>DermACELL</li>\n<li>Dermagraft</li>\n<li>DermaMatrix</li>\n<li>Epicel</li>\n<li>EpiCord</li>\n<li>EpiFix, sheet or membrane form</li>\n<li>EZ Derm</li>\n<li>FlexHD</li>\n<li>Fresh frozen unprocessed allograft skin products (for example, AlloSkin*, TheraSkin)</li>\n<li>Grafix PRIME</li>\n<li>GraftJacket, sheet or membrane form</li>\n<li>Integra Bilayer Matrix Wound Dressing</li>\n<li>Integra<sup>\u00ae</sup> Omnigraft Dermal Regeneration Template</li>\n<li>Kerecis<sup>\u2122</sup></li>\n<li>mVASC</li>\n<li>Oasis<sup>\u2122</sup></li>\n<li>Omnigraft (also see Integra Omnigraft Dermal Regeneration Template)</li>\n<li>OrCel</li>\n<li>OviTex</li>\n<li>PriMatrix</li>\n<li>Prokera</li>\n<li>ReCell\u2122 Autologous Harvesting Device</li>\n<li>SimpliDerm</li>\n<li>StrataGraft</li>\n<li>Strattice</li>\n<li>SurgiMend<sup>\u00ae</sup></li>\n<li>TheraSkin</li>\n<li>Vendaje Optic</li>\nInvestigational and Not Medically Necessary\nThe use of all other allogeneic, xenographic, synthetic, and composite products for wound healing or soft tissue grafting, including but not limited to the following products, is considered investigational and not medically necessary for all uses:\n<li>Ac5 advanced wound system</li>\n<li>Acesso DL</li>\n<li>Acesso TL</li>\n<li>ACM Extra Surgical Collagen</li>\n<li>ACM Extra Surgical Collagen Powder</li>\n<li>ACM Surgical Collagen</li>\n<li>Actishield<sup>\u2122</sup></li>\n<li>ActiveBarrier<sup>\u00ae</sup></li>\n<li>ActiveMatrix<sup>\u00ae</sup></li>\n<li>Affinity<sup>\u2122</sup></li>\n<li>AlloGen-LI<sup>\u2122</sup>\u00a0</li>\n<li>AlloGen<sup>\u2122</sup>\u00a0</li>\n<li>AlloMax<sup>\u2122</sup></li>\n<li>AlloMend<sup>\u2122</sup></li>\n<li>Allopatch HD<sup>\u2122</sup></li>\n<li>AlloPatch<sup>\u00ae</sup> Pliable</li>\n<li>Alloskin AC</li>\n<li>AlloSkin RT<sup> </sup></li>\n<li>AlloWrap<sup>\u00ae</sup></li>\n<li>AlloWrap<sup>\u2122</sup> Dry</li>\n<li>AlloWrap<sup>\u2122</sup> DS</li>\n<li>Alphaplex<sup>\u2122</sup> with MariGen Omega3<sup>\u2122</sup></li>\n<li>AltiPly<sup>\u2122</sup></li>\n<li>AmbientFactor<sup>\u2122</sup></li>\n<li>Ambio5<sup>\u00ae</sup></li>\n<li>AmniCore Pro+</li>\n<li>Amnio FRT\u2122</li>\n<li>Amnio F\u2122</li>\n<li>Amnio Quad-Core</li>\n<li>Amnio Restore<sup>\u2122</sup></li>\n<li>Amnio Tri-Core amniotic</li>\n<li>Amnio wound</li>\n<li>AmnioAMP-MP</li>\n<li>AmnioAMP-PF</li>\n<li>AmnioAMP-X</li>\n<li>AmnioArmor<sup>\u00ae</sup></li>\n<li>AmnioBand, particulate or injectable form</li>\n<li>AmnioBind</li>\n<li>AmnioCare<sup>\u00ae</sup></li>\n<li>AmnioClear<sup>\u00ae</sup></li>\n<li>AmnioCord<sup>\u00ae</sup></li>\n<li>AmnioCore</li>\n<li>AmnioCore Pro</li>\n<li>AmnioCyte</li>\n<li>AMNIOEXCEL<sup>\u2122</sup></li>\n<li>Amniofill<sup>\u00ae</sup></li>\n<li>AmnioFix<sup>\u2122</sup></li>\n<li>Amnioflex<sup>\u2122</sup></li>\n<li>AmnioGuard<sup>\u00ae</sup></li>\n<li>AmnioHeal<sup>\u00ae</sup></li>\n<li>AmnioMatrix<sup>\u2122</sup></li>\n<li>AmnioMTM<sup>\u2122</sup></li>\n<li>Amniopro<sup>\u2122</sup></li>\n<li>AMNIOREPAIR<sup>\u2122</sup></li>\n<li>Amnios<sup>\u00ae</sup></li>\n<li>Amnios<sup>\u00ae</sup> RT</li>\n<li>AmnioShield<sup>\u00ae</sup></li>\n<li>Amniostrip<sup>\u2122</sup></li>\n<li>Amniotext</li>\n<li>Amniovo\u2122 (Solo, Dual, and Matrix)</li>\n<li>Amniovo\u2122 Max</li>\n<li>Amniowrap2<sup>\u2122</sup></li>\n<li>Amniply</li>\n<li>AmnyoFactor<sup>\u2122</sup></li>\n<li>AmnyoFluid<sup>\u2122</sup></li>\n<li>Anu RHEO<sup>\u2122</sup></li>\n<li>Aongen<sup>\u2122</sup> Collagen Matrix</li>\n<li>Apis<sup>\u00ae</sup></li>\n<li>Architect Extracellular Matrix<sup>\u2122</sup></li>\n<li>AROA ECM<sup>\u2122</sup></li>\n<li>Artacent<sup>\u00ae</sup> AC Powder</li>\n<li>Artacent<sup>\u00ae</sup> cord</li>\n<li>Artacent<sup>\u00ae</sup> Flex</li>\n<li>Artacent<sup>\u00ae</sup> Wound</li>\n<li>Artelon<sup>\u00ae</sup></li>\n<li>Arthrex<sup>\u00ae</sup> Amnion matrix</li>\n<li>ArthroFlex<sup>\u2122</sup></li>\n<li>ARTIA\u2122 Reconstructive Tissue Matrix</li>\n<li>Ascent<sup>\u00ae</sup></li>\n<li>Atlas Wound Matrix</li>\n<li>Avance<sup>\u00ae</sup> Nerve Graft</li>\n<li>Avaulta Plus<sup>\u2122</sup></li>\n<li>Avive<sup>\u00ae</sup></li>\n<li>AxoBioMembrane</li>\n<li>Axograft<sup>\u2122</sup></li>\n<li>AxoGuard<sup>\u00ae</sup> nerve connector</li>\n<li>AxoGuard<sup>\u00ae</sup> nerve protector</li>\n<li>Axolotl Ambient<sup>\u2122</sup></li>\n<li>Axolotl Cryo<sup>\u2122</sup></li>\n<li>Axolotl DualGraft<sup>\u2122</sup></li>\n<li>Axolotl Graft<sup>\u2122</sup></li>\n<li>Axolotl Shot<sup>\u2122</sup></li>\n<li>BEAR<sup>\u00ae</sup> (Bridge-Enhanced ACL Repair) Implant</li>\n<li>BellaCell HD</li>\n<li>Belladerm<sup>\u00ae</sup></li>\n<li>BellaGen<sup>\u2122</sup></li>\n<li>Bio-ConneKt<sup>\u00ae</sup></li>\n<li>BioDDryFlex<sup>\u00ae </sup>Resorbable Adhesion Barrier</li>\n<li>Biodesign Nipple Reconstruction Cylinder</li>\n<li>BioDExCel<sup>\u2122</sup></li>\n<li>BioDFactor<sup>\u2122</sup></li>\n<li>BioDFence<sup>\u2122</sup></li>\n<li>BioDOptix<sup>\u2122</sup></li>\n<li>Bioengineered autologous skin-derived products (for example, SkinTE<sup>\u2122</sup>, MyOwn Skin<sup>\u2122</sup>)</li>\n<li>BioFiber<sup>\u2122</sup></li>\n<li>BioFix</li>\n<li>BioSkin<sup>\u00ae</sup> Flow Amniotic Wound Matrix</li>\n<li>Biotape XM Tissue Matrix</li>\n<li>BioWound</li>\n<li>BioWound plus</li>\n<li>BioWound Xplus</li>\n<li>Cardiamend<sup>\u2122</sup></li>\n<li>CardioCel<sup>\u00ae</sup></li>\n<li>CardioGRAFT<sup>\u00ae</sup></li>\n<li>Celera Dual Layer<sup>\u2122</sup></li>\n<li>Celera Dual Membrane<sup>\u2122</sup></li>\n<li>CellerateRX<sup>\u00ae</sup></li>\n<li>Cellesta amnion granulate</li>\n<li>Cellesta amniotic membrane</li>\n<li>Cellesta cord</li>\n<li>Cellesta flowable amnion</li>\n<li>Cellesta<sup>\u2122</sup> Amniotic Membrane</li>\n<li>CG CryoDerm<sup>\u2122</sup></li>\n<li>CLARIX<sup>\u2122</sup> 100 Quick-Peel Wound Matrix</li>\n<li>CLARIX<sup>\u2122</sup> 1k</li>\n<li>CLARIX<sup>\u2122</sup> FLO</li>\n<li>Cocoon Membrane</li>\n<li>Cogenex Amniotic Membrane</li>\n<li>Cogenex Flowable Amnion</li>\n<li>CollaFilm<sup>\u00ae</sup></li>\n<li>CollaFix<sup>\u2122</sup></li>\n<li>CollaGUARD<sup>\u00ae</sup></li>\n<li>CollaMend<sup>\u2122</sup></li>\n<li>COLLARX<sup>\u00ae</sup></li>\n<li>CollaSorb<sup>\u2122</sup></li>\n<li>CollaWound<sup>\u2122</sup></li>\n<li>Coll-e-Derm<sup>\u2122</sup></li>\n<li>Collexa<sup>\u00ae</sup></li>\n<li>Collieva<sup>\u00ae</sup></li>\n<li>Complete AA</li>\n<li>Complete ACA</li>\n<li>Complete FT</li>\n<li>Complete SL</li>\n<li>Conexa<sup>\u2122</sup></li>\n<li>Connext<sup>\u2122</sup> Surgical Matrix</li>\n<li>CoreCyte<sup>\u2122</sup></li>\n<li>Coreleader Colla-Pad</li>\n<li>Coretext<sup>\u2122</sup></li>\n<li>CorMatrix<sup>\u00ae</sup></li>\n<li>Corova</li>\n<li>Corplex<sup>\u2122</sup></li>\n<li>C-QUR<sup>\u2122</sup></li>\n<li>CRXa<sup>\u2122</sup></li>\n<li>Cryo-Cord<sup>\u2122</sup></li>\n<li>CryoMatrix<sup>\u00ae</sup></li>\n<li>CryoSkin<sup>\u00ae</sup></li>\n<li>Cuffpatch<sup>\u2122</sup></li>\n<li>CYGNUS Matrix<sup>\u2122</sup></li>\n<li>CYGNUS Max<sup>\u2122</sup></li>\n<li>CYGNUS Solo<sup>\u2122</sup></li>\n<li>Cymetra<sup>\u00ae</sup></li>\n<li>Cytal<sup>\u00ae</sup> Burn Matrix (formerly MatriStem)</li>\n<li>Cytal<sup>\u00ae </sup>Multilayer Matrix (formerly MatriStem)</li>\n<li>Cytal<sup>\u00ae</sup> Wound Matrix (formerly MatriStem)</li>\n<li>Cytoflex<sup>\u00ae</sup></li>\n<li>Cytoplast<sup>\u2122</sup></li>\n<li>DeNovo<sup>\u00ae</sup> NT Graft</li>\n<li>DermaBind CH</li>\n<li>DermaBind SL</li>\n<li>Dermacyte</li>\n<li>DermADAPT<sup>\u2122</sup> Wound Dressing</li>\n<li>Derma-Gide<sup>\u00ae</sup></li>\n<li>DermaPure<sup>\u2122</sup></li>\n<li>DermaSpan<sup>\u2122</sup></li>\n<li>Dermavest 2<sup>\u2122</sup></li>\n<li>Dermavest<sup>\u2122</sup></li>\n<li>DermMatrix</li>\n<li>Derm-Maxx</li>\n<li>DressSkin<sup>\u2122</sup></li>\n<li>DuraForm<sup>\u2122</sup></li>\n<li>Duragen<sup>\u00ae</sup> XS</li>\n<li>Duragen<sup>\u2122</sup> Plus</li>\n<li>DuraMatrix<sup>\u2122</sup></li>\n<li>Durepair<sup>\u00ae</sup> Regeneration Matrix</li>\n<li>Emerge Matrix</li>\n<li>Endobon<sup>\u00ae</sup> Xenograft Granules</li>\n<li>Endoform<sup>\u00ae </sup>Antimicrobial</li>\n<li>Endoform<sup>\u00ae </sup>Natural Dermal Template</li>\n<li>ENDURAgen<sup>\u2122</sup></li>\n<li>Enverse<sup>\u00ae</sup></li>\n<li>EpiBurn</li>\n<li>EpiDex<sup>\u00ae</sup></li>\n<li>EpiFix<sup>\u2122</sup>, particulate or injectable form</li>\n<li>EpiFlex<sup>\u00ae</sup></li>\n<li>Excellagen<sup>\u00ae</sup>\u00a0</li>\n<li>Fibro-Gide<sup>\u00ae</sup></li>\n<li>FloGraft<sup>\u2122</sup></li>\n<li>FlowerDerm<sup>\u2122</sup></li>\n<li>FlowerFlo<sup>\u2122</sup> (FlowerAmnioFlo)</li>\n<li>FlowerPatch<sup>\u2122</sup> (FlowerAMINOPatch)</li>\n<li>Fluid flow<sup>\u2122</sup></li>\n<li>Fluid GF<sup>\u2122</sup></li>\n<li>FortaDerm<sup>\u2122</sup> Wound Dressing (see PuraPly<sup>\u2122</sup>)</li>\n<li>Fortiva<sup>\u2122</sup> Porcine Dermis</li>\n<li>GalaFLEX<sup>\u00ae</sup></li>\n<li>GalaFORM<sup>\u00ae</sup></li>\n<li>GalaSHAPE<sup>\u00ae</sup> 3D</li>\n<li>Gammagraft<sup>\u2122</sup></li>\n<li>Genesis amniotic membrane</li>\n<li>Gentrix<sup>\u00ae</sup> Surgical Matrix</li>\n<li>GENTRIX<sup>\u2122</sup></li>\n<li>GORE BIO-A<sup>\u00ae</sup> Fistula Plug</li>\n<li>Gore<sup>\u00ae</sup> Acuseal Cardiovascular Patch</li>\n<li>Grafix plus</li>\n<li>Grafix<sup>\u00ae</sup> CORE</li>\n<li>GrafixPL PRIME<sup>\u00ae</sup></li>\n<li>Graftjacket<sup>\u2122</sup> Xpress injectable</li>\n<li>GraftJacket<sup>\u2122</sup>, injectable form</li>\n<li>GraftRope<sup>\u2122</sup></li>\n<li>HA Absorbent Wound Dressing</li>\n<li>Helicoll</li>\n<li>HeliMEND</li>\n<li>Helisorb<sup>\u00ae</sup></li>\n<li>hMatrix<sup>\u00ae</sup></li>\n<li>Human health factor 10<sup>\u2122</sup> amniotic patch (hhf10-p)</li>\n<li>Hyalomatrix<sup>\u00ae</sup></li>\n<li>Impax Dual Layer</li>\n<li>Inforce<sup>\u00ae</sup></li>\n<li>InnovaBurn\u00ae</li>\n<li>InnovaMatrix<sup>\u00ae</sup> PD</li>\n<li>InnovaMatrix<sup>\u00ae </sup>AC</li>\n<li>InnovaMatrix<sup>\u00ae</sup> FS</li>\n<li>Integra<sup>\u00ae</sup> Flow</li>\n<li>InteguPly<sup>\u2122</sup></li>\n<li>Interfy</li>\n<li>Jaloskin<sup>\u00ae</sup></li>\n<li>Keramatrix<sup>\u00ae</sup></li>\n<li>Kerasorb<sup>\u00ae</sup></li>\n<li>KeraSys<sup>\u2122</sup></li>\n<li>Keroxx Flowable Wound Matrix</li>\n<li>Lamellas</li>\n<li>Lamellas XT</li>\n<li>LiquidGen<sup>\u2122</sup></li>\n<li>Lyoplant<sup>\u00ae</sup> (See Tutopatch)</li>\n<li>MariGen Shield</li>\n<li>MatrACELL<sup>\u00ae</sup></li>\n<li>MatriDerm<sup>\u00ae</sup></li>\n<li>Matrion</li>\n<li>MatriStem<sup>\u00ae</sup></li>\n<li>Matrix HD<sup>\u2122</sup></li>\n<li>MatrixDerm<sup>\u2122</sup> (see Cytal)</li>\n<li>Medeor<sup>\u2122</sup></li>\n<li>MediHoney<sup>\u00ae</sup></li>\n<li>Mediskin<sup>\u00ae</sup></li>\n<li>Membrane Graft<sup>\u2122</sup></li>\n<li>Membrane Patch<sup>\u2122</sup></li>\n<li>Membrane Wrap <sup>\u2122</sup></li>\n<li>Membrane Wrap-Hydro</li>\n<li>Memoderm<sup>\u2122</sup></li>\n<li>Menaflex<sup>\u2122</sup> Collagen Meniscus Implant</li>\n<li>Meso BioMatrix<sup>\u2122</sup></li>\n<li>MIAMNION<sup>\u00ae</sup></li>\n<li>Microlyte matrix<sup>\u00ae</sup></li>\n<li>Miro3D</li>\n<li>MIRODERM<sup>\u2122</sup></li>\n<li>Miromatrix Biological Mesh</li>\n<li>Miromesh<sup>\u00ae</sup></li>\n<li>MLG-Complete</li>\n<li>MyOwn Skin</li>\n<li>Myriad Matrix<sup>\u2122</sup></li>\n<li>Myriad Morcells<sup>\u2122</sup></li>\n<li>Nanofactor<sup>\u2122</sup> Flow</li>\n<li>Nanofactor<sup>\u2122 </sup>Membrane</li>\n<li>Neoform Dermis<sup>\u2122</sup></li>\n<li>NeoMatriX</li>\n<li>Neopatch</li>\n<li>Neostim DL</li>\n<li>Neostim membrane</li>\n<li>Neostim TL</li>\n<li>Neox RT<sup>\u00ae</sup></li>\n<li>NEOX<sup>\u00ae </sup>100 Quick-Peel Wound Matrix</li>\n<li>NEOX<sup>\u00ae</sup> 1k Wound Matrix</li>\n<li>NEOX<sup>\u00ae </sup>FLO\u00a0</li>\n<li>Neuragen<sup>\u00ae</sup> Nerve Guide</li>\n<li>Neuragen<sup>\u00ae</sup> Nerve Wrap</li>\n<li>NeuraWrap<sup>\u2122</sup></li>\n<li>Neuroflex<sup>\u2122</sup></li>\n<li>NeuroMatrix<sup>\u2122</sup></li>\n<li>NeuroMend<sup>\u2122</sup></li>\n<li>NEVELIA<sup>\u00ae</sup> bi-layer matrix</li>\n<li>Novachor</li>\n<li>Novafix<sup>\u2122</sup></li>\n<li>Novomaix Rebound Matrix</li>\n<li>Novosorb<sup>\u2122</sup> Biodegradable Temporizing Matrix (BMT)</li>\n<li>NuCel<sup>\u00ae</sup></li>\n<li>NuDyn<sup>\u2122</sup></li>\n<li>NuShield<sup>\u00ae</sup></li>\n<li>Ologen<sup>\u2122</sup> Collagen Matrix</li>\n<li>Omeza Collagen Matrix</li>\n<li>OrthADAPT<sup>\u2122</sup></li>\n<li>Orthoflow</li>\n<li>OsseoGuard<sup>\u00ae</sup></li>\n<li>Ovation<sup>\u00ae</sup></li>\n<li>PalinGen Flow<sup>\u2122</sup></li>\n<li>PalinGen SportFlow<sup>\u2122</sup></li>\n<li>PalinGen<sup>\u00ae</sup> Xplus Hydromembrane</li>\n<li>PalinGen<sup>\u00ae</sup> Xplus Membrane</li>\n<li>Pelvicol<sup>\u00ae</sup></li>\n<li>PelviSoft<sup>\u00ae</sup></li>\n<li>Pericol<sup>\u00ae</sup></li>\n<li>Peri-Guard<sup>\u00ae</sup> Repair Patch</li>\n<li>Peri-Strips Dry<sup>\u00ae</sup></li>\n<li>Permacol<sup>\u2122</sup></li>\n<li>PermeaDerm B</li>\n<li>PermeaDerm C</li>\n<li>PermeaDerm Glove</li>\n<li>Phasix Mesh<sup>\u2122</sup></li>\n<li>Phoenix<sup>\u2122</sup> Wound Matrix</li>\n<li>PhotoFix<sup>\u00ae</sup> Decellularized Bovine Pericardium</li>\n<li>Plurivest<sup>\u00ae</sup></li>\n<li>PolyCyte\u2122</li>\n<li>Preclude<sup>\u00ae</sup> Pericardial Membrane</li>\n<li>Preclude<sup>\u00ae</sup> Vessel Guard</li>\n<li>Procenta<sup>\u00ae</sup></li>\n<li>ProgenaMatrix<sup>\u2122</sup></li>\n<li>ProLayer</li>\n<li>ProMatrX ACF</li>\n<li>Promogran<sup>\u2122</sup></li>\n<li>Protext<sup>\u2122</sup></li>\n<li>PTFE felt</li>\n<li>Puracol<sup>\u00ae</sup></li>\n<li>PuraPly<sup>\u2122</sup> (see Fortaderm)</li>\n<li>Puros<sup>\u00ae</sup> Dermis</li>\n<li>PX50<sup>\u00ae</sup> and X50<sup>\u00ae</sup> Plus</li>\n<li>RegenePro<sup>\u2122</sup></li>\n<li>REGENETEN<sup>\u2122</sup></li>\n<li>REGUaRD</li>\n<li>ReNu<sup>\u00ae</sup></li>\n<li>Renuva<sup>\u00ae</sup></li>\n<li>Repliform<sup>\u00ae</sup></li>\n<li>Repriza<sup>\u2122</sup></li>\n<li>Resolve Matrix\u2122</li>\n<li>Restore<sup>\u00ae</sup> Orthobiologic Soft Tissue Implant</li>\n<li>Restorigin</li>\n<li>Restrata<sup>\u00ae</sup></li>\n<li>REVITA<sup>\u00ae </sup></li>\n<li>Revita<sup>\u00ae</sup></li>\n<li>Revitalon<sup>\u2122</sup></li>\n<li>RevoShield + Amniotic Barrier</li>\n<li>Rx Flow</li>\n<li>Rx Membrane</li>\n<li>Seamguard<sup>\u00ae</sup></li>\n<li>SERAGYN<sup>\u00ae</sup> BR</li>\n<li>SERASYNTH<sup>\u00ae</sup> MESH</li>\n<li>SERI<sup>\u00ae</sup> Surgical Scaffold</li>\n<li>Signature A Patch</li>\n<li>SIS Wound Dressing II</li>\n<li>SJM<sup>\u2122</sup> Pericardial Patch</li>\n<li>SkinTE</li>\n<li>SportMatrix</li>\n<li>SportMesh<sup>\u2122</sup></li>\n<li>SS Matrix<sup>\u2122</sup></li>\n<li>SteriGraft<sup>\u2122</sup></li>\n<li>SteriMatrix<sup>\u2122</sup></li>\n<li>SteriShield<sup>\u2122</sup></li>\n<li>Stimulen<sup>\u2122</sup> Collagen</li>\n<li>Stravix<sup>\u2122</sup></li>\n<li>SUPRA SDRM<sup>\u00ae</sup></li>\n<li>Suprathel<sup>\u00ae</sup></li>\n<li>SureDerm<sup>\u00ae</sup></li>\n<li>SurFactor<sup>\u00ae</sup></li>\n<li>SurGraft<sup>\u00ae</sup></li>\n<li>SurGraft FT</li>\n<li>SurGraftXL</li>\n<li>SurgiCord<sup>\u2122</sup></li>\n<li>surgiGRAFT<sup>\u2122</sup></li>\n<li>surgiGRAFT<sup>\u2122</sup> nano</li>\n<li>surgiGRAFT<sup>\u2122</sup>-Dual</li>\n<li>Surgisis<sup>\u00ae</sup> (including Surgisis<sup>\u00ae</sup> AFP<sup>\u2122</sup> Anal Fistula Plug, Surgisis<sup>\u00ae</sup> Gold<sup>\u2122</sup> Hernia Repair Grafts, and Surgisis<sup>\u00ae</sup> Biodesign<sup>\u2122</sup>)</li>\n<li>Symphony<sup>\u2122</sup></li>\n<li>Talymed<sup>\u2122</sup></li>\n<li>tarSys<sup>\u2122</sup></li>\n<li>TenoGlide<sup>\u2122</sup></li>\n<li>TenSIX<sup>\u2122</sup></li>\n<li>TheraForm<sup>\u2122</sup> Standard/Sheet</li>\n<li>TheraGenesis<sup>\u00ae</sup></li>\n<li>TIGR Matrix Surgical Mesh</li>\n<li>TiLOOP<sup>\u00ae</sup> Bra</li>\n<li>TissueMend<sup>\u00ae</sup></li>\n<li>Tornier<sup>\u00ae</sup> BioFiber Absorbable Biological Scaffold</li>\n<li>TranzGraft<sup>\u00ae</sup></li>\n<li>TruSkin<sup>\u2122</sup></li>\n<li>Tutomesh<sup>\u2122</sup> Fenestrated Bovine Pericardium</li>\n<li>Tutopatch<sup>\u2122</sup> Bovine Pericardium</li>\n<li>Unite<sup>\u2122</sup></li>\n<li>Vascu-Guard<sup>\u00ae</sup></li>\n<li>Vendaje (Other than for ocular indications. See medically necessary section for use for ocular indications)</li>\n<li>Veritas<sup>\u00ae</sup> Collagen Matrix</li>\n<li>VersaShield<sup>\u2122</sup></li>\n<li>VersaWrap<sup>\u00ae</sup></li>\n<li>VIA DERMIS<sup>\u2122</sup></li>\n<li>Via Disc<sup>\u00ae </sup>NP</li>\n<li>Viable Allograft Supplemental Disc Regeneration (VAST)</li>\n<li>Viaflow</li>\n<li>VIAGENEX<sup>\u00ae</sup></li>\n<li>VIM<sup>\u00ae</sup> human amniotic membrane</li>\n<li>WoundEx<sup>\u00ae</sup></li>\n<li>Woundfix Plus</li>\n<li>Woundfix Xplus</li>\n<li>Woundfix,</li>\n<li>WoundFix<sup>\u2122</sup></li>\n<li>Xceed<sup>\u2122</sup></li>\n<li>Xcellistem<sup>\u00ae</sup></li>\n<li>XCM Biologic<sup>\u2122</sup></li>\n<li>Xelma<sup>\u00ae</sup></li>\n<li>XenMatrix<sup>\u2122</sup> Surgical Graft</li>\n<li>XenoSure<sup>\u00ae</sup> Biologic Patch</li>\n<li>X-Repair</li>\n<li>Xwrap<sup>\u2122</sup> (Hydro, DRY, and ECM)</li>\n<li>Zenith<sup>\u2122</sup> human amniotic membrane.</li>",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Breast reconstruction surgery",
            "sub_medical_act": null,
            "necessity_type": "Medically Necessary",
            "description": "The following products are considered medically necessary when used for breast reconstruction surgery:",
            "conditions": {
              "ANY": [
                {
                  "desc": "AlloDerm Regenerative Tissue Matrix (aseptic or sterile)",
                  "conditions": null
                },
                {
                  "desc": "Cortiva\u00ae",
                  "conditions": null
                },
                {
                  "desc": "DermACELL\u2122",
                  "conditions": null
                },
                {
                  "desc": "DermaMatrix\u00ae",
                  "conditions": null
                },
                {
                  "desc": "FlexHD\u00ae",
                  "conditions": null
                },
                {
                  "desc": "SimpliDerm\u2122",
                  "conditions": null
                },
                {
                  "desc": "Strattice\u2122",
                  "conditions": null
                },
                {
                  "desc": "SurgiMend\u00ae",
                  "conditions": null
                }
              ]
            }
          },
          {
            "medical_act": "Burns",
            "sub_medical_act": null,
            "necessity_type": "Medically Necessary",
            "description": "The following products are considered medically necessary when used for the treatment of full-thickness or deep partial-thickness burns:",
            "conditions": {
              "ANY": [
                {
                  "desc": "Biobrane",
                  "conditions": null
                },
                {
                  "desc": "Epicel\u00ae",
                  "conditions": null
                },
                {
                  "desc": "EZ Derm\u2122",
                  "conditions": null
                },
                {
                  "desc": "Fresh frozen unprocessed allograft skin products (for example, AlloSkin\u2122, TheraSkin\u00ae)",
                  "conditions": null
                },
                {
                  "desc": "Integra\u2122 Bilayer Matrix Wound Dressing",
                  "conditions": null
                },
                {
                  "desc": "Integra\u00ae Omnigraft Dermal Regeneration Template",
                  "conditions": null
                },
                {
                  "desc": "ReCell\u2122 Autologous Harvesting Device",
                  "conditions": null
                },
                {
                  "desc": "StrataGraft\u00ae",
                  "conditions": null
                }
              ]
            }
          },
          {
            "medical_act": "Complex abdominal wall wounds",
            "sub_medical_act": null,
            "necessity_type": "Medically Necessary",
            "description": "The following products are considered medically necessary for the surgical repair of complex abdominal wall wounds:",
            "conditions": {
              "ANY": [
                {
                  "desc": "AlloDerm Regenerative Tissue Matrix (aseptic or sterile)",
                  "conditions": null
                },
                {
                  "desc": "Strattice",
                  "conditions": null
                },
                {
                  "desc": "OviTex\u2122",
                  "conditions": null
                }
              ]
            }
          },
          {
            "medical_act": "Diabetic foot ulcers",
            "sub_medical_act": null,
            "necessity_type": "Medically Necessary",
            "description": "The following products are considered medically necessary for the treatment of diabetic foot ulcers when the clinical criteria below have been met:",
            "conditions": {
              "ALL": [
                {
                  "ANY": [
                    {
                      "desc": "AmnioBand\u00ae",
                      "conditions": null
                    },
                    {
                      "desc": "Apligraf\u00ae",
                      "conditions": null
                    },
                    {
                      "desc": "Biovance\u00ae",
                      "conditions": null
                    },
                    {
                      "desc": "DermACELL\u2122",
                      "conditions": null
                    },
                    {
                      "desc": "Dermagraft\u00ae",
                      "conditions": null
                    },
                    {
                      "desc": "EpiCord",
                      "conditions": null
                    },
                    {
                      "desc": "EpiFix\u2122",
                      "conditions": null
                    },
                    {
                      "desc": "Grafix\u00ae PRIME",
                      "conditions": null
                    },
                    {
                      "desc": "Kerecis\u00ae",
                      "conditions": null
                    },
                    {
                      "desc": "mVASC",
                      "conditions": null
                    },
                    {
                      "desc": "Oasis\u2122",
                      "conditions": null
                    },
                    {
                      "desc": "TheraSkin\u00ae",
                      "conditions": null
                    }
                  ]
                },
                {
                  "ALL": [
                    {
                      "desc": "Ulcers that have not healed with standard conservative therapy (such as surgical debridement, complete off-loading, and standard dressing changes) attempted for at least 1 month but not greater than 52 weeks.",
                      "conditions": null
                    }
                  ]
                }
              ]
            }
          },
          {
            "medical_act": "Dystrophic epidermolysis bullosa",
            "sub_medical_act": null,
            "necessity_type": "Medically Necessary",
            "description": "The following products are considered medically necessary for the treatment dystrophic epidermolysis bullosa:",
            "conditions": {
              "ANY": [
                {
                  "desc": "Dermagraft\u00ae",
                  "conditions": null
                },
                {
                  "desc": "OrCel\u2122",
                  "conditions": null
                }
              ]
            }
          },
          {
            "medical_act": "Lower extremity dermal wounds",
            "sub_medical_act": null,
            "necessity_type": "Medically Necessary",
            "description": "The following products are considered medically necessary for the treatment of lower extremity dermal wounds when the clinical criteria below have been met:",
            "conditions": {
              "ALL": [
                {
                  "ANY": [
                    {
                      "desc": "GraftJacket\u2122, sheet or membrane form",
                      "conditions": null
                    },
                    {
                      "desc": "Oasis\u2122",
                      "conditions": null
                    },
                    {
                      "desc": "PriMatrix\u2122",
                      "conditions": null
                    },
                    {
                      "desc": "TheraSkin",
                      "conditions": null
                    }
                  ]
                },
                {
                  "ALL": [
                    {
                      "desc": "Wounds that have not healed with standard conservative therapy (such as surgical debridement, complete off-loading, standard dressing changes, and compression therapy) attempted for at least 1 month but not greater than 52 weeks.",
                      "conditions": null
                    }
                  ]
                }
              ]
            }
          },
          {
            "medical_act": "Ocular indications",
            "sub_medical_act": null,
            "necessity_type": "Medically Necessary",
            "description": "Allogeneic amniotic membrane-derived grafts or wound coverings, including, but not limited to the following, are considered medically necessary when the clinical criteria below have been met:",
            "conditions": {
              "ALL": [
                {
                  "ANY": [
                    {
                      "desc": "AmbioDisk\u2122",
                      "conditions": null
                    },
                    {
                      "desc": "AmnioGraft\u00ae",
                      "conditions": null
                    },
                    {
                      "desc": "Artacent\u00ae Ocular",
                      "conditions": null
                    },
                    {
                      "desc": "Prokera\u00ae",
                      "conditions": null
                    },
                    {
                      "desc": "Vendaje Optic\u2122",
                      "conditions": null
                    }
                  ]
                },
                {
                  "ANY": [
                    {
                      "desc": "Reconstruction of large conjunctival resections",
                      "conditions": null
                    },
                    {
                      "desc": "Treatment of corneal injuries",
                      "conditions": null
                    },
                    {
                      "desc": "As an adjunct to surgical procedures involving the cornea",
                      "conditions": null
                    }
                  ]
                }
              ]
            }
          },
          {
            "medical_act": "Venous stasis ulcers",
            "sub_medical_act": null,
            "necessity_type": "Medically Necessary",
            "description": "The following products are considered medically necessary for the treatment of chronic venous stasis ulcers when the clinical criteria are met:",
            "conditions": {
              "ALL": [
                {
                  "ANY": [
                    {
                      "desc": "AmnioBand, sheet or membrane form",
                      "conditions": null
                    },
                    {
                      "desc": "Apligraf\u00ae",
                      "conditions": null
                    },
                    {
                      "desc": "EpiFix\u2122",
                      "conditions": null
                    }
                  ]
                },
                {
                  "ALL": [
                    {
                      "desc": "Wound has been present for at least 1 month",
                      "conditions": null
                    },
                    {
                      "desc": "Has been unsuccessfully treated with compression therapy for at least 14 days",
                      "conditions": null
                    }
                  ]
                }
              ]
            }
          },
          {
            "medical_act": "Various products",
            "sub_medical_act": null,
            "necessity_type": "Not Medically Necessary",
            "description": "The following products are considered not medically necessary when criteria above are not met and for any use not listed above:",
            "conditions": {
              "ANY": [
                {
                  "desc": "AlloDerm Regenerative Tissue Matrix (aseptic or sterile)",
                  "conditions": null
                },
                {
                  "desc": "Allogeneic amniotic membrane-derived grafts or wound coverings when used for ocular indications",
                  "conditions": null
                },
                {
                  "desc": "AlloSkin",
                  "conditions": null
                },
                {
                  "desc": "AmbioDisk",
                  "conditions": null
                },
                {
                  "desc": "AmnioBand, sheet or membrane form",
                  "conditions": null
                },
                {
                  "desc": "AmnioGraft",
                  "conditions": null
                },
                {
                  "desc": "Apligraf",
                  "conditions": null
                },
                {
                  "desc": "Artacent Ocular",
                  "conditions": null
                },
                {
                  "desc": "Biobrane",
                  "conditions": null
                },
                {
                  "desc": "Biovance",
                  "conditions": null
                },
                {
                  "desc": "Cortiva",
                  "conditions": null
                },
                {
                  "desc": "DermACELL",
                  "conditions": null
                },
                {
                  "desc": "Dermagraft",
                  "conditions": null
                },
                {
                  "desc": "DermaMatrix",
                  "conditions": null
                },
                {
                  "desc": "Epicel",
                  "conditions": null
                },
                {
                  "desc": "EpiCord",
                  "conditions": null
                },
                {
                  "desc": "EpiFix, sheet or membrane form",
                  "conditions": null
                },
                {
                  "desc": "EZ Derm",
                  "conditions": null
                },
                {
                  "desc": "FlexHD",
                  "conditions": null
                },
                {
                  "desc": "Fresh frozen unprocessed allograft skin products (for example, AlloSkin*, TheraSkin)",
                  "conditions": null
                },
                {
                  "desc": "Grafix PRIME",
                  "conditions": null
                },
                {
                  "desc": "GraftJacket, sheet or membrane form",
                  "conditions": null
                },
                {
                  "desc": "Integra Bilayer Matrix Wound Dressing",
                  "conditions": null
                },
                {
                  "desc": "Integra\u00ae Omnigraft Dermal Regeneration Template",
                  "conditions": null
                },
                {
                  "desc": "Kerecis\u2122",
                  "conditions": null
                },
                {
                  "desc": "mVASC",
                  "conditions": null
                },
                {
                  "desc": "Oasis\u2122",
                  "conditions": null
                },
                {
                  "desc": "Omnigraft (also see Integra Omnigraft Dermal Regeneration Template)",
                  "conditions": null
                },
                {
                  "desc": "OrCel",
                  "conditions": null
                },
                {
                  "desc": "OviTex",
                  "conditions": null
                },
                {
                  "desc": "PriMatrix",
                  "conditions": null
                },
                {
                  "desc": "Prokera",
                  "conditions": null
                },
                {
                  "desc": "ReCell\u2122 Autologous Harvesting Device",
                  "conditions": null
                },
                {
                  "desc": "SimpliDerm",
                  "conditions": null
                },
                {
                  "desc": "StrataGraft",
                  "conditions": null
                },
                {
                  "desc": "Strattice",
                  "conditions": null
                },
                {
                  "desc": "SurgiMend\u00ae",
                  "conditions": null
                },
                {
                  "desc": "TheraSkin",
                  "conditions": null
                },
                {
                  "desc": "Vendaje Optic",
                  "conditions": null
                }
              ]
            }
          },
          {
            "medical_act": "Various products",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "The use of all other allogeneic, xenographic, synthetic, and composite products for wound healing or soft tissue grafting, including but not limited to the following products, is considered investigational and not medically necessary for all uses:",
            "conditions": {
              "ANY": [
                {
                  "desc": "Ac5 advanced wound system",
                  "conditions": null
                },
                {
                  "desc": "Acesso DL",
                  "conditions": null
                },
                {
                  "desc": "Acesso TL",
                  "conditions": null
                },
                {
                  "desc": "ACM Extra Surgical Collagen",
                  "conditions": null
                },
                {
                  "desc": "ACM Extra Surgical Collagen Powder",
                  "conditions": null
                },
                {
                  "desc": "ACM Surgical Collagen",
                  "conditions": null
                },
                {
                  "desc": "Actishield\u2122",
                  "conditions": null
                },
                {
                  "desc": "ActiveBarrier\u00ae",
                  "conditions": null
                },
                {
                  "desc": "ActiveMatrix\u00ae",
                  "conditions": null
                },
                {
                  "desc": "Affinity\u2122",
                  "conditions": null
                },
                {
                  "desc": "AlloGen-LI\u2122",
                  "conditions": null
                },
                {
                  "desc": "AlloGen\u2122",
                  "conditions": null
                },
                {
                  "desc": "AlloMax\u2122",
                  "conditions": null
                },
                {
                  "desc": "AlloMend\u2122",
                  "conditions": null
                },
                {
                  "desc": "Allopatch HD\u2122",
                  "conditions": null
                },
                {
                  "desc": "AlloPatch\u00ae Pliable",
                  "conditions": null
                },
                {
                  "desc": "Alloskin AC",
                  "conditions": null
                },
                {
                  "desc": "AlloSkin RT",
                  "conditions": null
                },
                {
                  "desc": "AlloWrap\u00ae",
                  "conditions": null
                },
                {
                  "desc": "AlloWrap\u2122 Dry",
                  "conditions": null
                },
                {
                  "desc": "AlloWrap\u2122 DS",
                  "conditions": null
                },
                {
                  "desc": "Alphaplex\u2122 with MariGen Omega3\u2122",
                  "conditions": null
                },
                {
                  "desc": "AltiPly\u2122",
                  "conditions": null
                },
                {
                  "desc": "AmbientFactor\u2122",
                  "conditions": null
                },
                {
                  "desc": "Ambio5\u00ae",
                  "conditions": null
                },
                {
                  "desc": "AmniCore Pro+",
                  "conditions": null
                },
                {
                  "desc": "Amnio FRT\u2122",
                  "conditions": null
                },
                {
                  "desc": "Amnio F\u2122",
                  "conditions": null
                },
                {
                  "desc": "Amnio Quad-Core",
                  "conditions": null
                },
                {
                  "desc": "Amnio Restore\u2122",
                  "conditions": null
                },
                {
                  "desc": "Amnio Tri-Core amniotic",
                  "conditions": null
                },
                {
                  "desc": "Amnio wound",
                  "conditions": null
                },
                {
                  "desc": "AmnioAMP-MP",
                  "conditions": null
                },
                {
                  "desc": "AmnioAMP-PF",
                  "conditions": null
                },
                {
                  "desc": "AmnioAMP-X",
                  "conditions": null
                },
                {
                  "desc": "AmnioArmor\u00ae",
                  "conditions": null
                },
                {
                  "desc": "AmnioBand, particulate or injectable form",
                  "conditions": null
                },
                {
                  "desc": "AmnioBind",
                  "conditions": null
                },
                {
                  "desc": "AmnioCare\u00ae",
                  "conditions": null
                },
                {
                  "desc": "AmnioClear\u00ae",
                  "conditions": null
                },
                {
                  "desc": "AmnioCord\u00ae",
                  "conditions": null
                },
                {
                  "desc": "AmnioCore",
                  "conditions": null
                },
                {
                  "desc": "AmnioCore Pro",
                  "conditions": null
                },
                {
                  "desc": "AmnioCyte",
                  "conditions": null
                },
                {
                  "desc": "AMNIOEXCEL\u2122",
                  "conditions": null
                },
                {
                  "desc": "Amniofill\u00ae",
                  "conditions": null
                },
                {
                  "desc": "AmnioFix\u2122",
                  "conditions": null
                },
                {
                  "desc": "Amnioflex\u2122",
                  "conditions": null
                },
                {
                  "desc": "AmnioGuard\u00ae",
                  "conditions": null
                },
                {
                  "desc": "AmnioHeal\u00ae",
                  "conditions": null
                },
                {
                  "desc": "AmnioMatrix\u2122",
                  "conditions": null
                },
                {
                  "desc": "AmnioMTM\u2122",
                  "conditions": null
                },
                {
                  "desc": "Amniopro\u2122",
                  "conditions": null
                },
                {
                  "desc": "AMNIOREPAIR\u2122",
                  "conditions": null
                },
                {
                  "desc": "Amnios\u00ae",
                  "conditions": null
                },
                {
                  "desc": "Amnios\u00ae RT",
                  "conditions": null
                },
                {
                  "desc": "AmnioShield\u00ae",
                  "conditions": null
                },
                {
                  "desc": "Amniostrip\u2122",
                  "conditions": null
                },
                {
                  "desc": "Amniotext",
                  "conditions": null
                },
                {
                  "desc": "Amniovo\u2122 (Solo, Dual, and Matrix)",
                  "conditions": null
                },
                {
                  "desc": "Amniovo\u2122 Max",
                  "conditions": null
                },
                {
                  "desc": "Amniowrap2\u2122",
                  "conditions": null
                },
                {
                  "desc": "Amniply",
                  "conditions": null
                },
                {
                  "desc": "AmnyoFactor\u2122",
                  "conditions": null
                },
                {
                  "desc": "AmnyoFluid\u2122",
                  "conditions": null
                },
                {
                  "desc": "Anu RHEO\u2122",
                  "conditions": null
                },
                {
                  "desc": "Aongen\u2122 Collagen Matrix",
                  "conditions": null
                },
                {
                  "desc": "Apis\u00ae",
                  "conditions": null
                },
                {
                  "desc": "Architect Extracellular Matrix\u2122",
                  "conditions": null
                },
                {
                  "desc": "AROA ECM\u2122",
                  "conditions": null
                },
                {
                  "desc": "Artacent\u00ae AC Powder",
                  "conditions": null
                },
                {
                  "desc": "Artacent\u00ae cord",
                  "conditions": null
                },
                {
                  "desc": "Artacent\u00ae Flex",
                  "conditions": null
                },
                {
                  "desc": "Artacent\u00ae Wound",
                  "conditions": null
                },
                {
                  "desc": "Artelon\u00ae",
                  "conditions": null
                },
                {
                  "desc": "Arthrex\u00ae Amnion matrix",
                  "conditions": null
                },
                {
                  "desc": "ArthroFlex\u2122",
                  "conditions": null
                },
                {
                  "desc": "ARTIA\u2122 Reconstructive Tissue Matrix",
                  "conditions": null
                },
                {
                  "desc": "Ascent\u00ae",
                  "conditions": null
                },
                {
                  "desc": "Atlas Wound Matrix",
                  "conditions": null
                },
                {
                  "desc": "Avance\u00ae Nerve Graft",
                  "conditions": null
                },
                {
                  "desc": "Avaulta Plus\u2122",
                  "conditions": null
                },
                {
                  "desc": "Avive\u00ae",
                  "conditions": null
                },
                {
                  "desc": "AxoBioMembrane",
                  "conditions": null
                },
                {
                  "desc": "Axograft\u2122",
                  "conditions": null
                },
                {
                  "desc": "AxoGuard\u00ae nerve connector",
                  "conditions": null
                },
                {
                  "desc": "AxoGuard\u00ae nerve protector",
                  "conditions": null
                },
                {
                  "desc": "Axolotl Ambient\u2122",
                  "conditions": null
                },
                {
                  "desc": "Axolotl Cryo\u2122",
                  "conditions": null
                },
                {
                  "desc": "Axolotl DualGraft\u2122",
                  "conditions": null
                },
                {
                  "desc": "Axolotl Graft\u2122",
                  "conditions": null
                },
                {
                  "desc": "Axolotl Shot\u2122",
                  "conditions": null
                },
                {}
              ]
            }
          }
        ],
        "usage": {
          "total_tokens": 13313,
          "prompt_tokens": 9217,
          "completion_tokens": 4096,
          "total_cost": 0.10752500000000001,
          "processing_time": 83.96250772476196
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_c142348.html",
    "subject": "Irreversible Electroporation",
    "document_number": "SURG.00126",
    "publish_date": "04/01/2024",
    "status": "Reviewed",
    "last_review_date": "05/11/2023",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>Irreversible electroporation is considered <strong>investigational and not medically necessary </strong>for all indications, including, but not limited to, ablation of soft tissue or<strong> </strong>of solid organs, such as the liver and pancreas.</p>",
    "content": "Investigational and Not Medically Necessary:\nIrreversible electroporation is considered investigational and not medically necessary for all indications, including, but not limited to, ablation of soft tissue or of solid organs, such as the liver and pancreas.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Irreversible electroporation",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Irreversible electroporation is considered investigational and not medically necessary for all indications, including, but not limited to, ablation of soft tissue or of solid organs, such as the liver and pancreas.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 959,
          "prompt_tokens": 863,
          "completion_tokens": 96,
          "total_cost": 0.005755,
          "processing_time": 1.8221240043640137
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_e000369.html",
    "subject": "Microsurgical Procedures for the Prevention or Treatment of Lymphedema",
    "document_number": "SURG.00154",
    "publish_date": "04/01/2024",
    "status": "Reviewed",
    "last_review_date": "02/15/2024",
    "html_content": "<p style=\"margin-left:-6px\"><strong>Investigational and Not Medically Necessary:</strong></p>\n<p style=\"margin-left:-6px\">Microsurgery for the prevention or treatment of lymphedema (including lymphedema as a result of a mastectomy) is considered <strong>investigational and not medically necessary</strong>, including but not limited to the following:</p>\n<li>Lymphaticolymphatic bypass</li>\n<li>Lymphovenous bypass</li>\n<li>Lymphaticovenular anastomosis</li>\n<li>Vascularized lymph node transfer</li>\n<li>Tissue/Flap transfer (for example, omental flap transfer).</li>",
    "content": "Investigational and Not Medically Necessary:\nMicrosurgery for the prevention or treatment of lymphedema (including lymphedema as a result of a mastectomy) is considered investigational and not medically necessary, including but not limited to the following:\n<li>Lymphaticolymphatic bypass</li>\n<li>Lymphovenous bypass</li>\n<li>Lymphaticovenular anastomosis</li>\n<li>Vascularized lymph node transfer</li>\n<li>Tissue/Flap transfer (for example, omental flap transfer).</li>",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Microsurgery for the prevention or treatment of lymphedema",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Microsurgery for the prevention or treatment of lymphedema (including lymphedema as a result of a mastectomy) is considered investigational and not medically necessary, including but not limited to the following:",
            "conditions": {
              "ANY": [
                {
                  "desc": "Lymphaticolymphatic bypass",
                  "conditions": null
                },
                {
                  "desc": "Lymphovenous bypass",
                  "conditions": null
                },
                {
                  "desc": "Lymphaticovenular anastomosis",
                  "conditions": null
                },
                {
                  "desc": "Vascularized lymph node transfer",
                  "conditions": null
                },
                {
                  "desc": "Tissue/Flap transfer (for example, omental flap transfer)",
                  "conditions": null
                }
              ]
            }
          }
        ],
        "usage": {
          "total_tokens": 1148,
          "prompt_tokens": 930,
          "completion_tokens": 218,
          "total_cost": 0.00792,
          "processing_time": 4.127617835998535
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_e000818.html",
    "subject": "Implantable Peripheral Nerve Stimulation Devices as a Treatment for Pain",
    "document_number": "SURG.00158",
    "publish_date": "04/01/2024",
    "status": "Reviewed",
    "last_review_date": "11/09/2023",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>Implantable peripheral nerve stimulation devices are considered <strong>investigational and not medically necessary</strong> for all indications including, but not limited to, treatment of acute and chronic pain.</p>",
    "content": "Investigational and Not Medically Necessary:\nImplantable peripheral nerve stimulation devices are considered investigational and not medically necessary for all indications including, but not limited to, treatment of acute and chronic pain.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Implantable peripheral nerve stimulation devices",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Implantable peripheral nerve stimulation devices are considered investigational and not medically necessary for all indications including, but not limited to, treatment of acute and chronic pain.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 940,
          "prompt_tokens": 853,
          "completion_tokens": 87,
          "total_cost": 0.005569999999999999,
          "processing_time": 1.9448859691619873
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_e000642.html",
    "subject": "Minimally Invasive Treatment of the Posterior Nasal Nerve to Treat Rhinitis",
    "document_number": "SURG.00157",
    "publish_date": "04/01/2024",
    "status": "Reviewed",
    "last_review_date": "08/10/2023",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>Minimally invasive treatment of the posterior nasal nerve, such as cryotherapy or radiofrequency therapy, to decrease the symptoms of allergic or nonallergic rhinitis is considered <strong>investigational and not medically necessary</strong> in all cases.</p>",
    "content": "Investigational and Not Medically Necessary:\nMinimally invasive treatment of the posterior nasal nerve, such as cryotherapy or radiofrequency therapy, to decrease the symptoms of allergic or nonallergic rhinitis is considered investigational and not medically necessary in all cases.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Minimally invasive treatment of the posterior nasal nerve",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Minimally invasive treatment of the posterior nasal nerve, such as cryotherapy or radiofrequency therapy, to decrease the symptoms of allergic or nonallergic rhinitis is considered investigational and not medically necessary in all cases.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 967,
          "prompt_tokens": 865,
          "completion_tokens": 102,
          "total_cost": 0.005855,
          "processing_time": 3.3192198276519775
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_a050272.html",
    "subject": "Epiduroscopy",
    "document_number": "SURG.00073",
    "publish_date": "01/03/2024",
    "status": "Reviewed",
    "last_review_date": "11/09/2023",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p class=\"MsoHeader\">Epiduroscopy, also known as epidural spinal endoscopy or epidural myeloscopy, is considered <strong>investigational and not medically necessary.</strong></p>",
    "content": "Investigational and Not Medically Necessary:\nEpiduroscopy, also known as epidural spinal endoscopy or epidural myeloscopy, is considered investigational and not medically necessary.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Epiduroscopy",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Epiduroscopy, also known as epidural spinal endoscopy or epidural myeloscopy, is considered investigational and not medically necessary.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 931,
          "prompt_tokens": 850,
          "completion_tokens": 81,
          "total_cost": 0.005465,
          "processing_time": 2.427482843399048
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_c108472.html",
    "subject": "Implantation of Occipital, Supraorbital or Trigeminal Nerve Stimulation Devices (and Related Procedures)",
    "document_number": "SURG.00112",
    "publish_date": "01/03/2024",
    "status": "Reviewed",
    "last_review_date": "11/09/2023",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>Implantation of an occipital nerve stimulation device (and related procedures) is considered <strong>investigational and not medically</strong> <strong>necessary</strong> for all indications.</p>\n<p>Implantation of a supraorbital nerve stimulation device (and related procedures) is considered <strong>investigational and not medically</strong> <strong>necessary</strong> for all indications.</p>\n<p>Implantation of a trigeminal nerve stimulation device (and related procedures) is considered <strong>investigational and not medically</strong> <strong>necessary</strong> for all indications.</p>",
    "content": "Investigational and Not Medically Necessary:\nImplantation of an occipital nerve stimulation device (and related procedures) is considered investigational and not medically necessary for all indications.\nImplantation of a supraorbital nerve stimulation device (and related procedures) is considered investigational and not medically necessary for all indications.\nImplantation of a trigeminal nerve stimulation device (and related procedures) is considered investigational and not medically necessary for all indications.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Implantation of an occipital nerve stimulation device (and related procedures)",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Implantation of an occipital nerve stimulation device (and related procedures) is considered investigational and not medically necessary for all indications.",
            "conditions": null
          },
          {
            "medical_act": "Implantation of a supraorbital nerve stimulation device (and related procedures)",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Implantation of a supraorbital nerve stimulation device (and related procedures) is considered investigational and not medically necessary for all indications.",
            "conditions": null
          },
          {
            "medical_act": "Implantation of a trigeminal nerve stimulation device (and related procedures)",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Implantation of a trigeminal nerve stimulation device (and related procedures) is considered investigational and not medically necessary for all indications.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 1174,
          "prompt_tokens": 905,
          "completion_tokens": 269,
          "total_cost": 0.008560000000000002,
          "processing_time": 7.317336082458496
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_c169475.html",
    "subject": "Laser Treatment for Onychomycosis",
    "document_number": "SURG.00138",
    "publish_date": "01/03/2024",
    "status": "Reviewed",
    "last_review_date": "11/09/2023",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>Laser treatment of onychomycosis is considered <strong>investigational and not medically necessary.</strong></p>",
    "content": "Investigational and Not Medically Necessary:\nLaser treatment of onychomycosis is considered investigational and not medically necessary.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Laser treatment of onychomycosis",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Laser treatment of onychomycosis is considered investigational and not medically necessary.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 911,
          "prompt_tokens": 838,
          "completion_tokens": 73,
          "total_cost": 0.005285,
          "processing_time": 1.7048640251159668
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_c148393.html",
    "subject": "Annulus Closure After Discectomy",
    "document_number": "SURG.00130",
    "publish_date": "01/03/2024",
    "status": "Reviewed",
    "last_review_date": "11/09/2023",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>Annulus closure using devices for annular repair is considered <strong>investigational and not medically necessary.</strong></p>",
    "content": "Investigational and Not Medically Necessary:\nAnnulus closure using devices for annular repair is considered investigational and not medically necessary.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Annulus closure using devices for annular repair",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Annulus closure using devices for annular repair is considered investigational and not medically necessary.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 914,
          "prompt_tokens": 839,
          "completion_tokens": 75,
          "total_cost": 0.00532,
          "processing_time": 2.481281042098999
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_c136432.html",
    "subject": "Transmyocardial/Perventricular Device Closure of Ventricular Septal Defects",
    "document_number": "SURG.00123",
    "publish_date": "01/03/2024",
    "status": "Reviewed",
    "last_review_date": "11/09/2023",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>Transmyocardial/perventricular device closure of ventricular septal defects is considered <strong>investigational and not medically necessary.</strong></p>",
    "content": "Investigational and Not Medically Necessary:\nTransmyocardial/perventricular device closure of ventricular septal defects is considered investigational and not medically necessary.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Transmyocardial/perventricular device closure of ventricular septal defects",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Transmyocardial/perventricular device closure of ventricular septal defects is considered investigational and not medically necessary.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 932,
          "prompt_tokens": 845,
          "completion_tokens": 87,
          "total_cost": 0.005529999999999999,
          "processing_time": 2.00805401802063
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_c195269.html",
    "subject": "Extracorporeal Carbon Dioxide Removal",
    "document_number": "SURG.00146",
    "publish_date": "01/03/2024",
    "status": "Reviewed",
    "last_review_date": "11/09/2023",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>Extracorporeal carbon dioxide removal is considered <strong>investigational and not medically necessary</strong> for all conditions, including but not limited to acute hypercapnic respiratory failure.</p>",
    "content": "Investigational and Not Medically Necessary:\nExtracorporeal carbon dioxide removal is considered investigational and not medically necessary for all conditions, including but not limited to acute hypercapnic respiratory failure.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Extracorporeal carbon dioxide removal",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Extracorporeal carbon dioxide removal is considered investigational and not medically necessary for all conditions, including but not limited to acute hypercapnic respiratory failure.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 941,
          "prompt_tokens": 853,
          "completion_tokens": 88,
          "total_cost": 0.005585,
          "processing_time": 2.395663022994995
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_a053324.html",
    "subject": "Breast Ductal Examination and Fluid Cytology Analysis",
    "document_number": "SURG.00044",
    "publish_date": "01/03/2024",
    "status": "Reviewed",
    "last_review_date": "11/09/2023",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>Cytologic analysis of breast ductal fluid, acquired invasively or noninvasively, is considered <strong>investigational and not medically necessary</strong> as a diagnostic or risk assessment tool for those considered at high risk for breast cancer, as well as for general population screening.</p>\n<p class=\"MsoAcetate\">Breast fiberoptic ductoscopy is considered <strong>investigational and not medically necessary</strong> for the detection, diagnosis or treatment of breast cancer.</p>",
    "content": "Investigational and Not Medically Necessary:\nCytologic analysis of breast ductal fluid, acquired invasively or noninvasively, is considered investigational and not medically necessary as a diagnostic or risk assessment tool for those considered at high risk for breast cancer, as well as for general population screening.\nBreast fiberoptic ductoscopy is considered investigational and not medically necessary for the detection, diagnosis or treatment of breast cancer.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Cytologic analysis of breast ductal fluid",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Cytologic analysis of breast ductal fluid, acquired invasively or noninvasively, is considered investigational and not medically necessary as a diagnostic or risk assessment tool for those considered at high risk for breast cancer, as well as for general population screening.",
            "conditions": null
          },
          {
            "medical_act": "Breast fiberoptic ductoscopy",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Breast fiberoptic ductoscopy is considered investigational and not medically necessary for the detection, diagnosis or treatment of breast cancer.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 1084,
          "prompt_tokens": 898,
          "completion_tokens": 186,
          "total_cost": 0.00728,
          "processing_time": 3.3360178470611572
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_a050265.html",
    "subject": "Vein Embolization as a Treatment for Pelvic Congestion Syndrome and Varicocele",
    "document_number": "SURG.00062",
    "publish_date": "01/03/2024",
    "status": "Reviewed",
    "last_review_date": "11/09/2023",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>Embolization of the ovarian vein and internal iliac veins is considered <strong>investigational and not medically necessary</strong> as a treatment of pelvic congestion syndrome.</p>\n<p>Embolization of the testicular (spermatic) veins is considered <strong>investigational and not medically necessary</strong> as a treatment of testicular varicocele.</p>",
    "content": "Investigational and Not Medically Necessary:\nEmbolization of the ovarian vein and internal iliac veins is considered investigational and not medically necessary as a treatment of pelvic congestion syndrome.\nEmbolization of the testicular (spermatic) veins is considered investigational and not medically necessary as a treatment of testicular varicocele.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Embolization of the ovarian vein and internal iliac veins",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Embolization of the ovarian vein and internal iliac veins is considered investigational and not medically necessary as a treatment of pelvic congestion syndrome.",
            "conditions": null
          },
          {
            "medical_act": "Embolization of the testicular (spermatic) veins",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Embolization of the testicular (spermatic) veins is considered investigational and not medically necessary as a treatment of testicular varicocele.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 1058,
          "prompt_tokens": 880,
          "completion_tokens": 178,
          "total_cost": 0.00707,
          "processing_time": 5.757757186889648
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_a053315.html",
    "subject": "Breast Procedures; including Reconstructive Surgery, Implants and Other Breast Procedures",
    "document_number": "SURG.00023",
    "publish_date": "01/03/2024",
    "status": "Revised",
    "last_review_date": "11/09/2023",
    "html_content": "<p><strong>Medically Necessary:</strong></p>\n<p>Removal of implants<strong> </strong><em>partially or completely filled<strong> </strong>with</em><strong> <em>Silicone Gel</em> </strong>is considered<strong><strong> medically necessary </strong></strong>when there is documented implant rupture (that is, using mammography, ultrasound, or MRI).</p>\n<p>Removal of a<strong> <em>Silicone Gel filled,</em></strong><em><strong> Saline filled or \u201cAlternative\u201d</strong></em><strong> </strong>implant is considered<strong> medically necessary </strong>for any of the following:</p>\n<li><strong>I</strong>nfection of the implant or surrounding tissue; <strong>or</strong></li>\n<li>Implant exposure/extrusion; <strong>or</strong></li>\n<li>Pain related to Baker Class IV capsular contracture; <strong>or</strong></li>\n<li>Confirmed cases of breast implant-associated anaplastic large cell lymphoma; <strong>or</strong></li>\n<li>Elective removal in individuals with an increased risk of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) due to use of Allergan BIOCELL textured breast implants and tissue expanders; <strong>or</strong></li>\n<li>Prior to surgical treatment of breast cancer. (Note: Implant explantation is routinely performed at the time of mastectomy. In individuals treated with breast conserving surgery [that is, lumpectomy], a breast implant may or may not interfere with subsequent treatment, and thus explantation at the time of lumpectomy is at the discretion of the treating physician and the treated individual).</li>\n<p><strong>Reconstructive:</strong></p>\n<p>Breast surgery is considered <strong>reconstructive</strong> to rebuild the normal contour of the affected and the contralateral <em>unaffected</em> breast to produce a more normal appearance following a mastectomy, lumpectomy, or other breast surgery for breast cancer.</p>\n<p>Surgical procedures, such as reduction mammaplasty, may be considered <strong>reconstructive </strong>when done <em>in advance of</em> mastectomy or lumpectomy for breast cancer in order to produce improved cosmesis and prevent postoperative complications.</p>\n<p>Breast surgery of <em>both</em> breasts is considered <strong>reconstructive</strong> following the mastectomy of both breasts.</p>\n<p>Breast surgery to alter the contour of the breast is considered <strong>reconstructive </strong>when there are significant abnormalities related to trauma, congenital defects, infection or other non-malignant disease. A specific example of this is Poland syndrome which may be diagnosed when all of the following are present:</p>\n<li>Congenital absence or hypoplasia of pectoralis major and minor muscles; <strong>and</strong></li>\n<li>Breast hypoplasia; <strong>and</strong></li>\n<li>Congenital partial absence of the upper costal cartilage.</li>\n<p>Removal of an implant (any type) with or without reimplantation is considered <strong>reconstructive </strong>when:</p>\n<li>An implant, originally placed <strong>in an individual with a history of mastectomy, lumpectomy or treatment of breast cancer</strong> for reconstructive purposes as defined above; <strong>and</strong></li>\n<li>There has been development of a visible distortion (Baker Class III contracture). &nbsp;</li>\n<p>Removal of a ruptured saline-filled or \u201cAlternative\" implant with or without reimplantation is considered <strong>reconstructive</strong> when originally placed <strong>in an individual with a history of mastectomy, lumpectomy or treatment of breast cancer</strong> for reconstructive purposes, as defined above.</p>\n<p>Surgery on the contralateral breast to produce a symmetrical appearance after removal of an implant and reimplantation is considered reconstructive when the implant was originally placed for reconstructive purposes <strong>in an individual with a history of mastectomy, lumpectomy or treatment of breast cancer.</strong></p>\n<p><strong>Not Medically Necessary:</strong></p>\n<p>Removal of a ruptured saline<strong>-</strong>filled or \u201cAlternative\u201d implant is considered <strong>not medically necessary</strong> since the potential adverse medical consequences of implant rupture are related to silicone gel implants <em>only. </em></p>\n<p>Removal of <strong><em>ANY TYPE</em></strong> of<strong> </strong>breast implant is considered <strong>not medically necessary </strong>for any of the following:</p>\n<li>Systemic symptoms attributed to connective tissue disease, autoimmune diseases, etc.; <strong>or</strong></li>\n<li>Personal anxiety; <strong>or</strong></li>\n<li>Pain not related to contractures or rupture; <strong>or</strong></li>\n<li>The medically necessary or reconstructive criteria listed above have not been met.</li>\n<p><strong>Cosmetic and Not Medically Necessary:</strong></p>\n<p><em>Reimplantation of an implant inserted for cosmetic purposes only </em>(that is, for reasons other than a history of mastectomy, lumpectomy, treatment of breast cancer, significant abnormalities related to trauma, congenital defects, infection or other non-malignant disease) and <em>removed as part of a medically necessary or reconstructive surgery (see above) </em>is considered <strong>cosmetic and not medically necessary.&nbsp; </strong></p>\n<p>Other breast procedures, (including augmentation mammaplasty/breast lift, implant repositioning, repair of inverted nipples, mastopexy) are considered <strong>cosmetic and not medically necessary </strong>except when performed as part of a covered breast reconstruction service.</p>",
    "content": "Medically Necessary:\nRemoval of implants partially or completely filled with Silicone Gel is considered medically necessary when there is documented implant rupture (that is, using mammography, ultrasound, or MRI).\nRemoval of a Silicone Gel filled, Saline filled or \u201cAlternative\u201d implant is considered medically necessary for any of the following:\n<li>Infection of the implant or surrounding tissue; or</li>\n<li>Implant exposure/extrusion; or</li>\n<li>Pain related to Baker Class IV capsular contracture; or</li>\n<li>Confirmed cases of breast implant-associated anaplastic large cell lymphoma; or</li>\n<li>Elective removal in individuals with an increased risk of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) due to use of Allergan BIOCELL textured breast implants and tissue expanders; or</li>\n<li>Prior to surgical treatment of breast cancer. (Note: Implant explantation is routinely performed at the time of mastectomy. In individuals treated with breast conserving surgery [that is, lumpectomy], a breast implant may or may not interfere with subsequent treatment, and thus explantation at the time of lumpectomy is at the discretion of the treating physician and the treated individual).</li>\nReconstructive:\nBreast surgery is considered reconstructive to rebuild the normal contour of the affected and the contralateral unaffected breast to produce a more normal appearance following a mastectomy, lumpectomy, or other breast surgery for breast cancer.\nSurgical procedures, such as reduction mammaplasty, may be considered reconstructive when done in advance of mastectomy or lumpectomy for breast cancer in order to produce improved cosmesis and prevent postoperative complications.\nBreast surgery of both breasts is considered reconstructive following the mastectomy of both breasts.\nBreast surgery to alter the contour of the breast is considered reconstructive when there are significant abnormalities related to trauma, congenital defects, infection or other non-malignant disease. A specific example of this is Poland syndrome which may be diagnosed when all of the following are present:\n<li>Congenital absence or hypoplasia of pectoralis major and minor muscles; and</li>\n<li>Breast hypoplasia; and</li>\n<li>Congenital partial absence of the upper costal cartilage.</li>\nRemoval of an implant (any type) with or without reimplantation is considered reconstructive when:\n<li>An implant, originally placed in an individual with a history of mastectomy, lumpectomy or treatment of breast cancer for reconstructive purposes as defined above; and</li>\n<li>There has been development of a visible distortion (Baker Class III contracture). \u00a0</li>\nRemoval of a ruptured saline-filled or \u201cAlternative\" implant with or without reimplantation is considered reconstructive when originally placed in an individual with a history of mastectomy, lumpectomy or treatment of breast cancer for reconstructive purposes, as defined above.\nSurgery on the contralateral breast to produce a symmetrical appearance after removal of an implant and reimplantation is considered reconstructive when the implant was originally placed for reconstructive purposes in an individual with a history of mastectomy, lumpectomy or treatment of breast cancer.\nNot Medically Necessary:\nRemoval of a ruptured saline-filled or \u201cAlternative\u201d implant is considered not medically necessary since the potential adverse medical consequences of implant rupture are related to silicone gel implants only. \nRemoval of ANY TYPE of breast implant is considered not medically necessary for any of the following:\n<li>Systemic symptoms attributed to connective tissue disease, autoimmune diseases, etc.; or</li>\n<li>Personal anxiety; or</li>\n<li>Pain not related to contractures or rupture; or</li>\n<li>The medically necessary or reconstructive criteria listed above have not been met.</li>\nCosmetic and Not Medically Necessary:\nReimplantation of an implant inserted for cosmetic purposes only (that is, for reasons other than a history of mastectomy, lumpectomy, treatment of breast cancer, significant abnormalities related to trauma, congenital defects, infection or other non-malignant disease) and removed as part of a medically necessary or reconstructive surgery (see above) is considered cosmetic and not medically necessary.\u00a0 \nOther breast procedures, (including augmentation mammaplasty/breast lift, implant repositioning, repair of inverted nipples, mastopexy) are considered cosmetic and not medically necessary except when performed as part of a covered breast reconstruction service.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Removal of implants partially or completely filled with Silicone Gel",
            "sub_medical_act": null,
            "necessity_type": "Medically Necessary",
            "description": "Removal of implants partially or completely filled with Silicone Gel is considered medically necessary when there is documented implant rupture (that is, using mammography, ultrasound, or MRI).",
            "conditions": {
              "ALL": [
                {
                  "desc": "Documented implant rupture (using mammography, ultrasound, or MRI)",
                  "conditions": null
                }
              ]
            }
          },
          {
            "medical_act": "Removal of a Silicone Gel filled, Saline filled or \u201cAlternative\u201d implant",
            "sub_medical_act": null,
            "necessity_type": "Medically Necessary",
            "description": "Removal of a Silicone Gel filled, Saline filled or \u201cAlternative\u201d implant is considered medically necessary for any of the following:",
            "conditions": {
              "ANY": [
                {
                  "desc": "Infection of the implant or surrounding tissue",
                  "conditions": null
                },
                {
                  "desc": "Implant exposure/extrusion",
                  "conditions": null
                },
                {
                  "desc": "Pain related to Baker Class IV capsular contracture",
                  "conditions": null
                },
                {
                  "desc": "Confirmed cases of breast implant-associated anaplastic large cell lymphoma",
                  "conditions": null
                },
                {
                  "desc": "Elective removal in individuals with an increased risk of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) due to use of Allergan BIOCELL textured breast implants and tissue expanders",
                  "conditions": null
                },
                {
                  "desc": "Prior to surgical treatment of breast cancer",
                  "conditions": null
                }
              ]
            }
          },
          {
            "medical_act": "Breast surgery",
            "sub_medical_act": null,
            "necessity_type": "Reconstructive",
            "description": "Breast surgery is considered reconstructive to rebuild the normal contour of the affected and the contralateral unaffected breast to produce a more normal appearance following a mastectomy, lumpectomy, or other breast surgery for breast cancer.",
            "conditions": null
          },
          {
            "medical_act": "Reduction mammaplasty",
            "sub_medical_act": null,
            "necessity_type": "Reconstructive",
            "description": "Surgical procedures, such as reduction mammaplasty, may be considered reconstructive when done in advance of mastectomy or lumpectomy for breast cancer in order to produce improved cosmesis and prevent postoperative complications.",
            "conditions": null
          },
          {
            "medical_act": "Breast surgery of both breasts",
            "sub_medical_act": null,
            "necessity_type": "Reconstructive",
            "description": "Breast surgery of both breasts is considered reconstructive following the mastectomy of both breasts.",
            "conditions": null
          },
          {
            "medical_act": "Breast surgery to alter the contour of the breast",
            "sub_medical_act": null,
            "necessity_type": "Reconstructive",
            "description": "Breast surgery to alter the contour of the breast is considered reconstructive when there are significant abnormalities related to trauma, congenital defects, infection or other non-malignant disease. A specific example of this is Poland syndrome which may be diagnosed when all of the following are present:",
            "conditions": {
              "ALL": [
                {
                  "desc": "Congenital absence or hypoplasia of pectoralis major and minor muscles",
                  "conditions": null
                },
                {
                  "desc": "Breast hypoplasia",
                  "conditions": null
                },
                {
                  "desc": "Congenital partial absence of the upper costal cartilage",
                  "conditions": null
                }
              ]
            }
          },
          {
            "medical_act": "Removal of an implant (any type) with or without reimplantation",
            "sub_medical_act": null,
            "necessity_type": "Reconstructive",
            "description": "Removal of an implant (any type) with or without reimplantation is considered reconstructive when:",
            "conditions": {
              "ALL": [
                {
                  "desc": "An implant, originally placed in an individual with a history of mastectomy, lumpectomy or treatment of breast cancer for reconstructive purposes as defined above",
                  "conditions": null
                },
                {
                  "desc": "There has been development of a visible distortion (Baker Class III contracture)",
                  "conditions": null
                }
              ]
            }
          },
          {
            "medical_act": "Removal of a ruptured saline-filled or \u201cAlternative\u201d implant with or without reimplantation",
            "sub_medical_act": null,
            "necessity_type": "Reconstructive",
            "description": "Removal of a ruptured saline-filled or \u201cAlternative\u201d implant with or without reimplantation is considered reconstructive when originally placed in an individual with a history of mastectomy, lumpectomy or treatment of breast cancer for reconstructive purposes, as defined above.",
            "conditions": null
          },
          {
            "medical_act": "Surgery on the contralateral breast to produce a symmetrical appearance after removal of an implant and reimplantation",
            "sub_medical_act": null,
            "necessity_type": "Reconstructive",
            "description": "Surgery on the contralateral breast to produce a symmetrical appearance after removal of an implant and reimplantation is considered reconstructive when the implant was originally placed for reconstructive purposes in an individual with a history of mastectomy, lumpectomy or treatment of breast cancer.",
            "conditions": null
          },
          {
            "medical_act": "Removal of a ruptured saline-filled or \u201cAlternative\u201d implant",
            "sub_medical_act": null,
            "necessity_type": "Not Medically Necessary",
            "description": "Removal of a ruptured saline-filled or \u201cAlternative\u201d implant is considered not medically necessary since the potential adverse medical consequences of implant rupture are related to silicone gel implants only.",
            "conditions": null
          },
          {
            "medical_act": "Removal of ANY TYPE of breast implant",
            "sub_medical_act": null,
            "necessity_type": "Not Medically Necessary",
            "description": "Removal of ANY TYPE of breast implant is considered not medically necessary for any of the following:",
            "conditions": {
              "ANY": [
                {
                  "desc": "Systemic symptoms attributed to connective tissue disease, autoimmune diseases, etc.",
                  "conditions": null
                },
                {
                  "desc": "Personal anxiety",
                  "conditions": null
                },
                {
                  "desc": "Pain not related to contractures or rupture",
                  "conditions": null
                },
                {
                  "desc": "The medically necessary or reconstructive criteria listed above have not been met",
                  "conditions": null
                }
              ]
            }
          },
          {
            "medical_act": "Reimplantation of an implant inserted for cosmetic purposes only",
            "sub_medical_act": null,
            "necessity_type": "Cosmetic and Not Medically Necessary",
            "description": "Reimplantation of an implant inserted for cosmetic purposes only (that is, for reasons other than a history of mastectomy, lumpectomy, treatment of breast cancer, significant abnormalities related to trauma, congenital defects, infection or other non-malignant disease) and removed as part of a medically necessary or reconstructive surgery (see above) is considered cosmetic and not medically necessary.",
            "conditions": null
          },
          {
            "medical_act": "Other breast procedures",
            "sub_medical_act": null,
            "necessity_type": "Cosmetic and Not Medically Necessary",
            "description": "Other breast procedures, (including augmentation mammaplasty/breast lift, implant repositioning, repair of inverted nipples, mastopexy) are considered cosmetic and not medically necessary except when performed as part of a covered breast reconstruction service.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 3467,
          "prompt_tokens": 1732,
          "completion_tokens": 1735,
          "total_cost": 0.034685,
          "processing_time": 38.44363307952881
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_b078439.html",
    "subject": "Artificial Anal Sphincter for the Treatment of Severe Fecal Incontinence",
    "document_number": "SURG.00102",
    "publish_date": "01/03/2024",
    "status": "Reviewed",
    "last_review_date": "11/09/2023",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>The artificial anal sphincter is considered <strong>investigational and not medically necessary.</strong></p>",
    "content": "Investigational and Not Medically Necessary:\nThe artificial anal sphincter is considered investigational and not medically necessary.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Artificial Anal Sphincter",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "The artificial anal sphincter is considered investigational and not medically necessary.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 905,
          "prompt_tokens": 836,
          "completion_tokens": 69,
          "total_cost": 0.005215,
          "processing_time": 2.945413112640381
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_a053300.html",
    "subject": "Treatments for Urinary Incontinence",
    "document_number": "SURG.00010",
    "publish_date": "01/03/2024",
    "status": "Revised",
    "last_review_date": "11/09/2023",
    "html_content": "<p><strong>Medically Necessary:</strong></p>\n<p>Injection of periurethral bulking agents is considered <strong>medically necessary</strong> when the individual has stress urinary incontinence (SUI) meeting one the following two criteria (A or B):</p>\n<li>The incontinence is due to trauma or injury; <strong>or</strong></li>\n<li>Both of the following are true (1 and 2):\t<ol>\t\t<li>The incontinence persists despite conservative treatment for at least a sufficient duration to fully assess treatment effect*; <strong>and</strong></li>\t\t<li>One of the following is true:\t\t<ol style=\"list-style-type:lower-alpha\">\t\t\t<li>The incontinence is caused by intrinsic sphincter deficiency (ISD), <strong>or</strong></li>\t\t\t<li>The incontinence is due to urethral hypermobility in individuals with abdominal leak point less than 100 cm H<sub>2</sub>O.</li>\t\t</ol>\t\t</li>\t</ol>\t</li>\n<li>The incontinence persists despite conservative treatment for at least a sufficient duration to fully assess treatment effect*; <strong>and</strong></li>\n<li>One of the following is true:\t\t<ol style=\"list-style-type:lower-alpha\">\t\t\t<li>The incontinence is caused by intrinsic sphincter deficiency (ISD), <strong>or</strong></li>\t\t\t<li>The incontinence is due to urethral hypermobility in individuals with abdominal leak point less than 100 cm H<sub>2</sub>O.</li>\t\t</ol>\t\t</li>\n<li>The incontinence is caused by intrinsic sphincter deficiency (ISD), <strong>or</strong></li>\n<li>The incontinence is due to urethral hypermobility in individuals with abdominal leak point less than 100 cm H<sub>2</sub>O.</li>\n<p>Implantation of an artificial urinary sphincter device is considered <strong>medically necessary</strong> in adults following prostate surgery to treat urinary incontinence due to reduced outlet resistance (Intrinsic Sphincter Deficiency [ISD]) when the symptoms of incontinence persist despite conservative treatment for at least a sufficient duration to fully assess treatment effect.*</p>\n<p>*<strong>Note</strong>: The time frame for prior conservative treatment measures (for example, exercises, medication, behavioral therapy) to demonstrate a refractory response is at least 2 months duration, subject to individual variability.</p>\n<p class=\"MsoBodyTextIndent\" style=\"margin-bottom:8px\"><strong>Not Medically Necessary:</strong></p>\n<p class=\"MsoBodyTextIndent\">Injection of periurethral bulking agents is considered <strong>not medically necessary</strong> for individuals who do not meet the medically necessary criteria.</p>\n<p class=\"MsoBodyTextIndent\">Implantation of an artificial urinary sphincter device is considered <strong>not medically necessary</strong> for individuals who do not meet the medically necessary criteria.</p>\n<p class=\"MsoBodyTextIndent\" style=\"margin-bottom:8px\"><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>The following services are considered <strong>investigational and not medically necessary </strong>as treatments for urinary incontinence:</p>\n<li>inFlow<sup>\u2122</sup><sup> </sup>intraurethral valve-pump implantation;</li>\n<li>ProACT<sup>\u2122</sup> adjustable continence therapy;</li>\n<li>Vaginal weight training with specially designed weights (cones);</li>\n<li>Transvaginal radiofrequency bladder neck suspension;</li>\n<li>Transurethral radiofrequency energy collagen micro-remodeling;</li>\n<li>Endovaginal cryogen-cooled, monopolar radiofrequency remodeling.</li>",
    "content": "Medically Necessary:\nInjection of periurethral bulking agents is considered medically necessary when the individual has stress urinary incontinence (SUI) meeting one the following two criteria (A or B):\n<li>The incontinence is due to trauma or injury; or</li>\n<li>Both of the following are true (1 and 2):\t<ol> <li>The incontinence persists despite conservative treatment for at least a sufficient duration to fully assess treatment effect*; and</li> <li>One of the following is true:\t\t<ol style=\"list-style-type:lower-alpha\"> <li>The incontinence is caused by intrinsic sphincter deficiency (ISD), or</li> <li>The incontinence is due to urethral hypermobility in individuals with abdominal leak point less than 100 cm H<sub>2</sub>O.</li> </ol> </li> </ol> </li>\n<li>The incontinence persists despite conservative treatment for at least a sufficient duration to fully assess treatment effect*; and</li>\n<li>One of the following is true:\t\t<ol style=\"list-style-type:lower-alpha\"> <li>The incontinence is caused by intrinsic sphincter deficiency (ISD), or</li> <li>The incontinence is due to urethral hypermobility in individuals with abdominal leak point less than 100 cm H<sub>2</sub>O.</li> </ol> </li>\n<li>The incontinence is caused by intrinsic sphincter deficiency (ISD), or</li>\n<li>The incontinence is due to urethral hypermobility in individuals with abdominal leak point less than 100 cm H<sub>2</sub>O.</li>\nImplantation of an artificial urinary sphincter device is considered medically necessary in adults following prostate surgery to treat urinary incontinence due to reduced outlet resistance (Intrinsic Sphincter Deficiency [ISD]) when the symptoms of incontinence persist despite conservative treatment for at least a sufficient duration to fully assess treatment effect.*\n*Note: The time frame for prior conservative treatment measures (for example, exercises, medication, behavioral therapy) to demonstrate a refractory response is at least 2 months duration, subject to individual variability.\nNot Medically Necessary:\nInjection of periurethral bulking agents is considered not medically necessary for individuals who do not meet the medically necessary criteria.\nImplantation of an artificial urinary sphincter device is considered not medically necessary for individuals who do not meet the medically necessary criteria.\nInvestigational and Not Medically Necessary:\nThe following services are considered investigational and not medically necessary as treatments for urinary incontinence:\n<li>inFlow<sup>\u2122</sup><sup> </sup>intraurethral valve-pump implantation;</li>\n<li>ProACT<sup>\u2122</sup> adjustable continence therapy;</li>\n<li>Vaginal weight training with specially designed weights (cones);</li>\n<li>Transvaginal radiofrequency bladder neck suspension;</li>\n<li>Transurethral radiofrequency energy collagen micro-remodeling;</li>\n<li>Endovaginal cryogen-cooled, monopolar radiofrequency remodeling.</li>",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Injection of periurethral bulking agents",
            "sub_medical_act": null,
            "necessity_type": "Medically Necessary",
            "description": "Injection of periurethral bulking agents is considered medically necessary when the individual has stress urinary incontinence (SUI) meeting one the following two criteria (A or B):",
            "conditions": {
              "ANY": [
                {
                  "desc": "The incontinence is due to trauma or injury",
                  "conditions": null
                },
                {
                  "ALL": [
                    {
                      "desc": "The incontinence persists despite conservative treatment for at least a sufficient duration to fully assess treatment effect*",
                      "conditions": null
                    },
                    {
                      "ANY": [
                        {
                          "desc": "The incontinence is caused by intrinsic sphincter deficiency (ISD)",
                          "conditions": null
                        },
                        {
                          "desc": "The incontinence is due to urethral hypermobility in individuals with abdominal leak point less than 100 cm H2O",
                          "conditions": null
                        }
                      ]
                    }
                  ]
                }
              ]
            }
          },
          {
            "medical_act": "Implantation of an artificial urinary sphincter device",
            "sub_medical_act": "Adults",
            "necessity_type": "Medically Necessary",
            "description": "Implantation of an artificial urinary sphincter device is considered medically necessary in adults following prostate surgery to treat urinary incontinence due to reduced outlet resistance (Intrinsic Sphincter Deficiency [ISD]) when the symptoms of incontinence persist despite conservative treatment for at least a sufficient duration to fully assess treatment effect.*",
            "conditions": {
              "ALL": [
                {
                  "desc": "The symptoms of incontinence persist despite conservative treatment for at least a sufficient duration to fully assess treatment effect.*",
                  "conditions": null
                }
              ]
            }
          },
          {
            "medical_act": "Injection of periurethral bulking agents",
            "sub_medical_act": null,
            "necessity_type": "Not Medically Necessary",
            "description": "Injection of periurethral bulking agents is considered not medically necessary for individuals who do not meet the medically necessary criteria.",
            "conditions": null
          },
          {
            "medical_act": "Implantation of an artificial urinary sphincter device",
            "sub_medical_act": null,
            "necessity_type": "Not Medically Necessary",
            "description": "Implantation of an artificial urinary sphincter device is considered not medically necessary for individuals who do not meet the medically necessary criteria.",
            "conditions": null
          },
          {
            "medical_act": "inFlow\u2122 intraurethral valve-pump implantation",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "inFlow\u2122 intraurethral valve-pump implantation is considered investigational and not medically necessary as a treatment for urinary incontinence.",
            "conditions": null
          },
          {
            "medical_act": "ProACT\u2122 adjustable continence therapy",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "ProACT\u2122 adjustable continence therapy is considered investigational and not medically necessary as a treatment for urinary incontinence.",
            "conditions": null
          },
          {
            "medical_act": "Vaginal weight training with specially designed weights (cones)",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Vaginal weight training with specially designed weights (cones) is considered investigational and not medically necessary as a treatment for urinary incontinence.",
            "conditions": null
          },
          {
            "medical_act": "Transvaginal radiofrequency bladder neck suspension",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Transvaginal radiofrequency bladder neck suspension is considered investigational and not medically necessary as a treatment for urinary incontinence.",
            "conditions": null
          },
          {
            "medical_act": "Transurethral radiofrequency energy collagen micro-remodeling",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Transurethral radiofrequency energy collagen micro-remodeling is considered investigational and not medically necessary as a treatment for urinary incontinence.",
            "conditions": null
          },
          {
            "medical_act": "Endovaginal cryogen-cooled, monopolar radiofrequency remodeling",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Endovaginal cryogen-cooled, monopolar radiofrequency remodeling is considered investigational and not medically necessary as a treatment for urinary incontinence.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 2551,
          "prompt_tokens": 1472,
          "completion_tokens": 1079,
          "total_cost": 0.023544999999999996,
          "processing_time": 29.699548959732056
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_a053521.html",
    "subject": "Convection Enhanced Delivery of Therapeutic Agents to the Brain",
    "document_number": "SURG.00099",
    "publish_date": "01/03/2024",
    "status": "Reviewed",
    "last_review_date": "11/09/2023",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>Convection-enhanced delivery of therapeutic agents into the brain is considered <strong>investigational and not medically necessary.</strong></p>",
    "content": "Investigational and Not Medically Necessary:\nConvection-enhanced delivery of therapeutic agents into the brain is considered investigational and not medically necessary.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Convection-enhanced delivery of therapeutic agents into the brain",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Convection-enhanced delivery of therapeutic agents into the brain is considered investigational and not medically necessary.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 920,
          "prompt_tokens": 841,
          "completion_tokens": 79,
          "total_cost": 0.00539,
          "processing_time": 2.050806760787964
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_c187107.html",
    "subject": "Genicular Procedures for Treatment of Knee Pain",
    "document_number": "SURG.00142",
    "publish_date": "01/03/2024",
    "status": "Revised",
    "last_review_date": "11/09/2023",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>Genicular nerve blocks are considered <strong>investigational and not medically necessary</strong> as a treatment for knee pain.</p>\n<p>Genicular nerve radiofrequency ablation is considered <strong>investigational and not medically</strong> <strong>necessary </strong>as a treatment for knee pain.</p>\n<p>Genicular artery embolization is considered <strong>investigational and not medically</strong> <strong>necessary </strong>as a treatment for knee pain.</p>",
    "content": "Investigational and Not Medically Necessary:\nGenicular nerve blocks are considered investigational and not medically necessary as a treatment for knee pain.\nGenicular nerve radiofrequency ablation is considered investigational and not medically necessary as a treatment for knee pain.\nGenicular artery embolization is considered investigational and not medically necessary as a treatment for knee pain.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Genicular nerve blocks",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Genicular nerve blocks are considered investigational and not medically necessary as a treatment for knee pain.",
            "conditions": null
          },
          {
            "medical_act": "Genicular nerve radiofrequency ablation",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Genicular nerve radiofrequency ablation is considered investigational and not medically necessary as a treatment for knee pain.",
            "conditions": null
          },
          {
            "medical_act": "Genicular artery embolization",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Genicular artery embolization is considered investigational and not medically necessary as a treatment for knee pain.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 1099,
          "prompt_tokens": 882,
          "completion_tokens": 217,
          "total_cost": 0.007665,
          "processing_time": 4.18283224105835
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_a050275.html",
    "subject": "Cryoablation for Plantar Fasciitis and Plantar Fibroma",
    "document_number": "SURG.00100",
    "publish_date": "01/03/2024",
    "status": "Reviewed",
    "last_review_date": "11/09/2023",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p class=\"MsoAcetate\">Use of cryoablation (for example, cryosurgery, neuroablation) for the treatment of either plantar fasciitis or plantar fibroma is considered <strong>investigational and not medically necessary.</strong></p>",
    "content": "Investigational and Not Medically Necessary:\nUse of cryoablation (for example, cryosurgery, neuroablation) for the treatment of either plantar fasciitis or plantar fibroma is considered investigational and not medically necessary.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Use of cryoablation (for example, cryosurgery, neuroablation) for the treatment of either plantar fasciitis or plantar fibroma",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Use of cryoablation (for example, cryosurgery, neuroablation) for the treatment of either plantar fasciitis or plantar fibroma is considered investigational and not medically necessary.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 980,
          "prompt_tokens": 861,
          "completion_tokens": 119,
          "total_cost": 0.00609,
          "processing_time": 2.375549077987671
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_a050253.html",
    "subject": "Deep Brain, Cortical, and Cerebellar Stimulation",
    "document_number": "SURG.00026",
    "publish_date": "12/28/2023",
    "status": "Revised",
    "last_review_date": "11/09/2023",
    "html_content": "<p><strong>Medically Necessary:</strong></p>\n<p><em>Parkinson\u2019s disease</em></p>\n<p>Unilateral or bilateral deep brain stimulation is considered<strong> medically necessary</strong> for individuals with Parkinson\u2019s disease when the following criteria have been met:</p>\n<li>A minimal score of 30 points on the motor portion of the Unified Parkinson\u2019s Disease Rating Scale (UPDRS) when the individual has been without medication for 12 hours; <strong>and</strong></li>\n<li>Either of the following:\t<ol>\t\t<li>Motor complications of therapy that cannot be controlled pharmacologically; <strong>or</strong></li>\t\t<li>Tremor from Parkinson\u2019s disease cannot be controlled pharmacologically.</li>\t</ol>\t</li>\n<li>Motor complications of therapy that cannot be controlled pharmacologically; <strong>or</strong></li>\n<li>Tremor from Parkinson\u2019s disease cannot be controlled pharmacologically.</li>\n<p><em>Essential tremor</em></p>\n<p>Unilateral or bilateral deep brain stimulation is considered <strong>medically necessary</strong> for individuals with medically refractory essential tremor.</p>\n<p><em>Primary dystonia</em></p>\n<p>Unilateral or bilateral deep brain stimulation is considered <strong>medically necessary</strong> for individuals with primary dystonia when the following criteria have been met:</p>\n<li>7 years of age or older;<strong> and</strong></li>\n<li>Stimulated area is the subthalamic nucleus or globus pallidus; <strong>and</strong></li>\n<li>Dystonia is <strong>all</strong> of the following:\t<ol>\t\t<li>Chronic;<strong> and</strong></li>\t\t<li>Cannot be controlled pharmacologically; <strong>and</strong></li>\t\t<li>Has a significant effect upon daily activity; <strong>and</strong></li>\t\t<li>Not due to a secondary cause such as stroke, cerebral palsy, tumor, trauma, infection, multiple sclerosis, other neurodegenerative diseases, or medications.</li>\t</ol>\t</li>\n<li>Chronic;<strong> and</strong></li>\n<li>Cannot be controlled pharmacologically; <strong>and</strong></li>\n<li>Has a significant effect upon daily activity; <strong>and</strong></li>\n<li>Not due to a secondary cause such as stroke, cerebral palsy, tumor, trauma, infection, multiple sclerosis, other neurodegenerative diseases, or medications.</li>\n<p><em>Obsessive Compulsive Disorder</em></p>\n<p>Bilateral deep brain stimulation is considered <strong>medically necessary</strong> for individuals with obsessive compulsive disorder when the following criteria have been met:</p>\n<li>18 years of age or older; <strong>and</strong></li>\n<li>Stimulated area is the striatal axis; <strong>and</strong></li>\n<li>Well documented obsessive compulsive disorder for 5 years or longer; <strong>and</strong></li>\n<li>Severe functional impairment as indicated by a Yale-Brown Obsessive Compulsive Scale (Y-BOCS) score of 26 or greater despite conservative therapy meeting criteria 1 and 2 below<strong>:</strong>\t<ol>\t\t<li>Cognitive-behavioral therapy with a minimum of 20 sessions involving personal (in-person or videoconference) interaction between the individual and a certified behavioral specialist; <strong>and</strong></li>\t\t<li>Pharmacotherapy including both a and b below:\t\t<ol style=\"list-style-type:lower-alpha\">\t\t\t<li>A trial of clomipramine and at least two other serotonin-reuptake inhibitors at the maximum recommended dose or tolerated dose for at least 12 weeks; <strong>and</strong></li>\t\t\t<li>Augmentation of at least one serotonin-reuptake inhibitor trial with first- or second-generation neuroleptic over a period of at least 1 month; <strong>and</strong></li>\t\t</ol>\t\t</li>\t</ol>\t</li>\n<li>Cognitive-behavioral therapy with a minimum of 20 sessions involving personal (in-person or videoconference) interaction between the individual and a certified behavioral specialist; <strong>and</strong></li>\n<li>Pharmacotherapy including both a and b below:\t\t<ol style=\"list-style-type:lower-alpha\">\t\t\t<li>A trial of clomipramine and at least two other serotonin-reuptake inhibitors at the maximum recommended dose or tolerated dose for at least 12 weeks; <strong>and</strong></li>\t\t\t<li>Augmentation of at least one serotonin-reuptake inhibitor trial with first- or second-generation neuroleptic over a period of at least 1 month; <strong>and</strong></li>\t\t</ol>\t\t</li>\n<li>A trial of clomipramine and at least two other serotonin-reuptake inhibitors at the maximum recommended dose or tolerated dose for at least 12 weeks; <strong>and</strong></li>\n<li>Augmentation of at least one serotonin-reuptake inhibitor trial with first- or second-generation neuroleptic over a period of at least 1 month; <strong>and</strong></li>\n<li>Documentation indicates the individual or caregiver will be able to manage device in post-operative period; <strong>and</strong></li>\n<li>Absence of all of the following:\t<ol>\t\t<li>Contraindication to surgery including, but not limited to, any of the following:\t\t<ol style=\"list-style-type:lower-alpha\">\t\t\t<li>Significant neurological condition (for example, history of stroke, hypoxic brain injury, severe head trauma, cranial neoplasm, movement disorder); <strong>or</strong></li>\t\t\t<li>Contraindication and/or inability to undergo MRI; <strong>or</strong></li>\t\t\t<li>Clinically significant abnormality on MRI that may impair deep brain stimulator implantation; <strong>or</strong></li>\t\t\t<li>Clinically significant medical condition;<br>\t\t\t<strong>and</strong></li>\t\t</ol>\t\t</li>\t\t<li>Current significant psychological condition including, but not limited to, any of the following:\t\t<ol start=\"1\" style=\"list-style-type:lower-alpha\">\t\t\t<li>Active substance use disorder within the past 6 months; <strong>or</strong></li>\t\t\t<li>Manic episode in the preceding 3 years; <strong>or</strong></li>\t\t\t<li>Psychotic disorder within the past 3 years; <strong>or</strong></li>\t\t\t<li>Imminent risk of suicide; <strong>or</strong></li>\t\t\t<li>Severe personality disorder.</li>\t\t</ol>\t\t</li>\t</ol>\t</li>\n<li>Contraindication to surgery including, but not limited to, any of the following:\t\t<ol style=\"list-style-type:lower-alpha\">\t\t\t<li>Significant neurological condition (for example, history of stroke, hypoxic brain injury, severe head trauma, cranial neoplasm, movement disorder); <strong>or</strong></li>\t\t\t<li>Contraindication and/or inability to undergo MRI; <strong>or</strong></li>\t\t\t<li>Clinically significant abnormality on MRI that may impair deep brain stimulator implantation; <strong>or</strong></li>\t\t\t<li>Clinically significant medical condition;<br>\t\t\t<strong>and</strong></li>\t\t</ol>\t\t</li>\n<li>Significant neurological condition (for example, history of stroke, hypoxic brain injury, severe head trauma, cranial neoplasm, movement disorder); <strong>or</strong></li>\n<li>Contraindication and/or inability to undergo MRI; <strong>or</strong></li>\n<li>Clinically significant abnormality on MRI that may impair deep brain stimulator implantation; <strong>or</strong></li>\n<li>Clinically significant medical condition;<br>\t\t\t<strong>and</strong></li>\n<li>Current significant psychological condition including, but not limited to, any of the following:\t\t<ol start=\"1\" style=\"list-style-type:lower-alpha\">\t\t\t<li>Active substance use disorder within the past 6 months; <strong>or</strong></li>\t\t\t<li>Manic episode in the preceding 3 years; <strong>or</strong></li>\t\t\t<li>Psychotic disorder within the past 3 years; <strong>or</strong></li>\t\t\t<li>Imminent risk of suicide; <strong>or</strong></li>\t\t\t<li>Severe personality disorder.</li>\t\t</ol>\t\t</li>\n<li>Active substance use disorder within the past 6 months; <strong>or</strong></li>\n<li>Manic episode in the preceding 3 years; <strong>or</strong></li>\n<li>Psychotic disorder within the past 3 years; <strong>or</strong></li>\n<li>Imminent risk of suicide; <strong>or</strong></li>\n<li>Severe personality disorder.</li>\n<p><em>Epilepsy</em></p>\n<p>Unilateral or bilateral deep brain stimulation is considered <strong>medically necessary</strong> for individuals with epilepsy when the following criteria have been met:</p>\n<li>18 years of age or older; <strong>and</strong></li>\n<li>Stimulated area is the anterior nucleus of the thalamus; <strong>and</strong></li>\n<li>Focal partial onset seizures with or without generalized seizure; <strong>and</strong></li>\n<li>Refractory to two (2) or more antiepileptic medications; <strong>and</strong></li>\n<li>Currently having an average of three (3) or more disabling seizures (for example, motor partial seizures, complex partial seizures, or secondary generalized seizures) per month over the most recent three months; <strong>and</strong></li>\n<li>Absence of progressive neurological or medical conditions such as brain tumors or neurodegenerative disease; <strong>and</strong></li>\n<li>Non-epileptic seizures have been ruled out as the sole seizure etiology.</li>\n<p>Cortical stimulation is considered <strong>medically necessary</strong> for individuals with epilepsy when the following criteria have been met:</p>\n<li>18 years of age or older; <strong>and</strong></li>\n<li>Partial onset seizures; <strong>and</strong></li>\n<li>Diagnostic testing has localized no more than two (2) epileptogenic foci; <strong>and</strong></li>\n<li>Refractory to two (2) or more antiepileptic medications; <strong>and</strong></li>\n<li>Currently having an average of three (3) or more disabling seizures (for example, motor partial seizures, complex partial seizures, or secondary generalized seizures) per month over the most recent three months.</li>\n<p><em>Revision or replacement</em></p>\n<p>Revision or replacement of a deep brain stimulator, cortical stimulator, or battery for such devices is considered <strong>medically necessary</strong> when the following criteria are met:</p>\n<li>The individual has demonstrated clinical benefit from the stimulation; <strong>and</strong></li>\n<li>One or both of the following criteria are met:\t<ol>\t\t<li>The device has malfunctioned or is no longer working as intended; <strong>or</strong></li>\t\t<li>The neurostimulator or battery is within 12 months of its expected maximum service life.</li>\t</ol>\t</li>\n<li>The device has malfunctioned or is no longer working as intended; <strong>or</strong></li>\n<li>The neurostimulator or battery is within 12 months of its expected maximum service life.</li>\n<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>Deep brain stimulation is considered <strong>investigational and not medically necessary </strong>when criteria above have not been met.</p>\n<p>The use of cortical stimulation is considered <strong>investigational and not medically necessary</strong> when the criteria above have not been met.</p>\n<p>Revision or replacement of a deep brain stimulator, cortical stimulator, or battery for such devices is considered <strong>investigational and not medically necessary</strong> when the criteria above have not been met.</p>\n<p>The use of cerebellar stimulation/pacing is considered <strong>investigational and not medically necessary.</strong></p>",
    "content": "Medically Necessary:\nParkinson\u2019s disease\nUnilateral or bilateral deep brain stimulation is considered medically necessary for individuals with Parkinson\u2019s disease when the following criteria have been met:\n<li>A minimal score of 30 points on the motor portion of the Unified Parkinson\u2019s Disease Rating Scale (UPDRS) when the individual has been without medication for 12 hours; and</li>\n<li>Either of the following:\t<ol> <li>Motor complications of therapy that cannot be controlled pharmacologically; or</li> <li>Tremor from Parkinson\u2019s disease cannot be controlled pharmacologically.</li> </ol> </li>\n<li>Motor complications of therapy that cannot be controlled pharmacologically; or</li>\n<li>Tremor from Parkinson\u2019s disease cannot be controlled pharmacologically.</li>\nEssential tremor\nUnilateral or bilateral deep brain stimulation is considered medically necessary for individuals with medically refractory essential tremor.\nPrimary dystonia\nUnilateral or bilateral deep brain stimulation is considered medically necessary for individuals with primary dystonia when the following criteria have been met:\n<li>7 years of age or older; and</li>\n<li>Stimulated area is the subthalamic nucleus or globus pallidus; and</li>\n<li>Dystonia is all of the following:\t<ol> <li>Chronic; and</li> <li>Cannot be controlled pharmacologically; and</li> <li>Has a significant effect upon daily activity; and</li> <li>Not due to a secondary cause such as stroke, cerebral palsy, tumor, trauma, infection, multiple sclerosis, other neurodegenerative diseases, or medications.</li> </ol> </li>\n<li>Chronic; and</li>\n<li>Cannot be controlled pharmacologically; and</li>\n<li>Has a significant effect upon daily activity; and</li>\n<li>Not due to a secondary cause such as stroke, cerebral palsy, tumor, trauma, infection, multiple sclerosis, other neurodegenerative diseases, or medications.</li>\nObsessive Compulsive Disorder\nBilateral deep brain stimulation is considered medically necessary for individuals with obsessive compulsive disorder when the following criteria have been met:\n<li>18 years of age or older; and</li>\n<li>Stimulated area is the striatal axis; and</li>\n<li>Well documented obsessive compulsive disorder for 5 years or longer; and</li>\n<li>Severe functional impairment as indicated by a Yale-Brown Obsessive Compulsive Scale (Y-BOCS) score of 26 or greater despite conservative therapy meeting criteria 1 and 2 below: <ol> <li>Cognitive-behavioral therapy with a minimum of 20 sessions involving personal (in-person or videoconference) interaction between the individual and a certified behavioral specialist; and</li> <li>Pharmacotherapy including both a and b below:\t\t<ol style=\"list-style-type:lower-alpha\"> <li>A trial of clomipramine and at least two other serotonin-reuptake inhibitors at the maximum recommended dose or tolerated dose for at least 12 weeks; and</li> <li>Augmentation of at least one serotonin-reuptake inhibitor trial with first- or second-generation neuroleptic over a period of at least 1 month; and</li> </ol> </li> </ol> </li>\n<li>Cognitive-behavioral therapy with a minimum of 20 sessions involving personal (in-person or videoconference) interaction between the individual and a certified behavioral specialist; and</li>\n<li>Pharmacotherapy including both a and b below:\t\t<ol style=\"list-style-type:lower-alpha\"> <li>A trial of clomipramine and at least two other serotonin-reuptake inhibitors at the maximum recommended dose or tolerated dose for at least 12 weeks; and</li> <li>Augmentation of at least one serotonin-reuptake inhibitor trial with first- or second-generation neuroleptic over a period of at least 1 month; and</li> </ol> </li>\n<li>A trial of clomipramine and at least two other serotonin-reuptake inhibitors at the maximum recommended dose or tolerated dose for at least 12 weeks; and</li>\n<li>Augmentation of at least one serotonin-reuptake inhibitor trial with first- or second-generation neuroleptic over a period of at least 1 month; and</li>\n<li>Documentation indicates the individual or caregiver will be able to manage device in post-operative period; and</li>\n<li>Absence of all of the following:\t<ol> <li>Contraindication to surgery including, but not limited to, any of the following:\t\t<ol style=\"list-style-type:lower-alpha\"> <li>Significant neurological condition (for example, history of stroke, hypoxic brain injury, severe head trauma, cranial neoplasm, movement disorder); or</li> <li>Contraindication and/or inability to undergo MRI; or</li> <li>Clinically significant abnormality on MRI that may impair deep brain stimulator implantation; or</li> <li>Clinically significant medical condition;<br/> and</li> </ol> </li> <li>Current significant psychological condition including, but not limited to, any of the following:\t\t<ol start=\"1\" style=\"list-style-type:lower-alpha\"> <li>Active substance use disorder within the past 6 months; or</li> <li>Manic episode in the preceding 3 years; or</li> <li>Psychotic disorder within the past 3 years; or</li> <li>Imminent risk of suicide; or</li> <li>Severe personality disorder.</li> </ol> </li> </ol> </li>\n<li>Contraindication to surgery including, but not limited to, any of the following:\t\t<ol style=\"list-style-type:lower-alpha\"> <li>Significant neurological condition (for example, history of stroke, hypoxic brain injury, severe head trauma, cranial neoplasm, movement disorder); or</li> <li>Contraindication and/or inability to undergo MRI; or</li> <li>Clinically significant abnormality on MRI that may impair deep brain stimulator implantation; or</li> <li>Clinically significant medical condition;<br/> and</li> </ol> </li>\n<li>Significant neurological condition (for example, history of stroke, hypoxic brain injury, severe head trauma, cranial neoplasm, movement disorder); or</li>\n<li>Contraindication and/or inability to undergo MRI; or</li>\n<li>Clinically significant abnormality on MRI that may impair deep brain stimulator implantation; or</li>\n<li>Clinically significant medical condition;<br/> and</li>\n<li>Current significant psychological condition including, but not limited to, any of the following:\t\t<ol start=\"1\" style=\"list-style-type:lower-alpha\"> <li>Active substance use disorder within the past 6 months; or</li> <li>Manic episode in the preceding 3 years; or</li> <li>Psychotic disorder within the past 3 years; or</li> <li>Imminent risk of suicide; or</li> <li>Severe personality disorder.</li> </ol> </li>\n<li>Active substance use disorder within the past 6 months; or</li>\n<li>Manic episode in the preceding 3 years; or</li>\n<li>Psychotic disorder within the past 3 years; or</li>\n<li>Imminent risk of suicide; or</li>\n<li>Severe personality disorder.</li>\nEpilepsy\nUnilateral or bilateral deep brain stimulation is considered medically necessary for individuals with epilepsy when the following criteria have been met:\n<li>18 years of age or older; and</li>\n<li>Stimulated area is the anterior nucleus of the thalamus; and</li>\n<li>Focal partial onset seizures with or without generalized seizure; and</li>\n<li>Refractory to two (2) or more antiepileptic medications; and</li>\n<li>Currently having an average of three (3) or more disabling seizures (for example, motor partial seizures, complex partial seizures, or secondary generalized seizures) per month over the most recent three months; and</li>\n<li>Absence of progressive neurological or medical conditions such as brain tumors or neurodegenerative disease; and</li>\n<li>Non-epileptic seizures have been ruled out as the sole seizure etiology.</li>\nCortical stimulation is considered medically necessary for individuals with epilepsy when the following criteria have been met:\n<li>18 years of age or older; and</li>\n<li>Partial onset seizures; and</li>\n<li>Diagnostic testing has localized no more than two (2) epileptogenic foci; and</li>\n<li>Refractory to two (2) or more antiepileptic medications; and</li>\n<li>Currently having an average of three (3) or more disabling seizures (for example, motor partial seizures, complex partial seizures, or secondary generalized seizures) per month over the most recent three months.</li>\nRevision or replacement\nRevision or replacement of a deep brain stimulator, cortical stimulator, or battery for such devices is considered medically necessary when the following criteria are met:\n<li>The individual has demonstrated clinical benefit from the stimulation; and</li>\n<li>One or both of the following criteria are met:\t<ol> <li>The device has malfunctioned or is no longer working as intended; or</li> <li>The neurostimulator or battery is within 12 months of its expected maximum service life.</li> </ol> </li>\n<li>The device has malfunctioned or is no longer working as intended; or</li>\n<li>The neurostimulator or battery is within 12 months of its expected maximum service life.</li>\nInvestigational and Not Medically Necessary:\nDeep brain stimulation is considered investigational and not medically necessary when criteria above have not been met.\nThe use of cortical stimulation is considered investigational and not medically necessary when the criteria above have not been met.\nRevision or replacement of a deep brain stimulator, cortical stimulator, or battery for such devices is considered investigational and not medically necessary when the criteria above have not been met.\nThe use of cerebellar stimulation/pacing is considered investigational and not medically necessary.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Unilateral or bilateral deep brain stimulation",
            "sub_medical_act": "Parkinson\u2019s disease",
            "necessity_type": "Medically Necessary",
            "description": "Unilateral or bilateral deep brain stimulation is considered medically necessary for individuals with Parkinson\u2019s disease when the following criteria have been met:",
            "conditions": {
              "ALL": [
                {
                  "desc": "A minimal score of 30 points on the motor portion of the Unified Parkinson\u2019s Disease Rating Scale (UPDRS) when the individual has been without medication for 12 hours",
                  "conditions": null
                },
                {
                  "ANY": [
                    {
                      "desc": "Motor complications of therapy that cannot be controlled pharmacologically",
                      "conditions": null
                    },
                    {
                      "desc": "Tremor from Parkinson\u2019s disease cannot be controlled pharmacologically",
                      "conditions": null
                    }
                  ]
                }
              ]
            }
          },
          {
            "medical_act": "Unilateral or bilateral deep brain stimulation",
            "sub_medical_act": "Essential tremor",
            "necessity_type": "Medically Necessary",
            "description": "Unilateral or bilateral deep brain stimulation is considered medically necessary for individuals with medically refractory essential tremor.",
            "conditions": null
          },
          {
            "medical_act": "Unilateral or bilateral deep brain stimulation",
            "sub_medical_act": "Primary dystonia",
            "necessity_type": "Medically Necessary",
            "description": "Unilateral or bilateral deep brain stimulation is considered medically necessary for individuals with primary dystonia when the following criteria have been met:",
            "conditions": {
              "ALL": [
                {
                  "desc": "7 years of age or older",
                  "conditions": null
                },
                {
                  "desc": "Stimulated area is the subthalamic nucleus or globus pallidus",
                  "conditions": null
                },
                {
                  "ALL": [
                    {
                      "desc": "Dystonia is chronic",
                      "conditions": null
                    },
                    {
                      "desc": "Dystonia cannot be controlled pharmacologically",
                      "conditions": null
                    },
                    {
                      "desc": "Dystonia has a significant effect upon daily activity",
                      "conditions": null
                    },
                    {
                      "desc": "Dystonia is not due to a secondary cause such as stroke, cerebral palsy, tumor, trauma, infection, multiple sclerosis, other neurodegenerative diseases, or medications",
                      "conditions": null
                    }
                  ]
                }
              ]
            }
          },
          {
            "medical_act": "Bilateral deep brain stimulation",
            "sub_medical_act": "Obsessive Compulsive Disorder",
            "necessity_type": "Medically Necessary",
            "description": "Bilateral deep brain stimulation is considered medically necessary for individuals with obsessive compulsive disorder when the following criteria have been met:",
            "conditions": {
              "ALL": [
                {
                  "desc": "18 years of age or older",
                  "conditions": null
                },
                {
                  "desc": "Stimulated area is the striatal axis",
                  "conditions": null
                },
                {
                  "desc": "Well documented obsessive compulsive disorder for 5 years or longer",
                  "conditions": null
                },
                {
                  "desc": "Severe functional impairment as indicated by a Yale-Brown Obsessive Compulsive Scale (Y-BOCS) score of 26 or greater despite conservative therapy meeting criteria 1 and 2 below",
                  "conditions": {
                    "ALL": [
                      {
                        "desc": "Cognitive-behavioral therapy with a minimum of 20 sessions involving personal (in-person or videoconference) interaction between the individual and a certified behavioral specialist",
                        "conditions": null
                      },
                      {
                        "ALL": [
                          {
                            "desc": "A trial of clomipramine and at least two other serotonin-reuptake inhibitors at the maximum recommended dose or tolerated dose for at least 12 weeks",
                            "conditions": null
                          },
                          {
                            "desc": "Augmentation of at least one serotonin-reuptake inhibitor trial with first- or second-generation neuroleptic over a period of at least 1 month",
                            "conditions": null
                          }
                        ]
                      }
                    ]
                  }
                },
                {
                  "desc": "Documentation indicates the individual or caregiver will be able to manage device in post-operative period",
                  "conditions": null
                },
                {
                  "ALL": [
                    {
                      "desc": "Absence of contraindication to surgery including, but not limited to, any of the following",
                      "conditions": {
                        "ANY": [
                          {
                            "desc": "Significant neurological condition (for example, history of stroke, hypoxic brain injury, severe head trauma, cranial neoplasm, movement disorder)",
                            "conditions": null
                          },
                          {
                            "desc": "Contraindication and/or inability to undergo MRI",
                            "conditions": null
                          },
                          {
                            "desc": "Clinically significant abnormality on MRI that may impair deep brain stimulator implantation",
                            "conditions": null
                          },
                          {
                            "desc": "Clinically significant medical condition",
                            "conditions": null
                          }
                        ]
                      }
                    },
                    {
                      "desc": "Absence of current significant psychological condition including, but not limited to, any of the following",
                      "conditions": {
                        "ANY": [
                          {
                            "desc": "Active substance use disorder within the past 6 months",
                            "conditions": null
                          },
                          {
                            "desc": "Manic episode in the preceding 3 years",
                            "conditions": null
                          },
                          {
                            "desc": "Psychotic disorder within the past 3 years",
                            "conditions": null
                          },
                          {
                            "desc": "Imminent risk of suicide",
                            "conditions": null
                          },
                          {
                            "desc": "Severe personality disorder",
                            "conditions": null
                          }
                        ]
                      }
                    }
                  ]
                }
              ]
            }
          },
          {
            "medical_act": "Unilateral or bilateral deep brain stimulation",
            "sub_medical_act": "Epilepsy",
            "necessity_type": "Medically Necessary",
            "description": "Unilateral or bilateral deep brain stimulation is considered medically necessary for individuals with epilepsy when the following criteria have been met:",
            "conditions": {
              "ALL": [
                {
                  "desc": "18 years of age or older",
                  "conditions": null
                },
                {
                  "desc": "Stimulated area is the anterior nucleus of the thalamus",
                  "conditions": null
                },
                {
                  "desc": "Focal partial onset seizures with or without generalized seizure",
                  "conditions": null
                },
                {
                  "desc": "Refractory to two (2) or more antiepileptic medications",
                  "conditions": null
                },
                {
                  "desc": "Currently having an average of three (3) or more disabling seizures (for example, motor partial seizures, complex partial seizures, or secondary generalized seizures) per month over the most recent three months",
                  "conditions": null
                },
                {
                  "desc": "Absence of progressive neurological or medical conditions such as brain tumors or neurodegenerative disease",
                  "conditions": null
                },
                {
                  "desc": "Non-epileptic seizures have been ruled out as the sole seizure etiology",
                  "conditions": null
                }
              ]
            }
          },
          {
            "medical_act": "Cortical stimulation",
            "sub_medical_act": "Epilepsy",
            "necessity_type": "Medically Necessary",
            "description": "Cortical stimulation is considered medically necessary for individuals with epilepsy when the following criteria have been met:",
            "conditions": {
              "ALL": [
                {
                  "desc": "18 years of age or older",
                  "conditions": null
                },
                {
                  "desc": "Partial onset seizures",
                  "conditions": null
                },
                {
                  "desc": "Diagnostic testing has localized no more than two (2) epileptogenic foci",
                  "conditions": null
                },
                {
                  "desc": "Refractory to two (2) or more antiepileptic medications",
                  "conditions": null
                },
                {
                  "desc": "Currently having an average of three (3) or more disabling seizures (for example, motor partial seizures, complex partial seizures, or secondary generalized seizures) per month over the most recent three months",
                  "conditions": null
                }
              ]
            }
          },
          {
            "medical_act": "Revision or replacement of a deep brain stimulator, cortical stimulator, or battery",
            "sub_medical_act": null,
            "necessity_type": "Medically Necessary",
            "description": "Revision or replacement of a deep brain stimulator, cortical stimulator, or battery for such devices is considered medically necessary when the following criteria are met:",
            "conditions": {
              "ALL": [
                {
                  "desc": "The individual has demonstrated clinical benefit from the stimulation",
                  "conditions": null
                },
                {
                  "ANY": [
                    {
                      "desc": "The device has malfunctioned or is no longer working as intended",
                      "conditions": null
                    },
                    {
                      "desc": "The neurostimulator or battery is within 12 months of its expected maximum service life",
                      "conditions": null
                    }
                  ]
                }
              ]
            }
          },
          {
            "medical_act": "Deep brain stimulation",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Deep brain stimulation is considered investigational and not medically necessary when criteria above have not been met.",
            "conditions": null
          },
          {
            "medical_act": "Cortical stimulation",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "The use of cortical stimulation is considered investigational and not medically necessary when the criteria above have not been met.",
            "conditions": null
          },
          {
            "medical_act": "Revision or replacement of a deep brain stimulator, cortical stimulator, or battery",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Revision or replacement of a deep brain stimulator, cortical stimulator, or battery for such devices is considered investigational and not medically necessary when the criteria above have not been met.",
            "conditions": null
          },
          {
            "medical_act": "Cerebellar stimulation/pacing",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "The use of cerebellar stimulation/pacing is considered investigational and not medically necessary.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 5338,
          "prompt_tokens": 2997,
          "completion_tokens": 2341,
          "total_cost": 0.0501,
          "processing_time": 38.566768169403076
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_a050255.html",
    "subject": "Extracorporeal Shock Wave Therapy",
    "document_number": "SURG.00045",
    "publish_date": "12/28/2023",
    "status": "Reviewed",
    "last_review_date": "05/11/2023",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>Use of Extracorporeal Shock Wave Therapy (ESWT), including but not limited to the use of Extracorporeal Pulse Activation Therapy (EPAT<sup>\u00ae</sup>), for the treatment of musculoskeletal conditions and soft tissue injuries is considered <strong>investigational and not medically necessary.</strong> These conditions include, but are not limited to:</p>\n<ul style=\"list-style-type:disc\">\t<li>Chronic plantar fasciitis</li>\t<li>Calcified tendinitis of shoulder</li>\t<li>Chronic lateral epicondylitis (tennis elbow)</li>\t<li>Elbow tendinitis</li>\t<li>Erectile dysfunction</li>\t<li>Fixation of loosened cemented orthopedic prosthesis</li>\t<li>Non-union fractures</li>\t<li>Peyronie\u2019s disease</li>\t<li>Soft tissue or wound repair</li></ul>\n<li>Chronic plantar fasciitis</li>\n<li>Calcified tendinitis of shoulder</li>\n<li>Chronic lateral epicondylitis (tennis elbow)</li>\n<li>Elbow tendinitis</li>\n<li>Erectile dysfunction</li>\n<li>Fixation of loosened cemented orthopedic prosthesis</li>\n<li>Non-union fractures</li>\n<li>Peyronie\u2019s disease</li>\n<li>Soft tissue or wound repair</li>",
    "content": "Investigational and Not Medically Necessary:\nUse of Extracorporeal Shock Wave Therapy (ESWT), including but not limited to the use of Extracorporeal Pulse Activation Therapy (EPAT<sup>\u00ae</sup>), for the treatment of musculoskeletal conditions and soft tissue injuries is considered investigational and not medically necessary. These conditions include, but are not limited to:\n<ul style=\"list-style-type:disc\"> <li>Chronic plantar fasciitis</li> <li>Calcified tendinitis of shoulder</li> <li>Chronic lateral epicondylitis (tennis elbow)</li> <li>Elbow tendinitis</li> <li>Erectile dysfunction</li> <li>Fixation of loosened cemented orthopedic prosthesis</li> <li>Non-union fractures</li> <li>Peyronie\u2019s disease</li> <li>Soft tissue or wound repair</li></ul>\n<li>Chronic plantar fasciitis</li>\n<li>Calcified tendinitis of shoulder</li>\n<li>Chronic lateral epicondylitis (tennis elbow)</li>\n<li>Elbow tendinitis</li>\n<li>Erectile dysfunction</li>\n<li>Fixation of loosened cemented orthopedic prosthesis</li>\n<li>Non-union fractures</li>\n<li>Peyronie\u2019s disease</li>\n<li>Soft tissue or wound repair</li>",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Extracorporeal Shock Wave Therapy (ESWT)",
            "sub_medical_act": "Extracorporeal Pulse Activation Therapy (EPAT\u00ae)",
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Use of Extracorporeal Shock Wave Therapy (ESWT), including but not limited to the use of Extracorporeal Pulse Activation Therapy (EPAT\u00ae), for the treatment of musculoskeletal conditions and soft tissue injuries is considered investigational and not medically necessary. These conditions include, but are not limited to:",
            "conditions": {
              "ANY": [
                {
                  "desc": "Chronic plantar fasciitis",
                  "conditions": null
                },
                {
                  "desc": "Calcified tendinitis of shoulder",
                  "conditions": null
                },
                {
                  "desc": "Chronic lateral epicondylitis (tennis elbow)",
                  "conditions": null
                },
                {
                  "desc": "Elbow tendinitis",
                  "conditions": null
                },
                {
                  "desc": "Erectile dysfunction",
                  "conditions": null
                },
                {
                  "desc": "Fixation of loosened cemented orthopedic prosthesis",
                  "conditions": null
                },
                {
                  "desc": "Non-union fractures",
                  "conditions": null
                },
                {
                  "desc": "Peyronie\u2019s disease",
                  "conditions": null
                },
                {
                  "desc": "Soft tissue or wound repair",
                  "conditions": null
                }
              ]
            }
          }
        ],
        "usage": {
          "total_tokens": 1419,
          "prompt_tokens": 1108,
          "completion_tokens": 311,
          "total_cost": 0.010205,
          "processing_time": 5.877685070037842
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_a053519.html",
    "subject": "Scoliosis Surgery",
    "document_number": "SURG.00097",
    "publish_date": "12/28/2023",
    "status": "Revised",
    "last_review_date": "11/09/2023",
    "html_content": "<p><strong>Medically Necessary:</strong></p>\n<p>Vertebral body tethering for the treatment of scoliosis is considered <strong>medically necessary</strong> for <strong>all</strong> of the following criteria:</p>\n<li>Curve progression following conservative management (for example, observation, exercise therapy, or bracing); <strong>and</strong></li>\n<li>Cobb angle 40 to 60 degrees; <strong>and</strong></li>\n<li>Curve flexibility greater than 30%; <strong>and</strong></li>\n<li>Skeletal immaturity, defined as either:\t<ol style=\"list-style-type:lower-alpha\">\t\t<li>Risser grade 0 or 1; <strong>or</strong></li>\t\t<li>Sanders Maturity Scale less than or equal to 4.</li>\t</ol>\t</li>\n<li>Risser grade 0 or 1; <strong>or</strong></li>\n<li>Sanders Maturity Scale less than or equal to 4.</li>\n<p>Revision, replacement or removal of vertebral body tethering is considered <strong>medically necessary</strong> when there are complications associated with the device (for example, tether breakage or overcorrection).</p>\n<p style=\"text-align:justify\"><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>Vertebral body tethering for the treatment of scoliosis is considered <strong>investigational and not medically necessary </strong>when the above criteria are not met and for all other indications.</p>\n<p>Use of a minimally invasive deformity correction system for the treatment of scoliosis is considered <strong>investigational and not medically necessary.</strong></p>\n<p>Vertebral body stapling for the treatment of scoliosis is considered <strong>investigational and not medically necessary.</strong></p>\n<p>Use of magnetically controlled growing rods for the treatment of scoliosis is considered <strong>investigational and not medically necessary.</strong></p>\n<p>Revision, replacement or removal of vertebral body tethering is considered <strong>investigational and not medically necessary </strong>when the above criteria are not met<strong>. </strong></p>",
    "content": "Medically Necessary:\nVertebral body tethering for the treatment of scoliosis is considered medically necessary for all of the following criteria:\n<li>Curve progression following conservative management (for example, observation, exercise therapy, or bracing); and</li>\n<li>Cobb angle 40 to 60 degrees; and</li>\n<li>Curve flexibility greater than 30%; and</li>\n<li>Skeletal immaturity, defined as either:\t<ol style=\"list-style-type:lower-alpha\"> <li>Risser grade 0 or 1; or</li> <li>Sanders Maturity Scale less than or equal to 4.</li> </ol> </li>\n<li>Risser grade 0 or 1; or</li>\n<li>Sanders Maturity Scale less than or equal to 4.</li>\nRevision, replacement or removal of vertebral body tethering is considered medically necessary when there are complications associated with the device (for example, tether breakage or overcorrection).\nInvestigational and Not Medically Necessary:\nVertebral body tethering for the treatment of scoliosis is considered investigational and not medically necessary when the above criteria are not met and for all other indications.\nUse of a minimally invasive deformity correction system for the treatment of scoliosis is considered investigational and not medically necessary.\nVertebral body stapling for the treatment of scoliosis is considered investigational and not medically necessary.\nUse of magnetically controlled growing rods for the treatment of scoliosis is considered investigational and not medically necessary.\nRevision, replacement or removal of vertebral body tethering is considered investigational and not medically necessary when the above criteria are not met. ",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Vertebral body tethering for the treatment of scoliosis",
            "sub_medical_act": null,
            "necessity_type": "Medically Necessary",
            "description": "Vertebral body tethering for the treatment of scoliosis is considered medically necessary for all of the following criteria:",
            "conditions": {
              "ALL": [
                {
                  "desc": "Curve progression following conservative management (for example, observation, exercise therapy, or bracing)",
                  "conditions": null
                },
                {
                  "desc": "Cobb angle 40 to 60 degrees",
                  "conditions": null
                },
                {
                  "desc": "Curve flexibility greater than 30%",
                  "conditions": null
                },
                {
                  "ANY": [
                    {
                      "desc": "Risser grade 0 or 1",
                      "conditions": null
                    },
                    {
                      "desc": "Sanders Maturity Scale less than or equal to 4",
                      "conditions": null
                    }
                  ]
                }
              ]
            }
          },
          {
            "medical_act": "Revision, replacement or removal of vertebral body tethering",
            "sub_medical_act": null,
            "necessity_type": "Medically Necessary",
            "description": "Revision, replacement or removal of vertebral body tethering is considered medically necessary when there are complications associated with the device (for example, tether breakage or overcorrection).",
            "conditions": null
          },
          {
            "medical_act": "Vertebral body tethering for the treatment of scoliosis",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Vertebral body tethering for the treatment of scoliosis is considered investigational and not medically necessary when the above criteria are not met and for all other indications.",
            "conditions": null
          },
          {
            "medical_act": "Use of a minimally invasive deformity correction system for the treatment of scoliosis",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Use of a minimally invasive deformity correction system for the treatment of scoliosis is considered investigational and not medically necessary.",
            "conditions": null
          },
          {
            "medical_act": "Vertebral body stapling for the treatment of scoliosis",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Vertebral body stapling for the treatment of scoliosis is considered investigational and not medically necessary.",
            "conditions": null
          },
          {
            "medical_act": "Use of magnetically controlled growing rods for the treatment of scoliosis",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Use of magnetically controlled growing rods for the treatment of scoliosis is considered investigational and not medically necessary.",
            "conditions": null
          },
          {
            "medical_act": "Revision, replacement or removal of vertebral body tethering",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Revision, replacement or removal of vertebral body tethering is considered investigational and not medically necessary when the above criteria are not met.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 1880,
          "prompt_tokens": 1157,
          "completion_tokens": 723,
          "total_cost": 0.01663,
          "processing_time": 11.60705304145813
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_a053391.html",
    "subject": "Uterine Fibroid Ablation: Laparoscopic, Percutaneous or Transcervical Image Guided Techniques",
    "document_number": "SURG.00077",
    "publish_date": "12/28/2023",
    "status": "Reviewed",
    "last_review_date": "08/10/2023",
    "html_content": "<p><strong>Medically Necessary</strong></p>\n<p>The use of laparoscopic or transcervical radiofrequency ablation as a treatment for symptomatic uterine fibroids (e.g. excessive uterine bleeding or pelvic discomfort caused by uterine fibroids) is considered <strong>medically necessary</strong> when <em>all</em> of the following criteria are met:</p>\n<li>Uterine preservation is desired; <strong>and</strong></li>\n<li>Fibroids are less than 10 cm in any diameter; <strong>and</strong></li>\n<li>Uterine size does not exceed 16 weeks\u2019 gestation.</li>\n<p><strong>Not Medically Necessary:</strong></p>\n<p>The use of laparoscopic or transcervical radiofrequency ablation as a treatment for uterine fibroids is considered <strong>not medically necessary</strong> for individuals who do not meet the above criteria.</p>\n<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>The use of all other laparoscopic or percutaneous ablation techniques in combination with imaging guidance as a treatment of uterine fibroids is considered <strong>investigational and not medically necessary,</strong> including but not limited to lasers, bipolar electrodes, interstitial thermotherapy and cryotherapy.</p>",
    "content": "Medically Necessary\nThe use of laparoscopic or transcervical radiofrequency ablation as a treatment for symptomatic uterine fibroids (e.g. excessive uterine bleeding or pelvic discomfort caused by uterine fibroids) is considered medically necessary when all of the following criteria are met:\n<li>Uterine preservation is desired; and</li>\n<li>Fibroids are less than 10 cm in any diameter; and</li>\n<li>Uterine size does not exceed 16 weeks\u2019 gestation.</li>\nNot Medically Necessary:\nThe use of laparoscopic or transcervical radiofrequency ablation as a treatment for uterine fibroids is considered not medically necessary for individuals who do not meet the above criteria.\nInvestigational and Not Medically Necessary:\nThe use of all other laparoscopic or percutaneous ablation techniques in combination with imaging guidance as a treatment of uterine fibroids is considered investigational and not medically necessary, including but not limited to lasers, bipolar electrodes, interstitial thermotherapy and cryotherapy.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Laparoscopic or Transcervical Radiofrequency Ablation for Symptomatic Uterine Fibroids",
            "sub_medical_act": null,
            "necessity_type": "Medically Necessary",
            "description": "The use of laparoscopic or transcervical radiofrequency ablation as a treatment for symptomatic uterine fibroids (e.g. excessive uterine bleeding or pelvic discomfort caused by uterine fibroids) is considered medically necessary when all of the following criteria are met:",
            "conditions": {
              "ALL": [
                {
                  "desc": "Uterine preservation is desired",
                  "conditions": null
                },
                {
                  "desc": "Fibroids are less than 10 cm in any diameter",
                  "conditions": null
                },
                {
                  "desc": "Uterine size does not exceed 16 weeks\u2019 gestation",
                  "conditions": null
                }
              ]
            }
          },
          {
            "medical_act": "Laparoscopic or Transcervical Radiofrequency Ablation for Uterine Fibroids",
            "sub_medical_act": null,
            "necessity_type": "Not Medically Necessary",
            "description": "The use of laparoscopic or transcervical radiofrequency ablation as a treatment for uterine fibroids is considered not medically necessary for individuals who do not meet the above criteria.",
            "conditions": null
          },
          {
            "medical_act": "All Other Laparoscopic or Percutaneous Ablation Techniques in Combination with Imaging Guidance for Uterine Fibroids",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "The use of all other laparoscopic or percutaneous ablation techniques in combination with imaging guidance as a treatment of uterine fibroids is considered investigational and not medically necessary, including but not limited to lasers, bipolar electrodes, interstitial thermotherapy and cryotherapy.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 1435,
          "prompt_tokens": 1021,
          "completion_tokens": 414,
          "total_cost": 0.011314999999999999,
          "processing_time": 5.577933073043823
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_c191511.html",
    "subject": "Occipital and Sphenopalatine Ganglion Nerve Block Therapy for the Treatment of Headache and Neuralgia",
    "document_number": "SURG.00144",
    "publish_date": "09/27/2023",
    "status": "Revised",
    "last_review_date": "08/10/2023",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>Occipital nerve block therapy is considered <strong>investigational and not medically</strong> <strong>necessary</strong> for the treatment of occipital neuralgia and headache syndromes including, but not limited to, chronic migraine, chronic daily headache, cervicogenic and cluster headache.</p>\n<p>Sphenopalatine ganglion nerve block therapy is considered <strong>investigational and not medically necessary</strong> for all indications including, but not limited to, the treatment of migraine headaches and non -migraine headaches.</p>",
    "content": "Investigational and Not Medically Necessary:\nOccipital nerve block therapy is considered investigational and not medically necessary for the treatment of occipital neuralgia and headache syndromes including, but not limited to, chronic migraine, chronic daily headache, cervicogenic and cluster headache.\nSphenopalatine ganglion nerve block therapy is considered investigational and not medically necessary for all indications including, but not limited to, the treatment of migraine headaches and non -migraine headaches.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Occipital nerve block therapy",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Occipital nerve block therapy is considered investigational and not medically necessary for the treatment of occipital neuralgia and headache syndromes including, but not limited to, chronic migraine, chronic daily headache, cervicogenic and cluster headache.",
            "conditions": null
          },
          {
            "medical_act": "Sphenopalatine ganglion nerve block therapy",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Sphenopalatine ganglion nerve block therapy is considered investigational and not medically necessary for all indications including, but not limited to, the treatment of migraine headaches and non-migraine headaches.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 1107,
          "prompt_tokens": 909,
          "completion_tokens": 198,
          "total_cost": 0.007515000000000001,
          "processing_time": 3.174467086791992
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_c145660.html",
    "subject": "Implantable Left Atrial Hemodynamic Monitor",
    "document_number": "SURG.00128",
    "publish_date": "09/27/2023",
    "status": "Reviewed",
    "last_review_date": "08/10/2023",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>Left atrial hemodynamic monitoring utilizing implantable device (for example, HeartPOD\u2122 System, Promote<sup>\u00ae</sup> LAP System, and V-LAP\u2122 System) is considered <strong>investigational and not medically necessary</strong> for all indications.</p>",
    "content": "Investigational and Not Medically Necessary:\nLeft atrial hemodynamic monitoring utilizing implantable device (for example, HeartPOD\u2122 System, Promote<sup>\u00ae</sup> LAP System, and V-LAP\u2122 System) is considered investigational and not medically necessary for all indications.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Left atrial hemodynamic monitoring utilizing implantable device",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Left atrial hemodynamic monitoring utilizing implantable device (for example, HeartPOD\u2122 System, Promote\u00ae LAP System, and V-LAP\u2122 System) is considered investigational and not medically necessary for all indications.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 976,
          "prompt_tokens": 872,
          "completion_tokens": 104,
          "total_cost": 0.00592,
          "processing_time": 1.9356961250305176
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_c151320.html",
    "subject": "Lower Esophageal Sphincter Augmentation Devices for the Treatment of Gastroesophageal Reflux Disease (GERD)",
    "document_number": "SURG.00131",
    "publish_date": "09/27/2023",
    "status": "Reviewed",
    "last_review_date": "08/10/2023",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>Lower esophageal sphincter augmentation devices are considered <strong>investigational and not medically necessary</strong> for the treatment of gastroesophageal reflux disease (GERD) and for all other indications<strong>.</strong></p>",
    "content": "Investigational and Not Medically Necessary:\nLower esophageal sphincter augmentation devices are considered investigational and not medically necessary for the treatment of gastroesophageal reflux disease (GERD) and for all other indications.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Lower esophageal sphincter augmentation devices",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Lower esophageal sphincter augmentation devices are considered investigational and not medically necessary for the treatment of gastroesophageal reflux disease (GERD) and for all other indications.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 947,
          "prompt_tokens": 856,
          "completion_tokens": 91,
          "total_cost": 0.005645,
          "processing_time": 1.6264750957489014
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_c117104.html",
    "subject": "Facet Joint Allograft Implants for Facet Disease",
    "document_number": "SURG.00114",
    "publish_date": "09/27/2023",
    "status": "Reviewed",
    "last_review_date": "08/10/2023",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>Allograft facet implants are considered <strong>investigational and not medically necessary </strong>for all indications.</p>",
    "content": "Investigational and Not Medically Necessary:\nAllograft facet implants are considered investigational and not medically necessary for all indications.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Allograft facet implants",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Allograft facet implants are considered investigational and not medically necessary for all indications.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 908,
          "prompt_tokens": 838,
          "completion_tokens": 70,
          "total_cost": 0.00524,
          "processing_time": 1.470073938369751
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_a053482.html",
    "subject": "Coblation\u00ae Therapies for Musculoskeletal Conditions",
    "document_number": "SURG.00088",
    "publish_date": "09/27/2023",
    "status": "Reviewed",
    "last_review_date": "08/10/2023",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>The use of Coblation technology is considered <strong>investigational and not medically necessary</strong> for the treatment of musculoskeletal conditions.</p>",
    "content": "Investigational and Not Medically Necessary:\nThe use of Coblation technology is considered investigational and not medically necessary for the treatment of musculoskeletal conditions.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Coblation technology",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "The use of Coblation technology is considered investigational and not medically necessary for the treatment of musculoskeletal conditions.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 916,
          "prompt_tokens": 843,
          "completion_tokens": 73,
          "total_cost": 0.00531,
          "processing_time": 1.6362450122833252
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_a053367.html",
    "subject": "Percutaneous and Endoscopic Spinal Surgery",
    "document_number": "SURG.00071",
    "publish_date": "09/27/2023",
    "status": "Reviewed",
    "last_review_date": "05/11/2023",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>Percutaneous or endoscopic spinal surgical techniques are considered <strong>investigational and not medically necessary.</strong></p>",
    "content": "Investigational and Not Medically Necessary:\nPercutaneous or endoscopic spinal surgical techniques are considered investigational and not medically necessary.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Percutaneous or endoscopic spinal surgical techniques",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Percutaneous or endoscopic spinal surgical techniques are considered investigational and not medically necessary.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 914,
          "prompt_tokens": 839,
          "completion_tokens": 75,
          "total_cost": 0.00532,
          "processing_time": 2.620758056640625
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_b094101.html",
    "subject": "Extraosseous Subtalar Joint Implantation and Subtalar Arthroereisis",
    "document_number": "SURG.00104",
    "publish_date": "09/27/2023",
    "status": "Reviewed",
    "last_review_date": "08/10/2023",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<li>Subtalar arthroereisis is considered <strong>investigational and not medically necessary </strong>for all indications, including but not limited to the treatment of flatfoot conditions, symptomatic flexible flatfoot deformity, and posterior tibial tendon dysfunction.</li>\n<li>Extraosseous subtalar joint implantation is considered <strong>investigational and not medically necessary </strong>for all indications, including but not limited to, talotarsal joint stabilization.</li>",
    "content": "Investigational and Not Medically Necessary:\n<li>Subtalar arthroereisis is considered investigational and not medically necessary for all indications, including but not limited to the treatment of flatfoot conditions, symptomatic flexible flatfoot deformity, and posterior tibial tendon dysfunction.</li>\n<li>Extraosseous subtalar joint implantation is considered investigational and not medically necessary for all indications, including but not limited to, talotarsal joint stabilization.</li>",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Subtalar arthroereisis",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Subtalar arthroereisis is considered investigational and not medically necessary for all indications, including but not limited to the treatment of flatfoot conditions, symptomatic flexible flatfoot deformity, and posterior tibial tendon dysfunction.",
            "conditions": null
          },
          {
            "medical_act": "Extraosseous subtalar joint implantation",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Extraosseous subtalar joint implantation is considered investigational and not medically necessary for all indications, including but not limited to, talotarsal joint stabilization.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 1091,
          "prompt_tokens": 906,
          "completion_tokens": 185,
          "total_cost": 0.007305,
          "processing_time": 2.8007969856262207
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_b098248.html",
    "subject": "Prostate Saturation Biopsy",
    "document_number": "SURG.00107",
    "publish_date": "09/27/2023",
    "status": "Reviewed",
    "last_review_date": "08/10/2023",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>Transrectal ultrasound-guided prostate saturation biopsy is considered <strong>investigational and</strong> <strong>not medically necessary.</strong></p>\n<p>Transperineal stereotactic template-guided prostate saturation biopsy is considered <strong>investigational and not medically necessary.</strong></p>",
    "content": "Investigational and Not Medically Necessary:\nTransrectal ultrasound-guided prostate saturation biopsy is considered investigational and not medically necessary.\nTransperineal stereotactic template-guided prostate saturation biopsy is considered investigational and not medically necessary.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Transrectal ultrasound-guided prostate saturation biopsy",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Transrectal ultrasound-guided prostate saturation biopsy is considered investigational and not medically necessary.",
            "conditions": null
          },
          {
            "medical_act": "Transperineal stereotactic template-guided prostate saturation biopsy",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Transperineal stereotactic template-guided prostate saturation biopsy is considered investigational and not medically necessary.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 1017,
          "prompt_tokens": 861,
          "completion_tokens": 156,
          "total_cost": 0.006645,
          "processing_time": 3.0714762210845947
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_a050188.html",
    "subject": "Mechanized Spinal Distraction Therapy",
    "document_number": "SURG.00008",
    "publish_date": "09/27/2023",
    "status": "Reviewed",
    "last_review_date": "08/10/2023",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>Use of mechanized spinal distraction therapy, including, but not limited to, the VAX-D<sup>\u00ae</sup> Therapeutic Table, the Decompression Reduction Stabilization DRS<sup>\u00ae</sup> System, and Accu-Spina System<sup>\u2122</sup> IDD Therapy, is considered <strong>investigational and not medically necessary </strong>for the treatment of low back pain or any other condition.</p>",
    "content": "Investigational and Not Medically Necessary:\nUse of mechanized spinal distraction therapy, including, but not limited to, the VAX-D<sup>\u00ae</sup> Therapeutic Table, the Decompression Reduction Stabilization DRS<sup>\u00ae</sup> System, and Accu-Spina System<sup>\u2122</sup> IDD Therapy, is considered investigational and not medically necessary for the treatment of low back pain or any other condition.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Mechanized Spinal Distraction Therapy",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Use of mechanized spinal distraction therapy, including, but not limited to, the VAX-D\u00ae Therapeutic Table, the Decompression Reduction Stabilization DRS\u00ae System, and Accu-Spina System\u2122 IDD Therapy, is considered investigational and not medically necessary for the treatment of low back pain or any other condition.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 1026,
          "prompt_tokens": 905,
          "completion_tokens": 121,
          "total_cost": 0.00634,
          "processing_time": 1.8852601051330566
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_a050256.html",
    "subject": "Transendoscopic Therapy for Gastroesophageal Reflux Disease, Dysphagia and Gastroparesis",
    "document_number": "SURG.00047",
    "publish_date": "09/27/2023",
    "status": "Reviewed",
    "last_review_date": "08/10/2023",
    "html_content": "<p><strong>Medically Necessary:</strong></p>\n<p>Peroral endoscopic myotomy (POEM) is considered <strong>medically necessary</strong> when all the following criteria are met:</p>\n<li>The individual is 18 years of age or older; <strong>and</strong></li>\n<li>Has a diagnosis of primary achalasia; <strong>and</strong></li>\n<li>POEM is being proposed as an alternative to pneumatic dilation or myotomy (open or laparoscopic); <strong>and</strong></li>\n<li>Eckardt symptom score is greater than 3;<strong> and</strong></li>\n<li>There is no history of previous open surgery of the stomach or esophagus.</li>\n<p><strong>Not Medically Necessary:</strong></p>\n<p>POEM is considered <strong>not</strong> <strong>medically necessary</strong> when the criteria above are not met, and for all other indications.</p>\n<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>The following transendoscopic treatments for gastroesophageal reflux disease, dysphagia and gastroparesis are considered <strong>investigational and not medically necessary </strong>for all indications:</p>\n<li>Endoluminal gastric plication;</li>\n<li>Endoscopic submucosal injection of bulking agents, beads or other substances;</li>\n<li>Gastric peroral endoscopic myotomy or peroral pyloromyotomy;</li>\n<li>Transendoscopic gastroplasty;</li>\n<li>Transesophageal radiofrequency therapy (<u>note</u>: this does NOT include treatment of Barrett\u2019s Esophagus with radiofrequency energy);</li>\n<li>Transoral incisionless fundoplication.</li>",
    "content": "Medically Necessary:\nPeroral endoscopic myotomy (POEM) is considered medically necessary when all the following criteria are met:\n<li>The individual is 18 years of age or older; and</li>\n<li>Has a diagnosis of primary achalasia; and</li>\n<li>POEM is being proposed as an alternative to pneumatic dilation or myotomy (open or laparoscopic); and</li>\n<li>Eckardt symptom score is greater than 3; and</li>\n<li>There is no history of previous open surgery of the stomach or esophagus.</li>\nNot Medically Necessary:\nPOEM is considered not medically necessary when the criteria above are not met, and for all other indications.\nInvestigational and Not Medically Necessary:\nThe following transendoscopic treatments for gastroesophageal reflux disease, dysphagia and gastroparesis are considered investigational and not medically necessary for all indications:\n<li>Endoluminal gastric plication;</li>\n<li>Endoscopic submucosal injection of bulking agents, beads or other substances;</li>\n<li>Gastric peroral endoscopic myotomy or peroral pyloromyotomy;</li>\n<li>Transendoscopic gastroplasty;</li>\n<li>Transesophageal radiofrequency therapy (<u>note</u>: this does NOT include treatment of Barrett\u2019s Esophagus with radiofrequency energy);</li>\n<li>Transoral incisionless fundoplication.</li>",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Peroral endoscopic myotomy (POEM)",
            "sub_medical_act": null,
            "necessity_type": "Medically Necessary",
            "description": "POEM is considered medically necessary when all the following criteria are met:",
            "conditions": {
              "ALL": [
                {
                  "desc": "The individual is 18 years of age or older",
                  "conditions": null
                },
                {
                  "desc": "Has a diagnosis of primary achalasia",
                  "conditions": null
                },
                {
                  "desc": "POEM is being proposed as an alternative to pneumatic dilation or myotomy (open or laparoscopic)",
                  "conditions": null
                },
                {
                  "desc": "Eckardt symptom score is greater than 3",
                  "conditions": null
                },
                {
                  "desc": "There is no history of previous open surgery of the stomach or esophagus",
                  "conditions": null
                }
              ]
            }
          },
          {
            "medical_act": "Peroral endoscopic myotomy (POEM)",
            "sub_medical_act": null,
            "necessity_type": "Not Medically Necessary",
            "description": "POEM is considered not medically necessary when the criteria above are not met, and for all other indications.",
            "conditions": null
          },
          {
            "medical_act": "Transendoscopic treatments for gastroesophageal reflux disease, dysphagia and gastroparesis",
            "sub_medical_act": "Endoluminal gastric plication",
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "The following transendoscopic treatments for gastroesophageal reflux disease, dysphagia and gastroparesis are considered investigational and not medically necessary for all indications:",
            "conditions": null
          },
          {
            "medical_act": "Transendoscopic treatments for gastroesophageal reflux disease, dysphagia and gastroparesis",
            "sub_medical_act": "Endoscopic submucosal injection of bulking agents, beads or other substances",
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "The following transendoscopic treatments for gastroesophageal reflux disease, dysphagia and gastroparesis are considered investigational and not medically necessary for all indications:",
            "conditions": null
          },
          {
            "medical_act": "Transendoscopic treatments for gastroesophageal reflux disease, dysphagia and gastroparesis",
            "sub_medical_act": "Gastric peroral endoscopic myotomy or peroral pyloromyotomy",
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "The following transendoscopic treatments for gastroesophageal reflux disease, dysphagia and gastroparesis are considered investigational and not medically necessary for all indications:",
            "conditions": null
          },
          {
            "medical_act": "Transendoscopic treatments for gastroesophageal reflux disease, dysphagia and gastroparesis",
            "sub_medical_act": "Transendoscopic gastroplasty",
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "The following transendoscopic treatments for gastroesophageal reflux disease, dysphagia and gastroparesis are considered investigational and not medically necessary for all indications:",
            "conditions": null
          },
          {
            "medical_act": "Transendoscopic treatments for gastroesophageal reflux disease, dysphagia and gastroparesis",
            "sub_medical_act": "Transesophageal radiofrequency therapy",
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "The following transendoscopic treatments for gastroesophageal reflux disease, dysphagia and gastroparesis are considered investigational and not medically necessary for all indications:",
            "conditions": null
          },
          {
            "medical_act": "Transendoscopic treatments for gastroesophageal reflux disease, dysphagia and gastroparesis",
            "sub_medical_act": "Transoral incisionless fundoplication",
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "The following transendoscopic treatments for gastroesophageal reflux disease, dysphagia and gastroparesis are considered investigational and not medically necessary for all indications:",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 2027,
          "prompt_tokens": 1108,
          "completion_tokens": 919,
          "total_cost": 0.019325000000000002,
          "processing_time": 16.38230609893799
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_a050503.html",
    "subject": "Oral, Pharyngeal and Maxillofacial Surgical Treatment for Obstructive Sleep Apnea or Snoring",
    "document_number": "SURG.00129",
    "publish_date": "09/27/2023",
    "status": "Revised",
    "last_review_date": "08/10/2023",
    "html_content": "<p><strong>Medically Necessary:</strong></p>\n<p><strong><em>Uvulopalatopharyngoplasty</em></strong><strong><em> (UPPP</em></strong><strong><em>):</em></strong></p>\n<p>Uvulopalatopharyngoplasty (UPPP) is considered <strong>medically necessary </strong>when <strong>all</strong> of the following criteria (A-D below) are met:</p>\n<li>Documented OSA with apnea hypopnea index (AHI) or respiratory disturbance index (RDI) meeting any of the following:\t<ol>\t\t<li>UPPP as <strong>sole</strong> procedure with AHI (or RDI) greater than 15 events per hour and less than 40 events per hour,<br>\t\t<strong>or</strong></li>\t\t<li>UPPP as <strong>sole</strong> procedure with AHI (or RDI) between 10-15 events per hour and <strong>one or more</strong> of the conditions listed below:\t\t<ol start=\"1\" style=\"list-style-type:lower-alpha\">\t\t\t<li>Hypertension; <strong>or</strong></li>\t\t\t<li>Cardiac arrhythmias predominately during sleep; <strong>or</strong></li>\t\t\t<li>Pulmonary hypertension; <strong>or</strong></li>\t\t\t<li>Documented ischemic heart disease; <strong>or</strong></li>\t\t\t<li>Impaired cognition or mood disorders; <strong>or</strong></li>\t\t\t<li>History of stroke; <strong>or</strong></li>\t\t\t<li>Excessive daytime sleepiness, as documented by either a score of greater than <strong>10</strong> on the Epworth Sleepiness Scale or inappropriate daytime napping, (for example, during driving, conversation or eating) or sleepiness that interferes with daily activities.<br>\t\t\t<strong>or</strong></li>\t\t</ol>\t\t</li>\t\t<li>UPPP as part of a <strong>planned staged</strong> or <strong>combined</strong> surgery aimed at also relieving retrolingual obstruction, (for example, genioglossal advancement, hyoid myotomy and suspension) with AHI (or RDI) greater than 15 events per hour,<br>\t\t<strong>or</strong></li>\t\t<li>UPPP as part of a <strong>planned staged</strong> or <strong>combined</strong> surgery aimed at also relieving retrolingual obstruction, (for example, genioglossal advancement, hyoid myotomy and suspension) with AHI (or RDI) between 10-15 events per hour and <strong>one or more</strong> of the conditions listed below:<sup> </sup>\t\t<ol start=\"1\" style=\"list-style-type:lower-alpha\">\t\t\t<li>Hypertension; <strong>or</strong></li>\t\t\t<li>Cardiac arrhythmias predominately during sleep; <strong>or</strong></li>\t\t\t<li>Pulmonary hypertension; <strong>or</strong></li>\t\t\t<li>Documented ischemic heart disease; <strong>or</strong></li>\t\t\t<li>Impaired cognition or mood disorders; <strong>or</strong></li>\t\t\t<li>History of stroke; <strong>or</strong></li>\t\t\t<li>Excessive daytime sleepiness, as documented by either a score of greater than <strong>10</strong> on the Epworth Sleepiness Scale or inappropriate daytime napping, (for example, during driving, conversation or eating) or sleepiness that interferes with daily activities.<br>\t\t\t<strong>and</strong></li>\t\t</ol>\t\t</li>\t</ol>\t</li>\n<li>UPPP as <strong>sole</strong> procedure with AHI (or RDI) greater than 15 events per hour and less than 40 events per hour,<br>\t\t<strong>or</strong></li>\n<li>UPPP as <strong>sole</strong> procedure with AHI (or RDI) between 10-15 events per hour and <strong>one or more</strong> of the conditions listed below:\t\t<ol start=\"1\" style=\"list-style-type:lower-alpha\">\t\t\t<li>Hypertension; <strong>or</strong></li>\t\t\t<li>Cardiac arrhythmias predominately during sleep; <strong>or</strong></li>\t\t\t<li>Pulmonary hypertension; <strong>or</strong></li>\t\t\t<li>Documented ischemic heart disease; <strong>or</strong></li>\t\t\t<li>Impaired cognition or mood disorders; <strong>or</strong></li>\t\t\t<li>History of stroke; <strong>or</strong></li>\t\t\t<li>Excessive daytime sleepiness, as documented by either a score of greater than <strong>10</strong> on the Epworth Sleepiness Scale or inappropriate daytime napping, (for example, during driving, conversation or eating) or sleepiness that interferes with daily activities.<br>\t\t\t<strong>or</strong></li>\t\t</ol>\t\t</li>\n<li>Hypertension; <strong>or</strong></li>\n<li>Cardiac arrhythmias predominately during sleep; <strong>or</strong></li>\n<li>Pulmonary hypertension; <strong>or</strong></li>\n<li>Documented ischemic heart disease; <strong>or</strong></li>\n<li>Impaired cognition or mood disorders; <strong>or</strong></li>\n<li>History of stroke; <strong>or</strong></li>\n<li>Excessive daytime sleepiness, as documented by either a score of greater than <strong>10</strong> on the Epworth Sleepiness Scale or inappropriate daytime napping, (for example, during driving, conversation or eating) or sleepiness that interferes with daily activities.<br>\t\t\t<strong>or</strong></li>\n<li>UPPP as part of a <strong>planned staged</strong> or <strong>combined</strong> surgery aimed at also relieving retrolingual obstruction, (for example, genioglossal advancement, hyoid myotomy and suspension) with AHI (or RDI) greater than 15 events per hour,<br>\t\t<strong>or</strong></li>\n<li>UPPP as part of a <strong>planned staged</strong> or <strong>combined</strong> surgery aimed at also relieving retrolingual obstruction, (for example, genioglossal advancement, hyoid myotomy and suspension) with AHI (or RDI) between 10-15 events per hour and <strong>one or more</strong> of the conditions listed below:<sup> </sup>\t\t<ol start=\"1\" style=\"list-style-type:lower-alpha\">\t\t\t<li>Hypertension; <strong>or</strong></li>\t\t\t<li>Cardiac arrhythmias predominately during sleep; <strong>or</strong></li>\t\t\t<li>Pulmonary hypertension; <strong>or</strong></li>\t\t\t<li>Documented ischemic heart disease; <strong>or</strong></li>\t\t\t<li>Impaired cognition or mood disorders; <strong>or</strong></li>\t\t\t<li>History of stroke; <strong>or</strong></li>\t\t\t<li>Excessive daytime sleepiness, as documented by either a score of greater than <strong>10</strong> on the Epworth Sleepiness Scale or inappropriate daytime napping, (for example, during driving, conversation or eating) or sleepiness that interferes with daily activities.<br>\t\t\t<strong>and</strong></li>\t\t</ol>\t\t</li>\n<li>Hypertension; <strong>or</strong></li>\n<li>Cardiac arrhythmias predominately during sleep; <strong>or</strong></li>\n<li>Pulmonary hypertension; <strong>or</strong></li>\n<li>Documented ischemic heart disease; <strong>or</strong></li>\n<li>Impaired cognition or mood disorders; <strong>or</strong></li>\n<li>History of stroke; <strong>or</strong></li>\n<li>Excessive daytime sleepiness, as documented by either a score of greater than <strong>10</strong> on the Epworth Sleepiness Scale or inappropriate daytime napping, (for example, during driving, conversation or eating) or sleepiness that interferes with daily activities.<br>\t\t\t<strong>and</strong></li>\n<li>Have failed treatment with CPAP as demonstrated by either of the following (1 or 2):\t<ol>\t\t<li>An AHI greater than 15 when using PAP therapy for greater than 4 hours each night on at least 70% of nights; <strong>or</strong></li>\t\t<li>Inability to tolerate CPAP despite adjustments over at least a 1 month period;<br>\t\t<strong>and</strong></li>\t</ol>\t</li>\n<li>An AHI greater than 15 when using PAP therapy for greater than 4 hours each night on at least 70% of nights; <strong>or</strong></li>\n<li>Inability to tolerate CPAP despite adjustments over at least a 1 month period;<br>\t\t<strong>and</strong></li>\n<li>Fiberoptic endoscopy suggests retro-palatal narrowing is the primary source of airway obstruction if UPPP is the <strong>sole</strong> procedure or a <strong>contributing </strong>source of airway obstruction if part of a planned staged or combined surgery aimed at also relieving retrolingual obstruction;<br>\t<strong>and</strong></li>\n<li>The individual is 18 years of age or older, or there is documentation that skeletal growth is complete based on long bone x-ray or serial cephalometrics showing no change in facial bone relationships for at least the last 3 consecutive months.</li>\n<p><strong><em>Soft Tissue Reconstruction:</em></strong></p>\n<p>Hyoid myotomy and suspension, with or without mandibular osteotomy with genioglossus (tongue) advancement, for the treatment of OSA is considered <strong>medically necessary</strong> when all of the following criteria (A-D below) are met:</p>\n<li>The treatment of OSA in the individual is <strong>medically necessary</strong> based on either 1) or 2) below:\t<ol>\t\t<li>AHI or RDI greater than or equal to 15 events per hour;<strong> </strong><br>\t\t<strong>or</strong></li>\t\t<li>AHI (or RDI) greater than or equal to 5 events per hour, and less than 15 events per hour with documentation demonstrating <strong>any</strong> of the following symptoms:\t\t<ol start=\"1\" style=\"list-style-type:lower-alpha\">\t\t\t<li>Excessive daytime sleepiness, as documented by either a score of greater than <strong>10</strong> on the Epworth Sleepiness scale or inappropriate daytime napping, (for example, during driving, conversation or eating) or sleepiness that interferes with daily activities; <strong>or </strong></li>\t\t\t<li>Impaired cognition or mood disorders; <strong>or</strong></li>\t\t\t<li>Hypertension; <strong>or</strong></li>\t\t\t<li>Ischemic heart disease or history of stroke; <strong>or</strong></li>\t\t\t<li>Cardiac arrhythmias, <strong>or</strong></li>\t\t\t<li>Pulmonary hypertension.<br>\t\t\t<strong>and</strong></li>\t\t</ol>\t\t</li>\t</ol>\t</li>\n<li>AHI or RDI greater than or equal to 15 events per hour;<strong> </strong><br>\t\t<strong>or</strong></li>\n<li>AHI (or RDI) greater than or equal to 5 events per hour, and less than 15 events per hour with documentation demonstrating <strong>any</strong> of the following symptoms:\t\t<ol start=\"1\" style=\"list-style-type:lower-alpha\">\t\t\t<li>Excessive daytime sleepiness, as documented by either a score of greater than <strong>10</strong> on the Epworth Sleepiness scale or inappropriate daytime napping, (for example, during driving, conversation or eating) or sleepiness that interferes with daily activities; <strong>or </strong></li>\t\t\t<li>Impaired cognition or mood disorders; <strong>or</strong></li>\t\t\t<li>Hypertension; <strong>or</strong></li>\t\t\t<li>Ischemic heart disease or history of stroke; <strong>or</strong></li>\t\t\t<li>Cardiac arrhythmias, <strong>or</strong></li>\t\t\t<li>Pulmonary hypertension.<br>\t\t\t<strong>and</strong></li>\t\t</ol>\t\t</li>\n<li>Excessive daytime sleepiness, as documented by either a score of greater than <strong>10</strong> on the Epworth Sleepiness scale or inappropriate daytime napping, (for example, during driving, conversation or eating) or sleepiness that interferes with daily activities; <strong>or </strong></li>\n<li>Impaired cognition or mood disorders; <strong>or</strong></li>\n<li>Hypertension; <strong>or</strong></li>\n<li>Ischemic heart disease or history of stroke; <strong>or</strong></li>\n<li>Cardiac arrhythmias, <strong>or</strong></li>\n<li>Pulmonary hypertension.<br>\t\t\t<strong>and</strong></li>\n<li>The individual has failed treatment with CPAP as demonstrated by either of the following (1 or 2):\t<ol>\t\t<li>An AHI greater than 15 when using PAP therapy for greater than 4 hours each night on at least 70% of nights; <strong>or</strong></li>\t\t<li>Inability to tolerate CPAP despite adjustments over at least a 1 month period;<br>\t\t<strong>and</strong></li>\t</ol>\t</li>\n<li>An AHI greater than 15 when using PAP therapy for greater than 4 hours each night on at least 70% of nights; <strong>or</strong></li>\n<li>Inability to tolerate CPAP despite adjustments over at least a 1 month period;<br>\t\t<strong>and</strong></li>\n<li>There are significant soft tissue and/or tongue base abnormalities with airway collapse. (Objective evidence of hypopharyngeal obstruction may be documented by either fiberoptic endoscopy or cephalometric radiographs.<br>\t<strong>and</strong></li>\n<li>The individual is 18 years of age or older, or there is documentation that skeletal growth is complete based on long bone x-ray or serial cephalometrics showing no change in facial bone relationships for at least the last 3 consecutive months.</li>\n<p><strong><em>Jaw Realignment Surgery:</em></strong></p>\n<p>Jaw realignment surgery (that is, maxillomandibular advancement) is considered <strong>medically necessary</strong> when all of the following criteria (A-D below) are met:</p>\n<li>The treatment of OSA in the individual is <strong>medically necessary</strong> based on either 1) or 2) below:\t<ol>\t\t<li>AHI or RDI greater than or equal to 15 events per hour;<strong> </strong><br>\t\t<strong>or</strong></li>\t\t<li>AHI (or RDI) greater than or equal to 5 events per hour, and less than 15 events per hour with documentation demonstrating <strong>any</strong> of the following symptoms:\t\t<ol start=\"1\" style=\"list-style-type:lower-alpha\">\t\t\t<li>Excessive daytime sleepiness, as documented by either a score of greater than <strong>10</strong> on the Epworth Sleepiness scale or inappropriate daytime napping, (for example, during driving, conversation or eating) or sleepiness that interferes with daily activities; <strong>or</strong></li>\t\t\t<li>Impaired cognition or mood disorders; <strong>or</strong></li>\t\t\t<li>Hypertension; <strong>or</strong></li>\t\t\t<li>Ischemic heart disease or history of stroke; <strong>or</strong></li>\t\t\t<li>Cardiac arrhythmias, <strong>or</strong></li>\t\t\t<li>Pulmonary hypertension.<br>\t\t\t<strong>and</strong></li>\t\t</ol>\t\t</li>\t</ol>\t</li>\n<li>AHI or RDI greater than or equal to 15 events per hour;<strong> </strong><br>\t\t<strong>or</strong></li>\n<li>AHI (or RDI) greater than or equal to 5 events per hour, and less than 15 events per hour with documentation demonstrating <strong>any</strong> of the following symptoms:\t\t<ol start=\"1\" style=\"list-style-type:lower-alpha\">\t\t\t<li>Excessive daytime sleepiness, as documented by either a score of greater than <strong>10</strong> on the Epworth Sleepiness scale or inappropriate daytime napping, (for example, during driving, conversation or eating) or sleepiness that interferes with daily activities; <strong>or</strong></li>\t\t\t<li>Impaired cognition or mood disorders; <strong>or</strong></li>\t\t\t<li>Hypertension; <strong>or</strong></li>\t\t\t<li>Ischemic heart disease or history of stroke; <strong>or</strong></li>\t\t\t<li>Cardiac arrhythmias, <strong>or</strong></li>\t\t\t<li>Pulmonary hypertension.<br>\t\t\t<strong>and</strong></li>\t\t</ol>\t\t</li>\n<li>Excessive daytime sleepiness, as documented by either a score of greater than <strong>10</strong> on the Epworth Sleepiness scale or inappropriate daytime napping, (for example, during driving, conversation or eating) or sleepiness that interferes with daily activities; <strong>or</strong></li>\n<li>Impaired cognition or mood disorders; <strong>or</strong></li>\n<li>Hypertension; <strong>or</strong></li>\n<li>Ischemic heart disease or history of stroke; <strong>or</strong></li>\n<li>Cardiac arrhythmias, <strong>or</strong></li>\n<li>Pulmonary hypertension.<br>\t\t\t<strong>and</strong></li>\n<li>The individual has failed treatment with CPAP as demonstrated by either of the following (1 or 2):\t<ol>\t\t<li>An AHI greater than 15 when using PAP therapy for greater than 4 hours each night on at least 70% of nights; <strong>or</strong></li>\t\t<li>Inability to tolerate CPAP despite adjustments over at least a 1 month period;<br>\t\t<strong>and</strong></li>\t</ol>\t</li>\n<li>An AHI greater than 15 when using PAP therapy for greater than 4 hours each night on at least 70% of nights; <strong>or</strong></li>\n<li>Inability to tolerate CPAP despite adjustments over at least a 1 month period;<br>\t\t<strong>and</strong></li>\n<li>The individual has failed surgical intervention with any of the following:\t<ol>\t\t<li>UPPP; <strong>or</strong></li>\t\t<li>Genioglossus advancement and/or hyoid myotomy with suspension; <strong>or</strong></li>\t\t<li>Both of these surgical procedures.<br>\t\t<strong>and</strong></li>\t</ol>\t</li>\n<li>UPPP; <strong>or</strong></li>\n<li>Genioglossus advancement and/or hyoid myotomy with suspension; <strong>or</strong></li>\n<li>Both of these surgical procedures.<br>\t\t<strong>and</strong></li>\n<li>The individual is 18 years of age or older, or there is documentation that skeletal growth is complete based on long bone x-ray or serial cephalometrics showing no change in facial bone relationships for at least the last 3 consecutive months.</li>\n<p>Jaw realignment surgery is also considered <strong>medically necessary </strong>for individuals with a documented severe jaw/facial bony abnormality that contributes to OSA, including, but not limited to, craniofacial abnormalities, micrognathia, retrognathia or small retro-positioned jaw with associated overbite and small mouth.</p>\n<p><strong>Note:</strong> Individuals undergoing jaw realignment surgery may also undergo orthodontic therapy. Orthodontic therapy (that is, placement of orthodontic brackets and wires) may not be a covered benefit under all member benefit plans.</p>\n<p><strong><em>Hypoglossal nerve stimulation</em></strong></p>\n<p>Hypoglossal nerve stimulation may be considered <strong>medically necessary</strong> when <strong>all </strong>of the following criteria (A-E below) are met:</p>\n<li>AHI or RDI greater than or equal to 15 events per hour and less than or equal to 65 events per hour; <strong>and</strong></li>\n<li>Central or mixed apneas make up less than 25% of total AHI or RDI score; <strong>and</strong></li>\n<li>Body Mass Index (BMI) of 32 or less; <strong>and</strong></li>\n<li>Absence of complete concentric collapse at the soft palate level during drug-induced sleep endoscopy; <strong>and</strong></li>\n<li>The individual has failed treatment with CPAP as demonstrated by either of the following (1 or 2):\t<ol>\t\t<li>An AHI greater than 15 when using PAP therapy for greater than 4 hours each night on at least 70% of nights; <strong>or</strong></li>\t\t<li>Inability to tolerate CPAP despite adjustments over at least a 1 month period.</li>\t</ol>\t</li>\n<li>An AHI greater than 15 when using PAP therapy for greater than 4 hours each night on at least 70% of nights; <strong>or</strong></li>\n<li>Inability to tolerate CPAP despite adjustments over at least a 1 month period.</li>\n<p>In addition to the general criteria above, hypoglossal nerve stimulation may be considered<strong> medically necessary </strong>to treat OSA for individuals with Down Syndrome when <strong>all</strong> of the following criteria are met:</p>\n<li>Individual is 10 years of age or older; <strong>and</strong></li>\n<li>AHI or RDI greater than or equal to 10 events per hour and less than or equal to 50 events per hour following adenotonsillectomy; <strong>and</strong></li>\n<li>Central or mixed apneas make up less than 25% of total AHI or RDI score; <strong>and</strong></li>\n<li>The individual\u2019s body mass falls within the following age-based range:\t<ol>\t\t<li>BMI less than or equal to the 95th percentile for individuals under age 18; <strong>or</strong></li>\t\t<li>BMI of 32 or less in individuals age 18 or over; <strong>and</strong></li>\t</ol>\t</li>\n<li>BMI less than or equal to the 95th percentile for individuals under age 18; <strong>or</strong></li>\n<li>BMI of 32 or less in individuals age 18 or over; <strong>and</strong></li>\n<li>Absence of complete concentric collapse at the soft palate level during drug-induced sleep endoscopy;<strong> and</strong></li>\n<li>Inadequate treatment as evidenced by <strong>one</strong> or more of the following:\t<ol>\t\t<li>Lack of benefit from positive airway pressure (PAP) treatment (for example, due to nonadherence, discomfort, undesirable side effects, or to persistent symptoms despite compliance), <strong>or </strong></li>\t\t<li>Tracheotomy use during sleep.</li>\t</ol>\t</li>\n<li>Lack of benefit from positive airway pressure (PAP) treatment (for example, due to nonadherence, discomfort, undesirable side effects, or to persistent symptoms despite compliance), <strong>or </strong></li>\n<li>Tracheotomy use during sleep.</li>\n<p><strong>Not Medically Necessary:</strong></p>\n<p>UPPP, soft tissue reconstruction, jaw realignment surgery, or hypoglossal nerve stimulation are considered <strong>not medically necessary</strong> when the criteria above are not met.</p>\n<p>The surgical treatment of snoring without OSA is considered <strong>not medically necessary </strong>in all cases.</p>\n<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>Other surgical treatments for OSA are considered <strong>investigational and not medically necessary</strong>.</p>",
    "content": "Medically Necessary:\nUvulopalatopharyngoplasty (UPPP):\nUvulopalatopharyngoplasty (UPPP) is considered medically necessary when all of the following criteria (A-D below) are met:\n<li>Documented OSA with apnea hypopnea index (AHI) or respiratory disturbance index (RDI) meeting any of the following:\t<ol> <li>UPPP as sole procedure with AHI (or RDI) greater than 15 events per hour and less than 40 events per hour,<br/> or</li> <li>UPPP as sole procedure with AHI (or RDI) between 10-15 events per hour and one or more of the conditions listed below:\t\t<ol start=\"1\" style=\"list-style-type:lower-alpha\"> <li>Hypertension; or</li> <li>Cardiac arrhythmias predominately during sleep; or</li> <li>Pulmonary hypertension; or</li> <li>Documented ischemic heart disease; or</li> <li>Impaired cognition or mood disorders; or</li> <li>History of stroke; or</li> <li>Excessive daytime sleepiness, as documented by either a score of greater than 10 on the Epworth Sleepiness Scale or inappropriate daytime napping, (for example, during driving, conversation or eating) or sleepiness that interferes with daily activities.<br/> or</li> </ol> </li> <li>UPPP as part of a planned staged or combined surgery aimed at also relieving retrolingual obstruction, (for example, genioglossal advancement, hyoid myotomy and suspension) with AHI (or RDI) greater than 15 events per hour,<br/> or</li> <li>UPPP as part of a planned staged or combined surgery aimed at also relieving retrolingual obstruction, (for example, genioglossal advancement, hyoid myotomy and suspension) with AHI (or RDI) between 10-15 events per hour and one or more of the conditions listed below:<sup> </sup> <ol start=\"1\" style=\"list-style-type:lower-alpha\"> <li>Hypertension; or</li> <li>Cardiac arrhythmias predominately during sleep; or</li> <li>Pulmonary hypertension; or</li> <li>Documented ischemic heart disease; or</li> <li>Impaired cognition or mood disorders; or</li> <li>History of stroke; or</li> <li>Excessive daytime sleepiness, as documented by either a score of greater than 10 on the Epworth Sleepiness Scale or inappropriate daytime napping, (for example, during driving, conversation or eating) or sleepiness that interferes with daily activities.<br/> and</li> </ol> </li> </ol> </li>\n<li>UPPP as sole procedure with AHI (or RDI) greater than 15 events per hour and less than 40 events per hour,<br/> or</li>\n<li>UPPP as sole procedure with AHI (or RDI) between 10-15 events per hour and one or more of the conditions listed below:\t\t<ol start=\"1\" style=\"list-style-type:lower-alpha\"> <li>Hypertension; or</li> <li>Cardiac arrhythmias predominately during sleep; or</li> <li>Pulmonary hypertension; or</li> <li>Documented ischemic heart disease; or</li> <li>Impaired cognition or mood disorders; or</li> <li>History of stroke; or</li> <li>Excessive daytime sleepiness, as documented by either a score of greater than 10 on the Epworth Sleepiness Scale or inappropriate daytime napping, (for example, during driving, conversation or eating) or sleepiness that interferes with daily activities.<br/> or</li> </ol> </li>\n<li>Hypertension; or</li>\n<li>Cardiac arrhythmias predominately during sleep; or</li>\n<li>Pulmonary hypertension; or</li>\n<li>Documented ischemic heart disease; or</li>\n<li>Impaired cognition or mood disorders; or</li>\n<li>History of stroke; or</li>\n<li>Excessive daytime sleepiness, as documented by either a score of greater than 10 on the Epworth Sleepiness Scale or inappropriate daytime napping, (for example, during driving, conversation or eating) or sleepiness that interferes with daily activities.<br/> or</li>\n<li>UPPP as part of a planned staged or combined surgery aimed at also relieving retrolingual obstruction, (for example, genioglossal advancement, hyoid myotomy and suspension) with AHI (or RDI) greater than 15 events per hour,<br/> or</li>\n<li>UPPP as part of a planned staged or combined surgery aimed at also relieving retrolingual obstruction, (for example, genioglossal advancement, hyoid myotomy and suspension) with AHI (or RDI) between 10-15 events per hour and one or more of the conditions listed below:<sup> </sup> <ol start=\"1\" style=\"list-style-type:lower-alpha\"> <li>Hypertension; or</li> <li>Cardiac arrhythmias predominately during sleep; or</li> <li>Pulmonary hypertension; or</li> <li>Documented ischemic heart disease; or</li> <li>Impaired cognition or mood disorders; or</li> <li>History of stroke; or</li> <li>Excessive daytime sleepiness, as documented by either a score of greater than 10 on the Epworth Sleepiness Scale or inappropriate daytime napping, (for example, during driving, conversation or eating) or sleepiness that interferes with daily activities.<br/> and</li> </ol> </li>\n<li>Hypertension; or</li>\n<li>Cardiac arrhythmias predominately during sleep; or</li>\n<li>Pulmonary hypertension; or</li>\n<li>Documented ischemic heart disease; or</li>\n<li>Impaired cognition or mood disorders; or</li>\n<li>History of stroke; or</li>\n<li>Excessive daytime sleepiness, as documented by either a score of greater than 10 on the Epworth Sleepiness Scale or inappropriate daytime napping, (for example, during driving, conversation or eating) or sleepiness that interferes with daily activities.<br/> and</li>\n<li>Have failed treatment with CPAP as demonstrated by either of the following (1 or 2):\t<ol> <li>An AHI greater than 15 when using PAP therapy for greater than 4 hours each night on at least 70% of nights; or</li> <li>Inability to tolerate CPAP despite adjustments over at least a 1 month period;<br/> and</li> </ol> </li>\n<li>An AHI greater than 15 when using PAP therapy for greater than 4 hours each night on at least 70% of nights; or</li>\n<li>Inability to tolerate CPAP despite adjustments over at least a 1 month period;<br/> and</li>\n<li>Fiberoptic endoscopy suggests retro-palatal narrowing is the primary source of airway obstruction if UPPP is the sole procedure or a contributing source of airway obstruction if part of a planned staged or combined surgery aimed at also relieving retrolingual obstruction;<br/> and</li>\n<li>The individual is 18 years of age or older, or there is documentation that skeletal growth is complete based on long bone x-ray or serial cephalometrics showing no change in facial bone relationships for at least the last 3 consecutive months.</li>\nSoft Tissue Reconstruction:\nHyoid myotomy and suspension, with or without mandibular osteotomy with genioglossus (tongue) advancement, for the treatment of OSA is considered medically necessary when all of the following criteria (A-D below) are met:\n<li>The treatment of OSA in the individual is medically necessary based on either 1) or 2) below:\t<ol> <li>AHI or RDI greater than or equal to 15 events per hour; <br/> or</li> <li>AHI (or RDI) greater than or equal to 5 events per hour, and less than 15 events per hour with documentation demonstrating any of the following symptoms:\t\t<ol start=\"1\" style=\"list-style-type:lower-alpha\"> <li>Excessive daytime sleepiness, as documented by either a score of greater than 10 on the Epworth Sleepiness scale or inappropriate daytime napping, (for example, during driving, conversation or eating) or sleepiness that interferes with daily activities; or </li> <li>Impaired cognition or mood disorders; or</li> <li>Hypertension; or</li> <li>Ischemic heart disease or history of stroke; or</li> <li>Cardiac arrhythmias, or</li> <li>Pulmonary hypertension.<br/> and</li> </ol> </li> </ol> </li>\n<li>AHI or RDI greater than or equal to 15 events per hour; <br/> or</li>\n<li>AHI (or RDI) greater than or equal to 5 events per hour, and less than 15 events per hour with documentation demonstrating any of the following symptoms:\t\t<ol start=\"1\" style=\"list-style-type:lower-alpha\"> <li>Excessive daytime sleepiness, as documented by either a score of greater than 10 on the Epworth Sleepiness scale or inappropriate daytime napping, (for example, during driving, conversation or eating) or sleepiness that interferes with daily activities; or </li> <li>Impaired cognition or mood disorders; or</li> <li>Hypertension; or</li> <li>Ischemic heart disease or history of stroke; or</li> <li>Cardiac arrhythmias, or</li> <li>Pulmonary hypertension.<br/> and</li> </ol> </li>\n<li>Excessive daytime sleepiness, as documented by either a score of greater than 10 on the Epworth Sleepiness scale or inappropriate daytime napping, (for example, during driving, conversation or eating) or sleepiness that interferes with daily activities; or </li>\n<li>Impaired cognition or mood disorders; or</li>\n<li>Hypertension; or</li>\n<li>Ischemic heart disease or history of stroke; or</li>\n<li>Cardiac arrhythmias, or</li>\n<li>Pulmonary hypertension.<br/> and</li>\n<li>The individual has failed treatment with CPAP as demonstrated by either of the following (1 or 2):\t<ol> <li>An AHI greater than 15 when using PAP therapy for greater than 4 hours each night on at least 70% of nights; or</li> <li>Inability to tolerate CPAP despite adjustments over at least a 1 month period;<br/> and</li> </ol> </li>\n<li>An AHI greater than 15 when using PAP therapy for greater than 4 hours each night on at least 70% of nights; or</li>\n<li>Inability to tolerate CPAP despite adjustments over at least a 1 month period;<br/> and</li>\n<li>There are significant soft tissue and/or tongue base abnormalities with airway collapse. (Objective evidence of hypopharyngeal obstruction may be documented by either fiberoptic endoscopy or cephalometric radiographs.<br/> and</li>\n<li>The individual is 18 years of age or older, or there is documentation that skeletal growth is complete based on long bone x-ray or serial cephalometrics showing no change in facial bone relationships for at least the last 3 consecutive months.</li>\nJaw Realignment Surgery:\nJaw realignment surgery (that is, maxillomandibular advancement) is considered medically necessary when all of the following criteria (A-D below) are met:\n<li>The treatment of OSA in the individual is medically necessary based on either 1) or 2) below:\t<ol> <li>AHI or RDI greater than or equal to 15 events per hour; <br/> or</li> <li>AHI (or RDI) greater than or equal to 5 events per hour, and less than 15 events per hour with documentation demonstrating any of the following symptoms:\t\t<ol start=\"1\" style=\"list-style-type:lower-alpha\"> <li>Excessive daytime sleepiness, as documented by either a score of greater than 10 on the Epworth Sleepiness scale or inappropriate daytime napping, (for example, during driving, conversation or eating) or sleepiness that interferes with daily activities; or</li> <li>Impaired cognition or mood disorders; or</li> <li>Hypertension; or</li> <li>Ischemic heart disease or history of stroke; or</li> <li>Cardiac arrhythmias, or</li> <li>Pulmonary hypertension.<br/> and</li> </ol> </li> </ol> </li>\n<li>AHI or RDI greater than or equal to 15 events per hour; <br/> or</li>\n<li>AHI (or RDI) greater than or equal to 5 events per hour, and less than 15 events per hour with documentation demonstrating any of the following symptoms:\t\t<ol start=\"1\" style=\"list-style-type:lower-alpha\"> <li>Excessive daytime sleepiness, as documented by either a score of greater than 10 on the Epworth Sleepiness scale or inappropriate daytime napping, (for example, during driving, conversation or eating) or sleepiness that interferes with daily activities; or</li> <li>Impaired cognition or mood disorders; or</li> <li>Hypertension; or</li> <li>Ischemic heart disease or history of stroke; or</li> <li>Cardiac arrhythmias, or</li> <li>Pulmonary hypertension.<br/> and</li> </ol> </li>\n<li>Excessive daytime sleepiness, as documented by either a score of greater than 10 on the Epworth Sleepiness scale or inappropriate daytime napping, (for example, during driving, conversation or eating) or sleepiness that interferes with daily activities; or</li>\n<li>Impaired cognition or mood disorders; or</li>\n<li>Hypertension; or</li>\n<li>Ischemic heart disease or history of stroke; or</li>\n<li>Cardiac arrhythmias, or</li>\n<li>Pulmonary hypertension.<br/> and</li>\n<li>The individual has failed treatment with CPAP as demonstrated by either of the following (1 or 2):\t<ol> <li>An AHI greater than 15 when using PAP therapy for greater than 4 hours each night on at least 70% of nights; or</li> <li>Inability to tolerate CPAP despite adjustments over at least a 1 month period;<br/> and</li> </ol> </li>\n<li>An AHI greater than 15 when using PAP therapy for greater than 4 hours each night on at least 70% of nights; or</li>\n<li>Inability to tolerate CPAP despite adjustments over at least a 1 month period;<br/> and</li>\n<li>The individual has failed surgical intervention with any of the following:\t<ol> <li>UPPP; or</li> <li>Genioglossus advancement and/or hyoid myotomy with suspension; or</li> <li>Both of these surgical procedures.<br/> and</li> </ol> </li>\n<li>UPPP; or</li>\n<li>Genioglossus advancement and/or hyoid myotomy with suspension; or</li>\n<li>Both of these surgical procedures.<br/> and</li>\n<li>The individual is 18 years of age or older, or there is documentation that skeletal growth is complete based on long bone x-ray or serial cephalometrics showing no change in facial bone relationships for at least the last 3 consecutive months.</li>\nJaw realignment surgery is also considered medically necessary for individuals with a documented severe jaw/facial bony abnormality that contributes to OSA, including, but not limited to, craniofacial abnormalities, micrognathia, retrognathia or small retro-positioned jaw with associated overbite and small mouth.\nNote: Individuals undergoing jaw realignment surgery may also undergo orthodontic therapy. Orthodontic therapy (that is, placement of orthodontic brackets and wires) may not be a covered benefit under all member benefit plans.\nHypoglossal nerve stimulation\nHypoglossal nerve stimulation may be considered medically necessary when all of the following criteria (A-E below) are met:\n<li>AHI or RDI greater than or equal to 15 events per hour and less than or equal to 65 events per hour; and</li>\n<li>Central or mixed apneas make up less than 25% of total AHI or RDI score; and</li>\n<li>Body Mass Index (BMI) of 32 or less; and</li>\n<li>Absence of complete concentric collapse at the soft palate level during drug-induced sleep endoscopy; and</li>\n<li>The individual has failed treatment with CPAP as demonstrated by either of the following (1 or 2):\t<ol> <li>An AHI greater than 15 when using PAP therapy for greater than 4 hours each night on at least 70% of nights; or</li> <li>Inability to tolerate CPAP despite adjustments over at least a 1 month period.</li> </ol> </li>\n<li>An AHI greater than 15 when using PAP therapy for greater than 4 hours each night on at least 70% of nights; or</li>\n<li>Inability to tolerate CPAP despite adjustments over at least a 1 month period.</li>\nIn addition to the general criteria above, hypoglossal nerve stimulation may be considered medically necessary to treat OSA for individuals with Down Syndrome when all of the following criteria are met:\n<li>Individual is 10 years of age or older; and</li>\n<li>AHI or RDI greater than or equal to 10 events per hour and less than or equal to 50 events per hour following adenotonsillectomy; and</li>\n<li>Central or mixed apneas make up less than 25% of total AHI or RDI score; and</li>\n<li>The individual\u2019s body mass falls within the following age-based range:\t<ol> <li>BMI less than or equal to the 95th percentile for individuals under age 18; or</li> <li>BMI of 32 or less in individuals age 18 or over; and</li> </ol> </li>\n<li>BMI less than or equal to the 95th percentile for individuals under age 18; or</li>\n<li>BMI of 32 or less in individuals age 18 or over; and</li>\n<li>Absence of complete concentric collapse at the soft palate level during drug-induced sleep endoscopy; and</li>\n<li>Inadequate treatment as evidenced by one or more of the following:\t<ol> <li>Lack of benefit from positive airway pressure (PAP) treatment (for example, due to nonadherence, discomfort, undesirable side effects, or to persistent symptoms despite compliance), or </li> <li>Tracheotomy use during sleep.</li> </ol> </li>\n<li>Lack of benefit from positive airway pressure (PAP) treatment (for example, due to nonadherence, discomfort, undesirable side effects, or to persistent symptoms despite compliance), or </li>\n<li>Tracheotomy use during sleep.</li>\nNot Medically Necessary:\nUPPP, soft tissue reconstruction, jaw realignment surgery, or hypoglossal nerve stimulation are considered not medically necessary when the criteria above are not met.\nThe surgical treatment of snoring without OSA is considered not medically necessary in all cases.\nInvestigational and Not Medically Necessary:\nOther surgical treatments for OSA are considered investigational and not medically necessary.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Uvulopalatopharyngoplasty (UPPP)",
            "sub_medical_act": null,
            "necessity_type": "Medically Necessary",
            "description": "Uvulopalatopharyngoplasty (UPPP) is considered medically necessary when all of the following criteria (A-D below) are met:",
            "conditions": {
              "ALL": [
                {
                  "desc": "Documented OSA with apnea hypopnea index (AHI) or respiratory disturbance index (RDI) meeting any of the following:",
                  "conditions": {
                    "ANY": [
                      {
                        "desc": "UPPP as sole procedure with AHI (or RDI) greater than 15 events per hour and less than 40 events per hour",
                        "conditions": null
                      },
                      {
                        "desc": "UPPP as sole procedure with AHI (or RDI) between 10-15 events per hour and one or more of the conditions listed below:",
                        "conditions": {
                          "ANY": [
                            {
                              "desc": "Hypertension",
                              "conditions": null
                            },
                            {
                              "desc": "Cardiac arrhythmias predominately during sleep",
                              "conditions": null
                            },
                            {
                              "desc": "Pulmonary hypertension",
                              "conditions": null
                            },
                            {
                              "desc": "Documented ischemic heart disease",
                              "conditions": null
                            },
                            {
                              "desc": "Impaired cognition or mood disorders",
                              "conditions": null
                            },
                            {
                              "desc": "History of stroke",
                              "conditions": null
                            },
                            {
                              "desc": "Excessive daytime sleepiness, as documented by either a score of greater than 10 on the Epworth Sleepiness Scale or inappropriate daytime napping, (for example, during driving, conversation or eating) or sleepiness that interferes with daily activities",
                              "conditions": null
                            }
                          ]
                        }
                      },
                      {
                        "desc": "UPPP as part of a planned staged or combined surgery aimed at also relieving retrolingual obstruction, (for example, genioglossal advancement, hyoid myotomy and suspension) with AHI (or RDI) greater than 15 events per hour",
                        "conditions": null
                      },
                      {
                        "desc": "UPPP as part of a planned staged or combined surgery aimed at also relieving retrolingual obstruction, (for example, genioglossal advancement, hyoid myotomy and suspension) with AHI (or RDI) between 10-15 events per hour and one or more of the conditions listed below:",
                        "conditions": {
                          "ANY": [
                            {
                              "desc": "Hypertension",
                              "conditions": null
                            },
                            {
                              "desc": "Cardiac arrhythmias predominately during sleep",
                              "conditions": null
                            },
                            {
                              "desc": "Pulmonary hypertension",
                              "conditions": null
                            },
                            {
                              "desc": "Documented ischemic heart disease",
                              "conditions": null
                            },
                            {
                              "desc": "Impaired cognition or mood disorders",
                              "conditions": null
                            },
                            {
                              "desc": "History of stroke",
                              "conditions": null
                            },
                            {
                              "desc": "Excessive daytime sleepiness, as documented by either a score of greater than 10 on the Epworth Sleepiness Scale or inappropriate daytime napping, (for example, during driving, conversation or eating) or sleepiness that interferes with daily activities",
                              "conditions": null
                            }
                          ]
                        }
                      }
                    ]
                  }
                },
                {
                  "desc": "Have failed treatment with CPAP as demonstrated by either of the following (1 or 2):",
                  "conditions": {
                    "ANY": [
                      {
                        "desc": "An AHI greater than 15 when using PAP therapy for greater than 4 hours each night on at least 70% of nights",
                        "conditions": null
                      },
                      {
                        "desc": "Inability to tolerate CPAP despite adjustments over at least a 1 month period",
                        "conditions": null
                      }
                    ]
                  }
                },
                {
                  "desc": "Fiberoptic endoscopy suggests retro-palatal narrowing is the primary source of airway obstruction if UPPP is the sole procedure or a contributing source of airway obstruction if part of a planned staged or combined surgery aimed at also relieving retrolingual obstruction",
                  "conditions": null
                },
                {
                  "desc": "The individual is 18 years of age or older, or there is documentation that skeletal growth is complete based on long bone x-ray or serial cephalometrics showing no change in facial bone relationships for at least the last 3 consecutive months",
                  "conditions": null
                }
              ]
            }
          },
          {
            "medical_act": "Soft Tissue Reconstruction",
            "sub_medical_act": null,
            "necessity_type": "Medically Necessary",
            "description": "Hyoid myotomy and suspension, with or without mandibular osteotomy with genioglossus (tongue) advancement, for the treatment of OSA is considered medically necessary when all of the following criteria (A-D below) are met:",
            "conditions": {
              "ALL": [
                {
                  "desc": "The treatment of OSA in the individual is medically necessary based on either 1) or 2) below:",
                  "conditions": {
                    "ANY": [
                      {
                        "desc": "AHI or RDI greater than or equal to 15 events per hour",
                        "conditions": null
                      },
                      {
                        "desc": "AHI (or RDI) greater than or equal to 5 events per hour, and less than 15 events per hour with documentation demonstrating any of the following symptoms:",
                        "conditions": {
                          "ANY": [
                            {
                              "desc": "Excessive daytime sleepiness, as documented by either a score of greater than 10 on the Epworth Sleepiness scale or inappropriate daytime napping, (for example, during driving, conversation or eating) or sleepiness that interferes with daily activities",
                              "conditions": null
                            },
                            {
                              "desc": "Impaired cognition or mood disorders",
                              "conditions": null
                            },
                            {
                              "desc": "Hypertension",
                              "conditions": null
                            },
                            {
                              "desc": "Ischemic heart disease or history of stroke",
                              "conditions": null
                            },
                            {
                              "desc": "Cardiac arrhythmias",
                              "conditions": null
                            },
                            {
                              "desc": "Pulmonary hypertension",
                              "conditions": null
                            }
                          ]
                        }
                      }
                    ]
                  }
                },
                {
                  "desc": "The individual has failed treatment with CPAP as demonstrated by either of the following (1 or 2):",
                  "conditions": {
                    "ANY": [
                      {
                        "desc": "An AHI greater than 15 when using PAP therapy for greater than 4 hours each night on at least 70% of nights",
                        "conditions": null
                      },
                      {
                        "desc": "Inability to tolerate CPAP despite adjustments over at least a 1 month period",
                        "conditions": null
                      }
                    ]
                  }
                },
                {
                  "desc": "There are significant soft tissue and/or tongue base abnormalities with airway collapse. (Objective evidence of hypopharyngeal obstruction may be documented by either fiberoptic endoscopy or cephalometric radiographs.",
                  "conditions": null
                },
                {
                  "desc": "The individual is 18 years of age or older, or there is documentation that skeletal growth is complete based on long bone x-ray or serial cephalometrics showing no change in facial bone relationships for at least the last 3 consecutive months",
                  "conditions": null
                }
              ]
            }
          },
          {
            "medical_act": "Jaw Realignment Surgery",
            "sub_medical_act": null,
            "necessity_type": "Medically Necessary",
            "description": "Jaw realignment surgery (that is, maxillomandibular advancement) is considered medically necessary when all of the following criteria (A-D below) are met:",
            "conditions": {
              "ALL": [
                {
                  "desc": "The treatment of OSA in the individual is medically necessary based on either 1) or 2) below:",
                  "conditions": {
                    "ANY": [
                      {
                        "desc": "AHI or RDI greater than or equal to 15 events per hour",
                        "conditions": null
                      },
                      {
                        "desc": "AHI (or RDI) greater than or equal to 5 events per hour, and less than 15 events per hour with documentation demonstrating any of the following symptoms:",
                        "conditions": {
                          "ANY": [
                            {
                              "desc": "Excessive daytime sleepiness, as documented by either a score of greater than 10 on the Epworth Sleepiness scale or inappropriate daytime napping, (for example, during driving, conversation or eating) or sleepiness that interferes with daily activities",
                              "conditions": null
                            },
                            {
                              "desc": "Impaired cognition or mood disorders",
                              "conditions": null
                            },
                            {
                              "desc": "Hypertension",
                              "conditions": null
                            },
                            {
                              "desc": "Ischemic heart disease or history of stroke",
                              "conditions": null
                            },
                            {
                              "desc": "Cardiac arrhythmias",
                              "conditions": null
                            },
                            {
                              "desc": "Pulmonary hypertension",
                              "conditions": null
                            }
                          ]
                        }
                      }
                    ]
                  }
                },
                {
                  "desc": "The individual has failed treatment with CPAP as demonstrated by either of the following (1 or 2):",
                  "conditions": {
                    "ANY": [
                      {
                        "desc": "An AHI greater than 15 when using PAP therapy for greater than 4 hours each night on at least 70% of nights",
                        "conditions": null
                      },
                      {
                        "desc": "Inability to tolerate CPAP despite adjustments over at least a 1 month period",
                        "conditions": null
                      }
                    ]
                  }
                },
                {
                  "desc": "The individual has failed surgical intervention with any of the following:",
                  "conditions": {
                    "ANY": [
                      {
                        "desc": "UPPP",
                        "conditions": null
                      },
                      {
                        "desc": "Genioglossus advancement and/or hyoid myotomy with suspension",
                        "conditions": null
                      },
                      {
                        "desc": "Both of these surgical procedures",
                        "conditions": null
                      }
                    ]
                  }
                },
                {
                  "desc": "The individual is 18 years of age or older, or there is documentation that skeletal growth is complete based on long bone x-ray or serial cephalometrics showing no change in facial bone relationships for at least the last 3 consecutive months",
                  "conditions": null
                }
              ]
            }
          },
          {
            "medical_act": "Jaw Realignment Surgery",
            "sub_medical_act": "Severe Jaw/Facial Bony Abnormality",
            "necessity_type": "Medically Necessary",
            "description": "Jaw realignment surgery is also considered medically necessary for individuals with a documented severe jaw/facial bony abnormality that contributes to OSA, including, but not limited to, craniofacial abnormalities, micrognathia, retrognathia or small retro-positioned jaw with associated overbite and small mouth.",
            "conditions": null
          },
          {
            "medical_act": "Hypoglossal Nerve Stimulation",
            "sub_medical_act": null,
            "necessity_type": "Medically Necessary",
            "description": "Hypoglossal nerve stimulation may be considered medically necessary when all of the following criteria (A-E below) are met:",
            "conditions": {
              "ALL": [
                {
                  "desc": "AHI or RDI greater than or equal to 15 events per hour and less than or equal to 65 events per hour",
                  "conditions": null
                },
                {
                  "desc": "Central or mixed apneas make up less than 25% of total AHI or RDI score",
                  "conditions": null
                },
                {
                  "desc": "Body Mass Index (BMI) of 32 or less",
                  "conditions": null
                },
                {
                  "desc": "Absence of complete concentric collapse at the soft palate level during drug-induced sleep endoscopy",
                  "conditions": null
                },
                {
                  "desc": "The individual has failed treatment with CPAP as demonstrated by either of the following (1 or 2):",
                  "conditions": {
                    "ANY": [
                      {
                        "desc": "An AHI greater than 15 when using PAP therapy for greater than 4 hours each night on at least 70% of nights",
                        "conditions": null
                      },
                      {
                        "desc": "Inability to tolerate CPAP despite adjustments over at least a 1 month period",
                        "conditions": null
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "medical_act": "Hypoglossal Nerve Stimulation",
            "sub_medical_act": "Down Syndrome",
            "necessity_type": "Medically Necessary",
            "description": "In addition to the general criteria above, hypoglossal nerve stimulation may be considered medically necessary to treat OSA for individuals with Down Syndrome when all of the following criteria are met:",
            "conditions": {
              "ALL": [
                {
                  "desc": "Individual is 10 years of age or older",
                  "conditions": null
                },
                {
                  "desc": "AHI or RDI greater than or equal to 10 events per hour and less than or equal to 50 events per hour following adenotonsillectomy",
                  "conditions": null
                },
                {
                  "desc": "Central or mixed apneas make up less than 25% of total AHI or RDI score",
                  "conditions": null
                },
                {
                  "desc": "The individual\u2019s body mass falls within the following age-based range:",
                  "conditions": {
                    "ANY": [
                      {
                        "desc": "BMI less than or equal to the 95th percentile for individuals under age 18",
                        "conditions": null
                      },
                      {
                        "desc": "BMI of 32 or less in individuals age 18 or over",
                        "conditions": null
                      }
                    ]
                  }
                },
                {
                  "desc": "Absence of complete concentric collapse at the soft palate level during drug-induced sleep endoscopy",
                  "conditions": null
                },
                {
                  "desc": "Inadequate treatment as evidenced by one or more of the following:",
                  "conditions": {
                    "ANY": [
                      {
                        "desc": "Lack of benefit from positive airway pressure (PAP) treatment (for example, due to nonadherence, discomfort, undesirable side effects, or to persistent symptoms despite compliance)",
                        "conditions": null
                      },
                      {
                        "desc": "Tracheotomy use during sleep",
                        "conditions": null
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "medical_act": "UPPP, soft tissue reconstruction, jaw realignment surgery, or hypoglossal nerve stimulation",
            "sub_medical_act": null,
            "necessity_type": "Not Medically Necessary",
            "description": "UPPP, soft tissue reconstruction, jaw realignment surgery, or hypoglossal nerve stimulation are considered not medically necessary when the criteria above are not met.",
            "conditions": null
          },
          {
            "medical_act": "Surgical treatment of snoring without OSA",
            "sub_medical_act": null,
            "necessity_type": "Not Medically Necessary",
            "description": "The surgical treatment of snoring without OSA is considered not medically necessary in all cases.",
            "conditions": null
          },
          {
            "medical_act": "Other surgical treatments for OSA",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Other surgical treatments for OSA are considered investigational and not medically necessary.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 8445,
          "prompt_tokens": 5141,
          "completion_tokens": 3304,
          "total_cost": 0.075265,
          "processing_time": 70.94756317138672
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_a053496.html",
    "subject": "Implanted Devices for Spinal Stenosis",
    "document_number": "SURG.00092",
    "publish_date": "09/27/2023",
    "status": "Reviewed",
    "last_review_date": "08/10/2023",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>Implanted devices for treatment of spinal stenosis are considered <strong>investigational and not medically necessary.</strong></p>",
    "content": "Investigational and Not Medically Necessary:\nImplanted devices for treatment of spinal stenosis are considered investigational and not medically necessary.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Implanted devices for treatment of spinal stenosis",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Implanted devices for treatment of spinal stenosis are considered investigational and not medically necessary.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 914,
          "prompt_tokens": 839,
          "completion_tokens": 75,
          "total_cost": 0.00532,
          "processing_time": 1.623643159866333
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_a053319.html",
    "subject": "Patent Foramen Ovale and Left Atrial Appendage Closure Devices for Stroke Prevention",
    "document_number": "SURG.00032",
    "publish_date": "09/27/2023",
    "status": "Revised",
    "last_review_date": "08/10/2023",
    "html_content": "<p><strong>Medically Necessary:</strong></p>\n<p>Transcatheter closure of a patent foramen ovale (PFO) using a U.S. Food and Drug Administration (FDA) approved device approved for that indication is considered <strong>medically necessary</strong> for:</p>\n<li>The prevention of subsequent stroke in individuals with a history of cryptogenic stroke who:\t<ol>\t\t<li>have failed conventional drug therapy (for example, warfarin); <strong>or</strong></li>\t\t<li>are not candidates for conventional drug therapy; <strong>or</strong></li>\t</ol>\t</li>\n<li>have failed conventional drug therapy (for example, warfarin); <strong>or</strong></li>\n<li>are not candidates for conventional drug therapy; <strong>or</strong></li>\n<li>Individuals 60 years old and younger with a history of cryptogenic stroke who have:\t<ol>\t\t<li>an atrial septal aneurysm; <strong>or</strong></li>\t\t<li>a large interatrial shunt (<em>see definition section</em>).</li>\t</ol>\t</li>\n<li>an atrial septal aneurysm; <strong>or</strong></li>\n<li>a large interatrial shunt (<em>see definition section</em>).</li>\n<p>Transcatheter closure of left atrial appendage (LAA) is considered <strong>medically necessary</strong> in individuals with non-valvular atrial fibrillation for the prevention of stroke when the following criteria are met:</p>\n<li>Individual is a candidate for long-term anticoagulation therapy based upon their estimated risk of stroke and other thromboembolic events; <strong>and</strong></li>\n<li>Individual is ineligible for long-term oral anticoagulation therapy (for example, a direct oral anticoagulant [apixaban, dabigatran, edoxaban, or rivaroxaban] or warfarin) due to the presence of contraindication(s) (for example, an increased risk of bleeding), but is expected to be able to tolerate short-term oral anticoagulation necessary for device implantation.</li>\n<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>Transcatheter closure of a patent foramen ovale for the prevention of stroke is considered <strong>investigational and not medically necessary</strong> when the<strong> </strong>criteria above are not met.</p>\n<p>Transcatheter closure of a left atrial appendage is considered <strong>investigational and not medically necessary </strong>when the criteria above are not met.</p>\n<p>Left atrial appendage closure via surgical (non-percutaneous) implantation of a device is considered <strong>investigational and not medically necessary</strong> for all indications.</p>",
    "content": "Medically Necessary:\nTranscatheter closure of a patent foramen ovale (PFO) using a U.S. Food and Drug Administration (FDA) approved device approved for that indication is considered medically necessary for:\n<li>The prevention of subsequent stroke in individuals with a history of cryptogenic stroke who:\t<ol> <li>have failed conventional drug therapy (for example, warfarin); or</li> <li>are not candidates for conventional drug therapy; or</li> </ol> </li>\n<li>have failed conventional drug therapy (for example, warfarin); or</li>\n<li>are not candidates for conventional drug therapy; or</li>\n<li>Individuals 60 years old and younger with a history of cryptogenic stroke who have:\t<ol> <li>an atrial septal aneurysm; or</li> <li>a large interatrial shunt (see definition section).</li> </ol> </li>\n<li>an atrial septal aneurysm; or</li>\n<li>a large interatrial shunt (see definition section).</li>\nTranscatheter closure of left atrial appendage (LAA) is considered medically necessary in individuals with non-valvular atrial fibrillation for the prevention of stroke when the following criteria are met:\n<li>Individual is a candidate for long-term anticoagulation therapy based upon their estimated risk of stroke and other thromboembolic events; and</li>\n<li>Individual is ineligible for long-term oral anticoagulation therapy (for example, a direct oral anticoagulant [apixaban, dabigatran, edoxaban, or rivaroxaban] or warfarin) due to the presence of contraindication(s) (for example, an increased risk of bleeding), but is expected to be able to tolerate short-term oral anticoagulation necessary for device implantation.</li>\nInvestigational and Not Medically Necessary:\nTranscatheter closure of a patent foramen ovale for the prevention of stroke is considered investigational and not medically necessary when the criteria above are not met.\nTranscatheter closure of a left atrial appendage is considered investigational and not medically necessary when the criteria above are not met.\nLeft atrial appendage closure via surgical (non-percutaneous) implantation of a device is considered investigational and not medically necessary for all indications.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Transcatheter closure of a patent foramen ovale (PFO)",
            "sub_medical_act": null,
            "necessity_type": "Medically Necessary",
            "description": "Transcatheter closure of a patent foramen ovale (PFO) using a U.S. Food and Drug Administration (FDA) approved device approved for that indication is considered medically necessary for:",
            "conditions": {
              "ANY": [
                {
                  "desc": "The prevention of subsequent stroke in individuals with a history of cryptogenic stroke who:",
                  "conditions": {
                    "ANY": [
                      {
                        "desc": "have failed conventional drug therapy (for example, warfarin)",
                        "conditions": null
                      },
                      {
                        "desc": "are not candidates for conventional drug therapy",
                        "conditions": null
                      }
                    ]
                  }
                },
                {
                  "desc": "have failed conventional drug therapy (for example, warfarin)",
                  "conditions": null
                },
                {
                  "desc": "are not candidates for conventional drug therapy",
                  "conditions": null
                },
                {
                  "desc": "Individuals 60 years old and younger with a history of cryptogenic stroke who have:",
                  "conditions": {
                    "ANY": [
                      {
                        "desc": "an atrial septal aneurysm",
                        "conditions": null
                      },
                      {
                        "desc": "a large interatrial shunt (see definition section)",
                        "conditions": null
                      }
                    ]
                  }
                },
                {
                  "desc": "an atrial septal aneurysm",
                  "conditions": null
                },
                {
                  "desc": "a large interatrial shunt (see definition section)",
                  "conditions": null
                }
              ]
            }
          },
          {
            "medical_act": "Transcatheter closure of left atrial appendage (LAA)",
            "sub_medical_act": null,
            "necessity_type": "Medically Necessary",
            "description": "Transcatheter closure of left atrial appendage (LAA) is considered medically necessary in individuals with non-valvular atrial fibrillation for the prevention of stroke when the following criteria are met:",
            "conditions": {
              "ALL": [
                {
                  "desc": "Individual is a candidate for long-term anticoagulation therapy based upon their estimated risk of stroke and other thromboembolic events",
                  "conditions": null
                },
                {
                  "desc": "Individual is ineligible for long-term oral anticoagulation therapy (for example, a direct oral anticoagulant [apixaban, dabigatran, edoxaban, or rivaroxaban] or warfarin) due to the presence of contraindication(s) (for example, an increased risk of bleeding), but is expected to be able to tolerate short-term oral anticoagulation necessary for device implantation",
                  "conditions": null
                }
              ]
            }
          },
          {
            "medical_act": "Transcatheter closure of a patent foramen ovale (PFO)",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Transcatheter closure of a patent foramen ovale for the prevention of stroke is considered investigational and not medically necessary when the criteria above are not met.",
            "conditions": null
          },
          {
            "medical_act": "Transcatheter closure of a left atrial appendage (LAA)",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Transcatheter closure of a left atrial appendage is considered investigational and not medically necessary when the criteria above are not met.",
            "conditions": null
          },
          {
            "medical_act": "Left atrial appendage closure via surgical (non-percutaneous) implantation of a device",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Left atrial appendage closure via surgical (non-percutaneous) implantation of a device is considered investigational and not medically necessary for all indications.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 2160,
          "prompt_tokens": 1298,
          "completion_tokens": 862,
          "total_cost": 0.01942,
          "processing_time": 17.720571994781494
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_a050274.html",
    "subject": "Nasal Valve Repair",
    "document_number": "SURG.00079",
    "publish_date": "09/27/2023",
    "status": "Reviewed",
    "last_review_date": "08/10/2023",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>Nasal valve suspension as a surgical technique for the repair of nasal valve collapse is considered <strong>investigational and not medically necessary.</strong></p>\n<p>Low-dose radiofrequency intranasal tissue remodeling as a treatment of nasal airway obstruction is considered <strong>investigational and not medically necessary</strong>.</p>\n<p>Use of an absorbable nasal implant to repair collapsed nasal wall tissue is considered <strong>investigational and not medically necessary</strong>.</p>",
    "content": "Investigational and Not Medically Necessary:\nNasal valve suspension as a surgical technique for the repair of nasal valve collapse is considered investigational and not medically necessary.\nLow-dose radiofrequency intranasal tissue remodeling as a treatment of nasal airway obstruction is considered investigational and not medically necessary.\nUse of an absorbable nasal implant to repair collapsed nasal wall tissue is considered investigational and not medically necessary.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Nasal valve suspension",
            "sub_medical_act": "surgical technique for the repair of nasal valve collapse",
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Nasal valve suspension as a surgical technique for the repair of nasal valve collapse is considered investigational and not medically necessary.",
            "conditions": null
          },
          {
            "medical_act": "Low-dose radiofrequency intranasal tissue remodeling",
            "sub_medical_act": "treatment of nasal airway obstruction",
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Low-dose radiofrequency intranasal tissue remodeling as a treatment of nasal airway obstruction is considered investigational and not medically necessary.",
            "conditions": null
          },
          {
            "medical_act": "Use of an absorbable nasal implant",
            "sub_medical_act": "repair collapsed nasal wall tissue",
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Use of an absorbable nasal implant to repair collapsed nasal wall tissue is considered investigational and not medically necessary.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 1144,
          "prompt_tokens": 892,
          "completion_tokens": 252,
          "total_cost": 0.00824,
          "processing_time": 4.638768911361694
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_d093234.html",
    "subject": "Cardiac Contractility Modulation Therapy",
    "document_number": "SURG.00153",
    "publish_date": "09/27/2023",
    "status": "Reviewed",
    "last_review_date": "08/10/2023",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>The use of cardiac contractility modulation therapy is considered <strong>investigational and not medically necessary </strong>for all indications, including but not limited to heart failure.</p>",
    "content": "Investigational and Not Medically Necessary:\nThe use of cardiac contractility modulation therapy is considered investigational and not medically necessary for all indications, including but not limited to heart failure.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Cardiac Contractility Modulation Therapy",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "The use of cardiac contractility modulation therapy is considered investigational and not medically necessary for all indications, including but not limited to heart failure.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 932,
          "prompt_tokens": 849,
          "completion_tokens": 83,
          "total_cost": 0.00549,
          "processing_time": 1.7991087436676025
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_e000641.html",
    "subject": "Implanted Artificial Iris Devices",
    "document_number": "SURG.00156",
    "publish_date": "09/27/2023",
    "status": "Reviewed",
    "last_review_date": "08/10/2023",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>The use of implanted artificial iris devices are considered <strong>investigational and not medically necessary </strong>for all indications, including as a treatment of congenital or traumatic aniridia.</p>",
    "content": "Investigational and Not Medically Necessary:\nThe use of implanted artificial iris devices are considered investigational and not medically necessary for all indications, including as a treatment of congenital or traumatic aniridia.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Implanted Artificial Iris Devices",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "The use of implanted artificial iris devices are considered investigational and not medically necessary for all indications, including as a treatment of congenital or traumatic aniridia.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 936,
          "prompt_tokens": 852,
          "completion_tokens": 84,
          "total_cost": 0.00552,
          "processing_time": 2.885127305984497
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_e000359.html",
    "subject": "Cryoneurolysis",
    "document_number": "SURG.00155",
    "publish_date": "06/28/2023",
    "status": "Reviewed",
    "last_review_date": "05/11/2023",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>Cryoneurolysis is considered <strong>investigational and not medically necessary</strong> for all indications, including treatment of peripheral nerve pain associated with osteoarthritis of the knee.</p>",
    "content": "Investigational and Not Medically Necessary:\nCryoneurolysis is considered investigational and not medically necessary for all indications, including treatment of peripheral nerve pain associated with osteoarthritis of the knee.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Cryoneurolysis",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Cryoneurolysis is considered investigational and not medically necessary for all indications, including treatment of peripheral nerve pain associated with osteoarthritis of the knee.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 933,
          "prompt_tokens": 851,
          "completion_tokens": 82,
          "total_cost": 0.005485,
          "processing_time": 1.5790657997131348
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_c108471.html",
    "subject": "Axial Lumbar Interbody Fusion",
    "document_number": "SURG.00111",
    "publish_date": "06/28/2023",
    "status": "Reviewed",
    "last_review_date": "05/11/2023",
    "html_content": "<p style=\"margin-right:-61px\"><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>Axial or presacral lumbar interbody fusion is considered <strong>investigational and not medically necessary.</strong></p>",
    "content": "Investigational and Not Medically Necessary:\nAxial or presacral lumbar interbody fusion is considered investigational and not medically necessary.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Axial or presacral lumbar interbody fusion",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Axial or presacral lumbar interbody fusion is considered investigational and not medically necessary.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 917,
          "prompt_tokens": 840,
          "completion_tokens": 77,
          "total_cost": 0.0053549999999999995,
          "processing_time": 1.678192138671875
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_c127954.html",
    "subject": "Bronchial Thermoplasty",
    "document_number": "SURG.00118",
    "publish_date": "06/28/2023",
    "status": "Reviewed",
    "last_review_date": "05/11/2023",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>Bronchial thermoplasty is considered <strong>investigational and not medically necessary</strong> for the treatment of asthma and all other conditions.</p>",
    "content": "Investigational and Not Medically Necessary:\nBronchial thermoplasty is considered investigational and not medically necessary for the treatment of asthma and all other conditions.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Bronchial thermoplasty",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Bronchial thermoplasty is considered investigational and not medically necessary for the treatment of asthma and all other conditions.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 920,
          "prompt_tokens": 844,
          "completion_tokens": 76,
          "total_cost": 0.00536,
          "processing_time": 1.534473180770874
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_c132778.html",
    "subject": "Internal Rib Fixation Systems",
    "document_number": "SURG.00120",
    "publish_date": "06/28/2023",
    "status": "Reviewed",
    "last_review_date": "05/11/2023",
    "html_content": "<p><strong>Medically Necessary:</strong></p>\n<p>The use of an internal rib fixation system is considered <strong>medically necessary</strong> for the open treatment of flail chest in individuals dependent (require &gt; 4 hours per day of positive pressure ventilation) on mechanical ventilation in the absence of other causes of ventilator dependency such as severe brain injury.</p>\n<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>The use of an internal rib fixation system is considered <strong>investigational and not medically necessary</strong> for all other indications.</p>",
    "content": "Medically Necessary:\nThe use of an internal rib fixation system is considered medically necessary for the open treatment of flail chest in individuals dependent (require &gt; 4 hours per day of positive pressure ventilation) on mechanical ventilation in the absence of other causes of ventilator dependency such as severe brain injury.\nInvestigational and Not Medically Necessary:\nThe use of an internal rib fixation system is considered investigational and not medically necessary for all other indications.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Use of an internal rib fixation system",
            "sub_medical_act": null,
            "necessity_type": "Medically Necessary",
            "description": "The use of an internal rib fixation system is considered medically necessary for the open treatment of flail chest in individuals dependent (require > 4 hours per day of positive pressure ventilation) on mechanical ventilation in the absence of other causes of ventilator dependency such as severe brain injury.",
            "conditions": {
              "ALL": [
                {
                  "desc": "Open treatment of flail chest",
                  "conditions": null
                },
                {
                  "desc": "Individuals dependent on mechanical ventilation (require > 4 hours per day of positive pressure ventilation)",
                  "conditions": null
                },
                {
                  "desc": "Absence of other causes of ventilator dependency such as severe brain injury",
                  "conditions": null
                }
              ]
            }
          },
          {
            "medical_act": "Use of an internal rib fixation system",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "The use of an internal rib fixation system is considered investigational and not medically necessary for all other indications.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 1176,
          "prompt_tokens": 903,
          "completion_tokens": 273,
          "total_cost": 0.00861,
          "processing_time": 4.6103479862213135
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_c183647.html",
    "subject": "Doppler-Guided Transanal Hemorrhoidal Dearterialization",
    "document_number": "SURG.00141",
    "publish_date": "06/28/2023",
    "status": "Reviewed",
    "last_review_date": "05/11/2023",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>Doppler-guided transanal hemorrhoidal dearterialization is considered <strong>investigational and not medically necessary.</strong></p>",
    "content": "Investigational and Not Medically Necessary:\nDoppler-guided transanal hemorrhoidal dearterialization is considered investigational and not medically necessary.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Doppler-guided transanal hemorrhoidal dearterialization",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Doppler-guided transanal hemorrhoidal dearterialization is considered investigational and not medically necessary.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 926,
          "prompt_tokens": 843,
          "completion_tokens": 83,
          "total_cost": 0.00546,
          "processing_time": 1.955260992050171
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_c123692.html",
    "subject": "High Resolution Anoscopy Screening for Anal Intraepithelial Neoplasia (AIN) and Squamous Cell Cancer of the Anus",
    "document_number": "SURG.00116",
    "publish_date": "06/28/2023",
    "status": "Reviewed",
    "last_review_date": "05/11/2023",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>High-resolution anoscopy (with or without brushings/biopsies) is considered <strong>investigational and not medically necessary</strong> as a screening test for anal dysplasia and cancer of the anus.</p>",
    "content": "Investigational and Not Medically Necessary:\nHigh-resolution anoscopy (with or without brushings/biopsies) is considered investigational and not medically necessary as a screening test for anal dysplasia and cancer of the anus.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "High-resolution anoscopy (with or without brushings/biopsies)",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "High-resolution anoscopy (with or without brushings/biopsies) is considered investigational and not medically necessary as a screening test for anal dysplasia and cancer of the anus.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 957,
          "prompt_tokens": 858,
          "completion_tokens": 99,
          "total_cost": 0.005775000000000001,
          "processing_time": 2.0830538272857666
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_c142347.html",
    "subject": "Radiofrequency and Pulsed Radiofrequency Treatment of Trigger Point Pain",
    "document_number": "SURG.00125",
    "publish_date": "06/28/2023",
    "status": "Reviewed",
    "last_review_date": "05/11/2023",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>Radiofrequency (RF) and pulsed radiofrequency (PRF) treatment of trigger points are considered <strong>investigational and</strong> <strong>not medically necessary.</strong></p>",
    "content": "Investigational and Not Medically Necessary:\nRadiofrequency (RF) and pulsed radiofrequency (PRF) treatment of trigger points are considered investigational and not medically necessary.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Radiofrequency (RF) and pulsed radiofrequency (PRF) treatment of trigger points",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Radiofrequency (RF) and pulsed radiofrequency (PRF) treatment of trigger points are considered investigational and not medically necessary.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 941,
          "prompt_tokens": 848,
          "completion_tokens": 93,
          "total_cost": 0.005634999999999999,
          "processing_time": 2.06612491607666
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_a053395.html",
    "subject": "Implantable Middle Ear Hearing Aids",
    "document_number": "SURG.00084",
    "publish_date": "06/28/2023",
    "status": "Reviewed",
    "last_review_date": "05/11/2023",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>Semi-implantable and fully implantable middle ear hearing aids are considered <strong>investigational and not medically necessary </strong>for all indications.</p>",
    "content": "Investigational and Not Medically Necessary:\nSemi-implantable and fully implantable middle ear hearing aids are considered investigational and not medically necessary for all indications.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Semi-implantable and fully implantable middle ear hearing aids",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Semi-implantable and fully implantable middle ear hearing aids are considered investigational and not medically necessary for all indications.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 929,
          "prompt_tokens": 845,
          "completion_tokens": 84,
          "total_cost": 0.005484999999999999,
          "processing_time": 1.528663158416748
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_c152783.html",
    "subject": "Interspinous Process Fixation Devices",
    "document_number": "SURG.00134",
    "publish_date": "06/28/2023",
    "status": "Reviewed",
    "last_review_date": "05/11/2023",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>Interspinous process fixation devices are considered <strong>investigational and not medically necessary </strong>for all indications.</p>",
    "content": "Investigational and Not Medically Necessary:\nInterspinous process fixation devices are considered investigational and not medically necessary for all indications.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Interspinous process fixation devices",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Interspinous process fixation devices are considered investigational and not medically necessary for all indications.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 911,
          "prompt_tokens": 839,
          "completion_tokens": 72,
          "total_cost": 0.005275,
          "processing_time": 1.5013408660888672
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_a053390.html",
    "subject": "Nerve Graft after Prostatectomy",
    "document_number": "SURG.00076",
    "publish_date": "06/28/2023",
    "status": "Reviewed",
    "last_review_date": "05/11/2023",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>Nerve grafting is considered <strong>investigational and not medically necessary</strong> after unilateral or bilateral resection of the neurovascular bundles as part of a radical prostatectomy.</p>",
    "content": "Investigational and Not Medically Necessary:\nNerve grafting is considered investigational and not medically necessary after unilateral or bilateral resection of the neurovascular bundles as part of a radical prostatectomy.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Nerve grafting",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Nerve grafting is considered investigational and not medically necessary after unilateral or bilateral resection of the neurovascular bundles as part of a radical prostatectomy.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 935,
          "prompt_tokens": 852,
          "completion_tokens": 83,
          "total_cost": 0.0055049999999999995,
          "processing_time": 1.8842570781707764
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_a053282.html",
    "subject": "Partial Left Ventriculectomy",
    "document_number": "SURG.00005",
    "publish_date": "06/28/2023",
    "status": "Reviewed",
    "last_review_date": "05/11/2023",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>Partial left ventriculectomy is considered <strong>investigational and not medically necessary </strong>in all cases.</p>\n<p>Other methods of remodeling or reshaping of the cardiac ventricles to reduce ventricle size with or without surgical removal, (for example, ventricular remodeling or reshaping procedures using ventricular wrapping [dynamic cardiomyoplasty], piercing, or clasping techniques) are considered <strong>investigational and not medically necessary </strong>in all cases.</p>",
    "content": "Investigational and Not Medically Necessary:\nPartial left ventriculectomy is considered investigational and not medically necessary in all cases.\nOther methods of remodeling or reshaping of the cardiac ventricles to reduce ventricle size with or without surgical removal, (for example, ventricular remodeling or reshaping procedures using ventricular wrapping [dynamic cardiomyoplasty], piercing, or clasping techniques) are considered investigational and not medically necessary in all cases.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Partial left ventriculectomy",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Partial left ventriculectomy is considered investigational and not medically necessary in all cases.",
            "conditions": null
          },
          {
            "medical_act": "Other methods of remodeling or reshaping of the cardiac ventricles to reduce ventricle size",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Other methods of remodeling or reshaping of the cardiac ventricles to reduce ventricle size with or without surgical removal, (for example, ventricular remodeling or reshaping procedures using ventricular wrapping [dynamic cardiomyoplasty], piercing, or clasping techniques) are considered investigational and not medically necessary in all cases.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 1099,
          "prompt_tokens": 901,
          "completion_tokens": 198,
          "total_cost": 0.007475000000000001,
          "processing_time": 3.478785991668701
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_e002375.html",
    "subject": "Nanoparticle-Mediated Thermal Ablation",
    "document_number": "SURG.00161",
    "publish_date": "06/28/2023",
    "status": "New",
    "last_review_date": "05/11/2023",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>Nanoparticle-mediated thermal ablation is considered <strong>investigational and not medically necessary</strong> for all indications.</p>",
    "content": "Investigational and Not Medically Necessary:\nNanoparticle-mediated thermal ablation is considered investigational and not medically necessary for all indications.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Nanoparticle-mediated thermal ablation",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Nanoparticle-mediated thermal ablation is considered investigational and not medically necessary for all indications.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 914,
          "prompt_tokens": 840,
          "completion_tokens": 74,
          "total_cost": 0.00531,
          "processing_time": 2.035431385040283
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_a053510.html",
    "subject": "Viscocanalostomy and Canaloplasty",
    "document_number": "SURG.00095",
    "publish_date": "06/28/2023",
    "status": "Reviewed",
    "last_review_date": "05/11/2023",
    "html_content": "<p><strong>Medically Necessary:</strong></p>\n<p>Canaloplasty is considered <strong>medically necessary</strong> for the treatment of mild to moderate primary open-angle glaucoma (POAG).</p>\n<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>Viscocanalostomy is considered <strong>investigational and not medically necessary</strong> for all indications, including but not limited to the treatment of primary open-angle glaucoma (POAG).</p>\n<p>Canaloplasty is considered <strong>investigational and not medically necessary</strong> for all other indications.</p>",
    "content": "Medically Necessary:\nCanaloplasty is considered medically necessary for the treatment of mild to moderate primary open-angle glaucoma (POAG).\nInvestigational and Not Medically Necessary:\nViscocanalostomy is considered investigational and not medically necessary for all indications, including but not limited to the treatment of primary open-angle glaucoma (POAG).\nCanaloplasty is considered investigational and not medically necessary for all other indications.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Canaloplasty",
            "sub_medical_act": null,
            "necessity_type": "Medically Necessary",
            "description": "Canaloplasty is considered medically necessary for the treatment of mild to moderate primary open-angle glaucoma (POAG).",
            "conditions": null
          },
          {
            "medical_act": "Viscocanalostomy",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Viscocanalostomy is considered investigational and not medically necessary for all indications, including but not limited to the treatment of primary open-angle glaucoma (POAG).",
            "conditions": null
          },
          {
            "medical_act": "Canaloplasty",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Canaloplasty is considered investigational and not medically necessary for all other indications.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 1119,
          "prompt_tokens": 897,
          "completion_tokens": 222,
          "total_cost": 0.007815,
          "processing_time": 4.536027908325195
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_a053310.html",
    "subject": "Transmyocardial Revascularization",
    "document_number": "SURG.00019",
    "publish_date": "06/28/2023",
    "status": "Reviewed",
    "last_review_date": "05/11/2023",
    "html_content": "<p><strong>Medically Necessary:</strong></p>\n<p>Open transmyocardial revascularization, also known as transmyocardial laser revascularization, is considered <strong>medically necessary</strong> for individuals with class III or class IV angina who are not candidates for coronary artery bypass graft surgery or percutaneous transluminal coronary angioplasty surgery who meet all of the following criteria:</p>\n<ul style=\"list-style-type:circle\">\t<li>Presence of class III or IV angina refractory to medical management; <strong>and</strong></li>\t<li>Documentation of reversible ischemia; <strong>and</strong></li>\t<li>Left ventricular ejection fraction greater than 30%; <strong>and</strong></li>\t<li>No evidence of recent myocardial infarction or unstable angina within the last 21 days; <strong>and</strong></li>\t<li>No severe comorbid illness such as chronic obstructive pulmonary disease.</li></ul>\n<li>Presence of class III or IV angina refractory to medical management; <strong>and</strong></li>\n<li>Documentation of reversible ischemia; <strong>and</strong></li>\n<li>Left ventricular ejection fraction greater than 30%; <strong>and</strong></li>\n<li>No evidence of recent myocardial infarction or unstable angina within the last 21 days; <strong>and</strong></li>\n<li>No severe comorbid illness such as chronic obstructive pulmonary disease.</li>\n<p>Open transmyocardial revascularization is considered <strong>medically necessary</strong> as an adjunct to coronary artery bypass graft in those individuals with documented areas of ischemic myocardium that are not amenable to surgical revascularization.</p>\n<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>Percutaneous myocardial revascularization is considered <strong>investigational and not medically necessary.</strong></p>\n<p>All other uses of transmyocardial revascularization are considered <strong>investigational and not medically necessary.</strong></p>",
    "content": "Medically Necessary:\nOpen transmyocardial revascularization, also known as transmyocardial laser revascularization, is considered medically necessary for individuals with class III or class IV angina who are not candidates for coronary artery bypass graft surgery or percutaneous transluminal coronary angioplasty surgery who meet all of the following criteria:\n<ul style=\"list-style-type:circle\"> <li>Presence of class III or IV angina refractory to medical management; and</li> <li>Documentation of reversible ischemia; and</li> <li>Left ventricular ejection fraction greater than 30%; and</li> <li>No evidence of recent myocardial infarction or unstable angina within the last 21 days; and</li> <li>No severe comorbid illness such as chronic obstructive pulmonary disease.</li></ul>\n<li>Presence of class III or IV angina refractory to medical management; and</li>\n<li>Documentation of reversible ischemia; and</li>\n<li>Left ventricular ejection fraction greater than 30%; and</li>\n<li>No evidence of recent myocardial infarction or unstable angina within the last 21 days; and</li>\n<li>No severe comorbid illness such as chronic obstructive pulmonary disease.</li>\nOpen transmyocardial revascularization is considered medically necessary as an adjunct to coronary artery bypass graft in those individuals with documented areas of ischemic myocardium that are not amenable to surgical revascularization.\nInvestigational and Not Medically Necessary:\nPercutaneous myocardial revascularization is considered investigational and not medically necessary.\nAll other uses of transmyocardial revascularization are considered investigational and not medically necessary.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Open transmyocardial revascularization (transmyocardial laser revascularization)",
            "sub_medical_act": null,
            "necessity_type": "Medically Necessary",
            "description": "Open transmyocardial revascularization, also known as transmyocardial laser revascularization, is considered medically necessary for individuals with class III or class IV angina who are not candidates for coronary artery bypass graft surgery or percutaneous transluminal coronary angioplasty surgery who meet all of the following criteria:",
            "conditions": {
              "ALL": [
                {
                  "desc": "Presence of class III or IV angina refractory to medical management",
                  "conditions": null
                },
                {
                  "desc": "Documentation of reversible ischemia",
                  "conditions": null
                },
                {
                  "desc": "Left ventricular ejection fraction greater than 30%",
                  "conditions": null
                },
                {
                  "desc": "No evidence of recent myocardial infarction or unstable angina within the last 21 days",
                  "conditions": null
                },
                {
                  "desc": "No severe comorbid illness such as chronic obstructive pulmonary disease",
                  "conditions": null
                }
              ]
            }
          },
          {
            "medical_act": "Open transmyocardial revascularization (transmyocardial laser revascularization)",
            "sub_medical_act": null,
            "necessity_type": "Medically Necessary",
            "description": "Open transmyocardial revascularization is considered medically necessary as an adjunct to coronary artery bypass graft in those individuals with documented areas of ischemic myocardium that are not amenable to surgical revascularization.",
            "conditions": null
          },
          {
            "medical_act": "Percutaneous myocardial revascularization",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Percutaneous myocardial revascularization is considered investigational and not medically necessary.",
            "conditions": null
          },
          {
            "medical_act": "Transmyocardial revascularization",
            "sub_medical_act": "All other uses",
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "All other uses of transmyocardial revascularization are considered investigational and not medically necessary.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 1650,
          "prompt_tokens": 1156,
          "completion_tokens": 494,
          "total_cost": 0.01319,
          "processing_time": 8.570822954177856
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_c195275.html",
    "subject": "Synthetic Cartilage Implant for Metatarsophalangeal Joint Disorders",
    "document_number": "SURG.00147",
    "publish_date": "06/28/2023",
    "status": "Reviewed",
    "last_review_date": "05/11/2023",
    "html_content": "<p><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>Use of a metatarsophalangeal synthetic cartilage implant (consisting of biocompatible, molded cylindrical hydrogel) is considered <strong>investigational and not medically necessary</strong> as a treatment for metatarsophalangeal joint disorders including but not limited to hallux limitus or hallux rigidus.</p>",
    "content": "Investigational and Not Medically Necessary:\nUse of a metatarsophalangeal synthetic cartilage implant (consisting of biocompatible, molded cylindrical hydrogel) is considered investigational and not medically necessary as a treatment for metatarsophalangeal joint disorders including but not limited to hallux limitus or hallux rigidus.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Use of a metatarsophalangeal synthetic cartilage implant",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Use of a metatarsophalangeal synthetic cartilage implant (consisting of biocompatible, molded cylindrical hydrogel) is considered investigational and not medically necessary as a treatment for metatarsophalangeal joint disorders including but not limited to hallux limitus or hallux rigidus.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 1008,
          "prompt_tokens": 884,
          "completion_tokens": 124,
          "total_cost": 0.00628,
          "processing_time": 2.824592113494873
        }
      }
    ]
  },
  {
    "url": "https://www.anthem.com/dam/medpolicies/abc/active/policies/mp_pw_c132780.html",
    "subject": "Transcatheter Heart Valve Procedures",
    "document_number": "SURG.00121",
    "publish_date": "05/25/2023",
    "status": "Revised",
    "last_review_date": "05/11/2023",
    "html_content": "<p><strong>Medically Necessary:</strong></p>\n<p><strong>Transcatheter Aortic Valve Replacement (TAVR):</strong></p>\n<p>TAVR using a U.S. Food and Drug Administration (FDA) approved device* is considered <strong>medically necessary</strong> when the following criteria have been met:</p>\n<li>The individual has severe degenerative, native valve aortic stenosis demonstrated by <strong>one</strong> of the following:\t<ol>\t\t<li>The aortic valve area (AVA) is equal to or less than 0.8 cm<sup>2</sup>; <strong>or</strong></li>\t\t<li>The AVA index is equal to or less than 0.5 cm<sup>2</sup>/m<sup>2</sup>; <strong>or</strong></li>\t\t<li>A mean aortic valve gradient of more than 40 mm Hg; <strong>or</strong></li>\t\t<li>A peak aortic-jet velocity of more than 4.0 m/sec; <strong>and</strong></li>\t</ol>\t</li>\n<li>The aortic valve area (AVA) is equal to or less than 0.8 cm<sup>2</sup>; <strong>or</strong></li>\n<li>The AVA index is equal to or less than 0.5 cm<sup>2</sup>/m<sup>2</sup>; <strong>or</strong></li>\n<li>A mean aortic valve gradient of more than 40 mm Hg; <strong>or</strong></li>\n<li>A peak aortic-jet velocity of more than 4.0 m/sec; <strong>and</strong></li>\n<li>Heart failure symptoms of New York Heart Association (NYHA) class II or greater; <strong>and</strong></li>\n<li>The individual is in <strong>one</strong> of the following categories:\t<ol>\t\t<li><em>Age 65 years or older with</em> <strong>any open surgical risk</strong>; <strong>or</strong></li>\t\t<li><em>Age younger than 65 with</em><strong> intermediate or greater open surgical risk</strong> (predicted risk of surgical mortality at 30 days greater than or equal to 3%) as determined by at least two physicians.</li>\t</ol>\t</li>\n<li><em>Age 65 years or older with</em> <strong>any open surgical risk</strong>; <strong>or</strong></li>\n<li><em>Age younger than 65 with</em><strong> intermediate or greater open surgical risk</strong> (predicted risk of surgical mortality at 30 days greater than or equal to 3%) as determined by at least two physicians.</li>\n<p>Valve-in-valve TAVR implantation using an FDA approved device* is considered <strong>medically necessary</strong> for treatment when the following criteria are met:</p>\n<li>The individual has failure (that is, stenosed, insufficient, or both) of previous open surgical bioprosthetic <em>aortic</em> valve; <strong>and </strong></li>\n<li>The individual is at high or greater risk for open surgical therapy (that is, Society of Thoracic Surgeons operative risk score greater than or equal to 8% or at a 15% or greater risk of operative mortality at 30 days) as determined by at least two physicians.</li>\n<p><strong>*Note: </strong>Please refer to background section of document for list of FDA approved transcatheter heart valve (THV) devices used for TAVR</p>\n<p><strong>Transcatheter Mitral Edge-to-Edge Repair:</strong></p>\n<p>Transcatheter mitral edge-to-edge repair/transcatheter mitral valve repair using an FDA approved device** is considered <strong>medically necessary</strong> when individual has <strong>one</strong> of the following conditions:</p>\n<li><strong><em>Chronic degenerative</em></strong><em> (<strong>primary) mitral regurgitation</strong></em> (<strong><em>MR)</em></strong> and meets <strong>all</strong> the following criteria;\t<ol>\t\t<li>Graded as moderate-to severe (3+ to 4+) MR; <strong>and</strong></li>\t\t<li>Severely symptomatic heart failure (NYHA class III or IV); <strong>and</strong></li>\t\t<li>Echocardiogram demonstrates that the primary regurgitant jet results from malcoaptation of the A2 and P2 scallops of the mitral valve; <strong>and</strong></li>\t\t<li>Prohibitive surgical risk for open surgical therapy (predicted risk of surgical mortality greater than or equal to 8% at 30 days) as determined by at least two physicians (Multidisciplinary Heart valve team);<br>\t\t<strong>or</strong></li>\t</ol>\t</li>\n<li>Graded as moderate-to severe (3+ to 4+) MR; <strong>and</strong></li>\n<li>Severely symptomatic heart failure (NYHA class III or IV); <strong>and</strong></li>\n<li>Echocardiogram demonstrates that the primary regurgitant jet results from malcoaptation of the A2 and P2 scallops of the mitral valve; <strong>and</strong></li>\n<li>Prohibitive surgical risk for open surgical therapy (predicted risk of surgical mortality greater than or equal to 8% at 30 days) as determined by at least two physicians (Multidisciplinary Heart valve team);<br>\t\t<strong>or</strong></li>\n<li><strong><em>Functional (secondary) MR</em></strong> and meets <strong>all </strong>the following criteria:\t<ol>\t\t<li>Graded as moderate-severe (3+ to 4+) MR; <strong>and</strong></li>\t\t<li>Severely symptomatic heart failure (NYHA class III or IV); <strong>and</strong></li>\t\t<li>Echocardiogram demonstrates that the primary regurgitant jet results from malcoaptation of the A2 and P2 scallops of the mitral valve; <strong>and</strong></li>\t\t<li>MR severity persist despite maximally tolerated guideline-directed medical therapy as determined by at least two physicians (Multidisciplinary Heart Team).</li>\t</ol>\t</li>\n<li>Graded as moderate-severe (3+ to 4+) MR; <strong>and</strong></li>\n<li>Severely symptomatic heart failure (NYHA class III or IV); <strong>and</strong></li>\n<li>Echocardiogram demonstrates that the primary regurgitant jet results from malcoaptation of the A2 and P2 scallops of the mitral valve; <strong>and</strong></li>\n<li>MR severity persist despite maximally tolerated guideline-directed medical therapy as determined by at least two physicians (Multidisciplinary Heart Team).</li>\n<p><strong>**Note:</strong> Please refer to background section of document for list of FDA approved transcatheter mitral valve repair devices.</p>\n<p><strong>Transcatheter Pulmonary Valve (TPV):</strong></p>\n<p>TPV implantation with an FDA approved device*** is considered <strong>medically necessary</strong> when the following criteria are met:</p>\n<li>Dysfunctional right ventricular outflow tract (RVOT) tract (native, patched or implanted conduit) with <strong>one</strong> of the following clinical indications for intervention:\t<ol>\t\t<li>moderate or greater pulmonic regurgitation; <strong>or</strong></li>\t\t<li>pulmonic stenosis with a<strong> </strong>mean RVOT gradient greater or equal to 35 mm Hg.</li>\t</ol>\t</li>\n<li>moderate or greater pulmonic regurgitation; <strong>or</strong></li>\n<li>pulmonic stenosis with a<strong> </strong>mean RVOT gradient greater or equal to 35 mm Hg.</li>\n<p style=\"text-align:justify\"><strong>***Note: </strong>Please refer to background section of document for list of FDA approved TPVs.</p>\n<p style=\"text-align:justify\"><strong>Not Medically Necessary:</strong></p>\n<p>Transcatheter (aortic, pulmonic, or valve-in-valve) valve replacement is considered<strong> not medically necessary</strong> when the criteria above are not met.</p>\n<p>Transcatheter mitral edge-to-edge repair/transcatheter mitral valve repair is considered <strong>not medically necessary</strong> for the treatment of primary or secondary (functional) MR when the criteria above are not met.</p>\n<p style=\"text-align:justify\"><strong>Investigational and Not Medically Necessary:</strong></p>\n<p>TAVR cerebral protection devices (for example, Sentinel<sup>\u2122</sup> Cerebral Protection System) are considered <strong>investigational and not medically necessary</strong> for all indications.</p>\n<p>Transcatheter mitral edge-to-edge repair/transcatheter mitral valve repair is considered <strong>investigational and not medically necessary</strong> for all other indications.</p>\n<p>Valve-in-valve transcatheter mitral valve replacement is considered <strong>investigational and not medically necessary</strong> for all indications.</p>\n<p>Transcatheter mitral valve repair using percutaneous annuloplasty (for example, CARILLON Mitral Contour System) is considered <strong>investigational and not medically necessary</strong> for all indications.</p>\n<p>Transcatheter tricuspid valve repair or replacement is considered <strong>investigational and not medically necessary</strong> for all indications.</p>",
    "content": "Medically Necessary:\nTranscatheter Aortic Valve Replacement (TAVR):\nTAVR using a U.S. Food and Drug Administration (FDA) approved device* is considered medically necessary when the following criteria have been met:\n<li>The individual has severe degenerative, native valve aortic stenosis demonstrated by one of the following:\t<ol> <li>The aortic valve area (AVA) is equal to or less than 0.8 cm<sup>2</sup>; or</li> <li>The AVA index is equal to or less than 0.5 cm<sup>2</sup>/m<sup>2</sup>; or</li> <li>A mean aortic valve gradient of more than 40 mm Hg; or</li> <li>A peak aortic-jet velocity of more than 4.0 m/sec; and</li> </ol> </li>\n<li>The aortic valve area (AVA) is equal to or less than 0.8 cm<sup>2</sup>; or</li>\n<li>The AVA index is equal to or less than 0.5 cm<sup>2</sup>/m<sup>2</sup>; or</li>\n<li>A mean aortic valve gradient of more than 40 mm Hg; or</li>\n<li>A peak aortic-jet velocity of more than 4.0 m/sec; and</li>\n<li>Heart failure symptoms of New York Heart Association (NYHA) class II or greater; and</li>\n<li>The individual is in one of the following categories:\t<ol> <li>Age 65 years or older with any open surgical risk; or</li> <li>Age younger than 65 with intermediate or greater open surgical risk (predicted risk of surgical mortality at 30 days greater than or equal to 3%) as determined by at least two physicians.</li> </ol> </li>\n<li>Age 65 years or older with any open surgical risk; or</li>\n<li>Age younger than 65 with intermediate or greater open surgical risk (predicted risk of surgical mortality at 30 days greater than or equal to 3%) as determined by at least two physicians.</li>\nValve-in-valve TAVR implantation using an FDA approved device* is considered medically necessary for treatment when the following criteria are met:\n<li>The individual has failure (that is, stenosed, insufficient, or both) of previous open surgical bioprosthetic aortic valve; and </li>\n<li>The individual is at high or greater risk for open surgical therapy (that is, Society of Thoracic Surgeons operative risk score greater than or equal to 8% or at a 15% or greater risk of operative mortality at 30 days) as determined by at least two physicians.</li>\n*Note: Please refer to background section of document for list of FDA approved transcatheter heart valve (THV) devices used for TAVR\nTranscatheter Mitral Edge-to-Edge Repair:\nTranscatheter mitral edge-to-edge repair/transcatheter mitral valve repair using an FDA approved device** is considered medically necessary when individual has one of the following conditions:\n<li>Chronic degenerative (primary) mitral regurgitation (MR) and meets all the following criteria;\t<ol> <li>Graded as moderate-to severe (3+ to 4+) MR; and</li> <li>Severely symptomatic heart failure (NYHA class III or IV); and</li> <li>Echocardiogram demonstrates that the primary regurgitant jet results from malcoaptation of the A2 and P2 scallops of the mitral valve; and</li> <li>Prohibitive surgical risk for open surgical therapy (predicted risk of surgical mortality greater than or equal to 8% at 30 days) as determined by at least two physicians (Multidisciplinary Heart valve team);<br/> or</li> </ol> </li>\n<li>Graded as moderate-to severe (3+ to 4+) MR; and</li>\n<li>Severely symptomatic heart failure (NYHA class III or IV); and</li>\n<li>Echocardiogram demonstrates that the primary regurgitant jet results from malcoaptation of the A2 and P2 scallops of the mitral valve; and</li>\n<li>Prohibitive surgical risk for open surgical therapy (predicted risk of surgical mortality greater than or equal to 8% at 30 days) as determined by at least two physicians (Multidisciplinary Heart valve team);<br/> or</li>\n<li>Functional (secondary) MR and meets all the following criteria:\t<ol> <li>Graded as moderate-severe (3+ to 4+) MR; and</li> <li>Severely symptomatic heart failure (NYHA class III or IV); and</li> <li>Echocardiogram demonstrates that the primary regurgitant jet results from malcoaptation of the A2 and P2 scallops of the mitral valve; and</li> <li>MR severity persist despite maximally tolerated guideline-directed medical therapy as determined by at least two physicians (Multidisciplinary Heart Team).</li> </ol> </li>\n<li>Graded as moderate-severe (3+ to 4+) MR; and</li>\n<li>Severely symptomatic heart failure (NYHA class III or IV); and</li>\n<li>Echocardiogram demonstrates that the primary regurgitant jet results from malcoaptation of the A2 and P2 scallops of the mitral valve; and</li>\n<li>MR severity persist despite maximally tolerated guideline-directed medical therapy as determined by at least two physicians (Multidisciplinary Heart Team).</li>\n**Note: Please refer to background section of document for list of FDA approved transcatheter mitral valve repair devices.\nTranscatheter Pulmonary Valve (TPV):\nTPV implantation with an FDA approved device*** is considered medically necessary when the following criteria are met:\n<li>Dysfunctional right ventricular outflow tract (RVOT) tract (native, patched or implanted conduit) with one of the following clinical indications for intervention:\t<ol> <li>moderate or greater pulmonic regurgitation; or</li> <li>pulmonic stenosis with a mean RVOT gradient greater or equal to 35 mm Hg.</li> </ol> </li>\n<li>moderate or greater pulmonic regurgitation; or</li>\n<li>pulmonic stenosis with a mean RVOT gradient greater or equal to 35 mm Hg.</li>\n***Note: Please refer to background section of document for list of FDA approved TPVs.\nNot Medically Necessary:\nTranscatheter (aortic, pulmonic, or valve-in-valve) valve replacement is considered not medically necessary when the criteria above are not met.\nTranscatheter mitral edge-to-edge repair/transcatheter mitral valve repair is considered not medically necessary for the treatment of primary or secondary (functional) MR when the criteria above are not met.\nInvestigational and Not Medically Necessary:\nTAVR cerebral protection devices (for example, Sentinel<sup>\u2122</sup> Cerebral Protection System) are considered investigational and not medically necessary for all indications.\nTranscatheter mitral edge-to-edge repair/transcatheter mitral valve repair is considered investigational and not medically necessary for all other indications.\nValve-in-valve transcatheter mitral valve replacement is considered investigational and not medically necessary for all indications.\nTranscatheter mitral valve repair using percutaneous annuloplasty (for example, CARILLON Mitral Contour System) is considered investigational and not medically necessary for all indications.\nTranscatheter tricuspid valve repair or replacement is considered investigational and not medically necessary for all indications.",
    "criteria": [
      {
        "model": "gpt-4o",
        "criteria": [
          {
            "medical_act": "Transcatheter Aortic Valve Replacement (TAVR)",
            "sub_medical_act": null,
            "necessity_type": "Medically Necessary",
            "description": "TAVR using a U.S. Food and Drug Administration (FDA) approved device* is considered medically necessary when the following criteria have been met:",
            "conditions": {
              "ALL": [
                {
                  "ANY": [
                    {
                      "desc": "The aortic valve area (AVA) is equal to or less than 0.8 cm\u00b2",
                      "conditions": null
                    },
                    {
                      "desc": "The AVA index is equal to or less than 0.5 cm\u00b2/m\u00b2",
                      "conditions": null
                    },
                    {
                      "desc": "A mean aortic valve gradient of more than 40 mm Hg",
                      "conditions": null
                    },
                    {
                      "desc": "A peak aortic-jet velocity of more than 4.0 m/sec",
                      "conditions": null
                    }
                  ]
                },
                {
                  "desc": "Heart failure symptoms of New York Heart Association (NYHA) class II or greater",
                  "conditions": null
                },
                {
                  "ANY": [
                    {
                      "desc": "Age 65 years or older with any open surgical risk",
                      "conditions": null
                    },
                    {
                      "desc": "Age younger than 65 with intermediate or greater open surgical risk (predicted risk of surgical mortality at 30 days greater than or equal to 3%) as determined by at least two physicians",
                      "conditions": null
                    }
                  ]
                }
              ]
            }
          },
          {
            "medical_act": "Valve-in-valve TAVR implantation",
            "sub_medical_act": null,
            "necessity_type": "Medically Necessary",
            "description": "Valve-in-valve TAVR implantation using an FDA approved device* is considered medically necessary for treatment when the following criteria are met:",
            "conditions": {
              "ALL": [
                {
                  "desc": "The individual has failure (that is, stenosed, insufficient, or both) of previous open surgical bioprosthetic aortic valve",
                  "conditions": null
                },
                {
                  "desc": "The individual is at high or greater risk for open surgical therapy (that is, Society of Thoracic Surgeons operative risk score greater than or equal to 8% or at a 15% or greater risk of operative mortality at 30 days) as determined by at least two physicians",
                  "conditions": null
                }
              ]
            }
          },
          {
            "medical_act": "Transcatheter Mitral Edge-to-Edge Repair",
            "sub_medical_act": null,
            "necessity_type": "Medically Necessary",
            "description": "Transcatheter mitral edge-to-edge repair/transcatheter mitral valve repair using an FDA approved device** is considered medically necessary when individual has one of the following conditions:",
            "conditions": {
              "ANY": [
                {
                  "ALL": [
                    {
                      "desc": "Chronic degenerative (primary) mitral regurgitation (MR) graded as moderate-to severe (3+ to 4+)",
                      "conditions": null
                    },
                    {
                      "desc": "Severely symptomatic heart failure (NYHA class III or IV)",
                      "conditions": null
                    },
                    {
                      "desc": "Echocardiogram demonstrates that the primary regurgitant jet results from malcoaptation of the A2 and P2 scallops of the mitral valve",
                      "conditions": null
                    },
                    {
                      "desc": "Prohibitive surgical risk for open surgical therapy (predicted risk of surgical mortality greater than or equal to 8% at 30 days) as determined by at least two physicians (Multidisciplinary Heart valve team)",
                      "conditions": null
                    }
                  ]
                },
                {
                  "ALL": [
                    {
                      "desc": "Functional (secondary) MR graded as moderate-severe (3+ to 4+)",
                      "conditions": null
                    },
                    {
                      "desc": "Severely symptomatic heart failure (NYHA class III or IV)",
                      "conditions": null
                    },
                    {
                      "desc": "Echocardiogram demonstrates that the primary regurgitant jet results from malcoaptation of the A2 and P2 scallops of the mitral valve",
                      "conditions": null
                    },
                    {
                      "desc": "MR severity persist despite maximally tolerated guideline-directed medical therapy as determined by at least two physicians (Multidisciplinary Heart Team)",
                      "conditions": null
                    }
                  ]
                }
              ]
            }
          },
          {
            "medical_act": "Transcatheter Pulmonary Valve (TPV)",
            "sub_medical_act": null,
            "necessity_type": "Medically Necessary",
            "description": "TPV implantation with an FDA approved device*** is considered medically necessary when the following criteria are met:",
            "conditions": {
              "ANY": [
                {
                  "desc": "Moderate or greater pulmonic regurgitation",
                  "conditions": null
                },
                {
                  "desc": "Pulmonic stenosis with a mean RVOT gradient greater or equal to 35 mm Hg",
                  "conditions": null
                }
              ]
            }
          },
          {
            "medical_act": "Transcatheter (aortic, pulmonic, or valve-in-valve) valve replacement",
            "sub_medical_act": null,
            "necessity_type": "Not Medically Necessary",
            "description": "Transcatheter (aortic, pulmonic, or valve-in-valve) valve replacement is considered not medically necessary when the criteria above are not met.",
            "conditions": null
          },
          {
            "medical_act": "Transcatheter mitral edge-to-edge repair/transcatheter mitral valve repair",
            "sub_medical_act": null,
            "necessity_type": "Not Medically Necessary",
            "description": "Transcatheter mitral edge-to-edge repair/transcatheter mitral valve repair is considered not medically necessary for the treatment of primary or secondary (functional) MR when the criteria above are not met.",
            "conditions": null
          },
          {
            "medical_act": "TAVR cerebral protection devices",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "TAVR cerebral protection devices (for example, Sentinel\u2122 Cerebral Protection System) are considered investigational and not medically necessary for all indications.",
            "conditions": null
          },
          {
            "medical_act": "Transcatheter mitral edge-to-edge repair/transcatheter mitral valve repair",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Transcatheter mitral edge-to-edge repair/transcatheter mitral valve repair is considered investigational and not medically necessary for all other indications.",
            "conditions": null
          },
          {
            "medical_act": "Valve-in-valve transcatheter mitral valve replacement",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Valve-in-valve transcatheter mitral valve replacement is considered investigational and not medically necessary for all indications.",
            "conditions": null
          },
          {
            "medical_act": "Transcatheter mitral valve repair using percutaneous annuloplasty",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Transcatheter mitral valve repair using percutaneous annuloplasty (for example, CARILLON Mitral Contour System) is considered investigational and not medically necessary for all indications.",
            "conditions": null
          },
          {
            "medical_act": "Transcatheter tricuspid valve repair or replacement",
            "sub_medical_act": null,
            "necessity_type": "Investigational and Not Medically Necessary",
            "description": "Transcatheter tricuspid valve repair or replacement is considered investigational and not medically necessary for all indications.",
            "conditions": null
          }
        ],
        "usage": {
          "total_tokens": 4135,
          "prompt_tokens": 2446,
          "completion_tokens": 1689,
          "total_cost": 0.037565,
          "processing_time": 31.760401010513306
        }
      }
    ]
  }
]